Page last updated: 2024-08-09 06:00:43
Bacterial Skin Diseases
Synonyms(1)
| Synonym |
|---|
| Bacterial Skin Diseases |
Research
Studies (1,284)
| Timeframe | Studies, This Condition (%) | All Conditions % |
|---|
| pre-1990 | 26 (2.02) | 23.3326 |
| 1990's | 170 (13.24) | 12.5806 |
| 2000's | 386 (30.06) | 18.1394 |
| 2010's | 551 (42.91) | 28.8240 |
| 2020's | 66 (5.14) | 9.53 |
| Drug | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|
| protocatechuic acid | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| aminolevulinic acid | 0 | | 2008 | 2020 | 9.2 | low | 1 | 0 | 0 | 1 | 3 | 0 |
| acetic acid | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| adenine | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| catechol | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| chlorine | 0 | | 2005 | 2011 | 16.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| salicylic acid | 0 | | 2005 | 2009 | 16.6 | low | 0 | 0 | 0 | 5 | 0 | 0 |
| gallic acid | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| octanoic acid | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| hydrogen sulfide | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| n(g),n(g')-dimethyl-l-arginine | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| phosphonoacetic acid | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| formaldehyde | 0 | | 1996 | 2004 | 24.7 | low | 2 | 0 | 2 | 1 | 0 | 0 |
| hydrogen | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| iodine | 0 | | 2010 | 2019 | 9.3 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| methanol | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| nickel | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| niacinamide | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| propylene glycol | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| pyrazinamide | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| urea | 0 | | 2002 | 2004 | 21.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
| 1-anilino-8-naphthalenesulfonate | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| azathioprine | 0 | | 2000 | 2018 | 13.3 | low | 0 | 0 | 1 | 0 | 2 | 0 |
| aztreonam | 0 | | 2005 | 2021 | 12.4 | low | 15 | 0 | 0 | 8 | 9 | 1 |
| benzothiazide | 0 | | 1997 | 2013 | 18.8 | low | 0 | 0 | 1 | 2 | 1 | 0 |
| cannabinol | 0 | | 2018 | 2018 | 6.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| cefuroxime | 0 | | 1999 | 2016 | 16.5 | low | 1 | 0 | 1 | 0 | 1 | 0 |
| cetirizine | 0 | | 2006 | 2006 | 18.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| chlorambucil | 0 | | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| chloroquine | 0 | | 1955 | 1955 | 69.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ciprofloxacin | 0 | | 1993 | 2020 | 18.5 | medium | 6 | 0 | 16 | 35 | 22 | 0 |
| clofazimine | 0 | | 2003 | 2012 | 15.2 | low | 1 | 0 | 0 | 3 | 2 | 0 |
| clonazepam | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| clotrimazole | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| dapsone | 0 | | 1951 | 2018 | 23.9 | low | 1 | 1 | 1 | 4 | 2 | 0 |
| diclofenac | 0 | | 2006 | 2007 | 17.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
| ethion | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| fleroxacin | 0 | | 1993 | 1993 | 31.0 | low | 4 | 0 | 5 | 0 | 0 | 0 |
| fluconazole | 0 | | 1992 | 2020 | 18.0 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| flucytosine | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| gentamicin | 0 | | 1995 | 2014 | 21.3 | low | 3 | 0 | 7 | 4 | 3 | 0 |
| glutaral | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| hexachlorophene | 0 | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ibuprofen | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| lidocaine | 0 | | 1996 | 1997 | 27.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| isoconazole | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 3 | 0 |
| isoflurane | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| isoniazid | 0 | | 2001 | 2017 | 15.3 | low | 0 | 0 | 0 | 5 | 1 | 0 |
| 2-propanol | 0 | | 2001 | 2004 | 22.0 | low | 0 | 0 | 0 | 3 | 0 | 0 |
| leflunomide | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| loratadine | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| methadone | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| methylphenidate | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| metronidazole | 0 | | 1995 | 2014 | 19.3 | low | 1 | 0 | 2 | 3 | 1 | 0 |
| miconazole | 0 | | 1995 | 2017 | 13.4 | low | 1 | 0 | 1 | 1 | 6 | 0 |
| nadifloxacin | 0 | | 1998 | 2016 | 18.0 | low | 0 | 0 | 1 | 1 | 1 | 0 |
| ofloxacin | 0 | | 1993 | 2019 | 22.5 | low | 5 | 0 | 11 | 9 | 2 | 0 |
| omeprazole | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| pamidronate | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| pentoxifylline | 0 | | 2012 | 2020 | 8.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| phenylbutazone | 0 | | 1959 | 1959 | 65.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| phloretin | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| potassium iodide | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| propofol | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| risperidone | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| sulfadiazine | 0 | | 1957 | 1957 | 67.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sulfamethizole | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| sulfamethoxazole | 0 | | 2001 | 2010 | 19.7 | low | 1 | 0 | 0 | 3 | 0 | 0 |
| sulfamethoxypyridazine | 0 | | 1960 | 1960 | 64.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sulfanilamide | 0 | | 1957 | 1960 | 65.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| suramin | 0 | | 1952 | 2002 | 47.0 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| gatifloxacin | 0 | | 2001 | 2001 | 23.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| thalidomide | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| tosufloxacin | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| triclosan | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| trimethoprim | 0 | | 1993 | 2017 | 17.5 | low | 1 | 0 | 1 | 3 | 2 | 0 |
| usnic acid | 0 | | 1955 | 1958 | 67.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| prednisolone | 0 | | 1993 | 2018 | 15.8 | low | 2 | 0 | 1 | 6 | 6 | 0 |
| prednisone | 0 | | 1993 | 2017 | 18.2 | low | 0 | 0 | 5 | 7 | 5 | 0 |
| penicillin g | 0 | | 1997 | 2019 | 15.3 | low | 1 | 0 | 3 | 9 | 9 | 0 |
| biguanides | 0 | | 2012 | 2013 | 11.5 | low | 1 | 0 | 0 | 0 | 2 | 0 |
| chloramphenicol | 0 | | 1952 | 2013 | 44.5 | low | 0 | 4 | 1 | 1 | 2 | 0 |
| aspartic acid | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| lysine | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| kanamycin a | 0 | | 2011 | 2015 | 11.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| galactose | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| carbostyril | 0 | | 1993 | 2016 | 20.3 | low | 0 | 0 | 3 | 2 | 2 | 0 |
| tyrosine | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| methicillin | 0 | | 1998 | 2022 | 13.8 | low | 0 | 0 | 1 | 3 | 4 | 1 |
| cloxacillin | 0 | | 1998 | 2014 | 20.5 | low | 0 | 0 | 2 | 1 | 1 | 0 |
| methylene blue | 0 | | 2015 | 2018 | 7.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| colchicine | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| oxacillin | 0 | | 1999 | 2011 | 19.8 | low | 3 | 0 | 2 | 3 | 1 | 0 |
| ampicillin | 0 | | 1992 | 2015 | 19.5 | low | 3 | 0 | 7 | 0 | 6 | 0 |
| cytarabine | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| arginine | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| triamcinolone acetonide | 0 | | 2006 | 2011 | 15.5 | low | 1 | 0 | 0 | 1 | 1 | 0 |
| linalool | 0 | | 2012 | 2012 | 12.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| methylprednisolone | 0 | | 2000 | 2019 | 12.7 | low | 0 | 0 | 1 | 2 | 3 | 0 |
| penicillin v | 0 | | 1999 | 2018 | 13.7 | low | 0 | 0 | 1 | 0 | 2 | 0 |
| penicillanic acid | 0 | | 1993 | 2018 | 17.1 | low | 8 | 0 | 2 | 6 | 6 | 0 |
| quinoxalines | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| benzoyl peroxide | 0 | | 2012 | 2021 | 8.7 | low | 2 | 0 | 0 | 0 | 2 | 1 |
| pentane | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| pyrroles | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| furan | 0 | | 1955 | 1955 | 69.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 1,5-pentanediol | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| framycetin | 0 | | 1953 | 2018 | 23.9 | low | 0 | 1 | 3 | 3 | 2 | 0 |
| catechin | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| oxazoles | 0 | | 2011 | 2021 | 8.2 | low | 10 | 0 | 0 | 0 | 33 | 3 |
| pyrimidine | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| opipramol | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| betamethasone | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| alpha-aminopyridine | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| hematoxylin | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| malondialdehyde | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| eosine yellowish-(ys) | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| violacein | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| gentian violet | 0 | | 1998 | 2019 | 13.2 | low | 0 | 0 | 1 | 1 | 3 | 0 |
| glycopyrrolate | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| acetylcysteine | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| c.i. 42510 | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| erythromycin | 0 | | 1953 | 2021 | 22.9 | low | 7 | 2 | 16 | 8 | 9 | 1 |
| ethambutol | 0 | | 1992 | 2019 | 18.5 | low | 0 | 0 | 10 | 7 | 9 | 0 |
| potassium hydroxide | 0 | | 2001 | 2017 | 15.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| zinc oxide | 0 | | 2021 | 2021 | 3.0 | low | 1 | 0 | 0 | 0 | 0 | 1 |
| vancomycin | 0 | | 1996 | 2022 | 11.8 | high | 40 | 0 | 3 | 31 | 58 | 3 |
| glycyrrhizic acid | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| tocopherols | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| spectinomycin | 0 | | 1995 | 1998 | 27.5 | low | 1 | 0 | 2 | 0 | 0 | 0 |
| dronabinol | 0 | | 2018 | 2018 | 6.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| betamethasone valerate | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| sulfadoxine | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| dicloxacillin | 0 | | 1993 | 2000 | 28.7 | low | 3 | 0 | 3 | 0 | 0 | 0 |
| streptomycin | 0 | | 2000 | 2018 | 18.5 | low | 1 | 0 | 1 | 4 | 1 | 0 |
| vantocil | 0 | | 2012 | 2013 | 11.5 | low | 1 | 0 | 0 | 0 | 2 | 0 |
| floxacillin | 0 | | 1993 | 2018 | 18.1 | low | 1 | 0 | 2 | 3 | 2 | 0 |
| vidarabine | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| manganese | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| mercury | 0 | | 1955 | 1955 | 69.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| molybdenum | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| silver | 0 | | 2005 | 2021 | 7.7 | low | 0 | 0 | 0 | 1 | 5 | 1 |
| technetium | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| gadolinium | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| aluminum chloride | 0 | | 2005 | 2011 | 16.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| hypochlorous acid | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| copper sulfate | 0 | | 2004 | 2004 | 20.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| ozone | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| aluminum sulfate | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| trolamine salicylate | 0 | | 1947 | 2015 | 32.3 | low | 0 | 2 | 1 | 2 | 1 | 0 |
| clodronic acid | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cephalexin | 0 | | 1993 | 2019 | 17.2 | low | 4 | 0 | 4 | 3 | 5 | 0 |
| triamcinolone | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cefazolin | 0 | | 1994 | 2018 | 15.9 | low | 3 | 0 | 3 | 0 | 6 | 0 |
| amoxicillin | 0 | | 1993 | 2021 | 18.5 | low | 5 | 0 | 8 | 7 | 7 | 1 |
| timolol | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| tramadol | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| enterobactin | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| tobramycin | 0 | | 2010 | 2019 | 10.7 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| paclitaxel | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| amitraz | 0 | | 2000 | 2006 | 22.0 | low | 0 | 0 | 2 | 1 | 0 | 0 |
| etoposide | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| substance p | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| ticarcillin | 0 | | 1993 | 1997 | 29.3 | low | 1 | 0 | 3 | 0 | 0 | 0 |
| amikacin | 0 | | 1992 | 2020 | 18.6 | low | 4 | 0 | 9 | 5 | 9 | 0 |
| permethrin | 0 | | 1993 | 2019 | 13.0 | low | 0 | 0 | 1 | 0 | 3 | 0 |
| cefmetazole | 0 | | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| propiconazole | 0 | | 2012 | 2021 | 7.5 | low | 0 | 0 | 0 | 0 | 1 | 1 |
| piperacillin | 0 | | 1993 | 2017 | 18.8 | low | 8 | 0 | 2 | 6 | 4 | 0 |
| cefoperazone | 0 | | 1997 | 2000 | 25.5 | low | 1 | 0 | 2 | 0 | 0 | 0 |
| cefadroxil anhydrous | 0 | | 1993 | 2003 | 27.7 | low | 3 | 0 | 2 | 1 | 0 | 0 |
| cefaclor anhydrous | 0 | | 1992 | 2019 | 26.0 | low | 1 | 0 | 4 | 0 | 1 | 0 |
| octenidine | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cefotetan | 0 | | 1993 | 1996 | 29.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| itraconazole | 0 | | 2008 | 2012 | 13.7 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| sparfloxacin | 0 | | 1999 | 2000 | 24.7 | low | 1 | 0 | 3 | 0 | 0 | 0 |
| marbofloxacin | 0 | | 2014 | 2019 | 7.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| trazodone hydrochloride | 0 | | 2023 | 2023 | 1.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| trovafloxacin | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| chloroquine diphosphate | 0 | | 1955 | 1955 | 69.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| trimethoprim sulfamethizole | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| trimethoprim, sulfadoxine drug combination | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| baicalin | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| hexamidine | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| metaperiodate | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| cephalosporin c | 0 | | 1993 | 2021 | 14.1 | high | 23 | 0 | 17 | 34 | 59 | 2 |
| fropenem | 0 | | 1997 | 2009 | 21.8 | low | 0 | 0 | 1 | 3 | 0 | 0 |
| fluorodeoxyglucose f18 | 0 | | 2012 | 2012 | 12.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| enrofloxacin | 0 | | 1993 | 2011 | 22.0 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| erythromycin propionate | 0 | | 1960 | 1960 | 64.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| voriconazole | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| grepafloxacin | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| doripenem | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| glycyl-histidyl-lysine | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| oxazolidin-2-one | 0 | | 2000 | 2022 | 13.5 | medium | 22 | 0 | 2 | 29 | 29 | 5 |
| 2-aminoimidazole | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| clarithromycin | 0 | | 1993 | 2022 | 17.2 | high | 5 | 0 | 24 | 30 | 30 | 2 |
| nsc-172755 | 0 | | 1994 | 2013 | 20.7 | low | 0 | 0 | 2 | 4 | 1 | 0 |
| fibrinogen | 0 | | 1997 | 2011 | 18.8 | low | 0 | 0 | 1 | 2 | 1 | 0 |
| diflucortolone valerate | 0 | | 2006 | 2013 | 13.3 | low | 1 | 0 | 0 | 1 | 2 | 0 |
| glycidyl nitrate | 0 | | 2013 | 2017 | 9.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| glucuronic acid | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| imipenem, anhydrous | 0 | | 1995 | 2020 | 19.2 | low | 3 | 0 | 4 | 4 | 2 | 0 |
| 1-hexadecyl-2-acetyl-glycero-3-phosphocholine | 0 | | 2012 | 2012 | 12.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| zinc coproporphyrin iii | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| clofarabine | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| caprylates | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| tazobactam | 0 | | 1993 | 2020 | 12.9 | low | 2 | 0 | 2 | 1 | 6 | 0 |
| aerobactin | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| n,n-dimethylarginine | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| garenoxacin | 0 | | 2002 | 2007 | 19.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
| methotrexate | 0 | | 2002 | 2014 | 14.7 | low | 0 | 0 | 0 | 2 | 4 | 0 |
| sulbactam | 0 | | 1992 | 2015 | 20.1 | low | 4 | 0 | 6 | 0 | 5 | 0 |
| travocort | 0 | | 2013 | 2013 | 11.0 | medium | 0 | 0 | 0 | 0 | 2 | 0 |
| carbapenems | 0 | | 1995 | 2019 | 13.8 | low | 1 | 0 | 1 | 3 | 7 | 0 |
| beta-lactams | 0 | | 1997 | 2012 | 19.5 | low | 7 | 0 | 3 | 18 | 1 | 0 |
| betamethasone-17,21-dipropionate | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| docetaxel anhydrous | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| levofloxacin | 0 | | 1997 | 2023 | 15.7 | low | 4 | 0 | 4 | 8 | 7 | 1 |
| ertapenem | 0 | | 2002 | 2009 | 20.1 | low | 7 | 0 | 0 | 9 | 0 | 0 |
| moxifloxacin | 0 | | 1997 | 2017 | 14.8 | low | 3 | 0 | 1 | 5 | 10 | 0 |
| methyl 5-aminolevulinate | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| paromomycin | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| iclaprim | 0 | | 2009 | 2019 | 8.4 | medium | 4 | 0 | 0 | 2 | 5 | 0 |
| sorafenib | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| lenalidomide | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| cholic acid | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cortisone | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| 3-nitrotyrosine | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| benzofurans | 0 | | 1955 | 1958 | 67.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| trimethoprim, sulfamethoxazole drug combination | 0 | | 1993 | 2020 | 15.5 | medium | 7 | 0 | 12 | 29 | 33 | 0 |
| povidone-iodine | 0 | | 1996 | 2015 | 19.7 | low | 1 | 0 | 1 | 1 | 1 | 0 |
| permanganate | 0 | | 1957 | 1957 | 67.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| n-acetylneuraminic acid | 0 | | 2004 | 2008 | 18.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
| fibrin | 0 | | 2011 | 2018 | 9.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| diaminopimelic acid | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| inositol 3-phosphate | 0 | | 1954 | 2018 | 29.7 | low | 0 | 1 | 0 | 0 | 2 | 0 |
| meropenem | 0 | | 1995 | 2021 | 13.6 | low | 4 | 0 | 1 | 5 | 7 | 1 |
| cefoxitin | 0 | | 1993 | 2016 | 21.4 | low | 2 | 0 | 3 | 1 | 1 | 0 |
| netilmicin | 0 | | 2000 | 2000 | 24.0 | low | 1 | 0 | 1 | 0 | 0 | 0 |
| linezolid | 0 | | 2000 | 2022 | 12.1 | high | 29 | 0 | 2 | 28 | 39 | 6 |
| sultamicillin | 0 | | 1992 | 2013 | 19.6 | low | 3 | 0 | 4 | 0 | 4 | 0 |
| tretinoin | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| resveratrol | 0 | | 2014 | 2017 | 8.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| retinol | 0 | | 2014 | 2019 | 7.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| tacrolimus | 0 | | 2001 | 2015 | 16.0 | low | 0 | 0 | 0 | 2 | 2 | 0 |
| cocaine | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| mycophenolic acid | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| mupirocin | 0 | | 1993 | 2019 | 17.5 | low | 2 | 0 | 6 | 8 | 6 | 0 |
| clindamycin | 0 | | 1995 | 2020 | 11.8 | low | 4 | 0 | 3 | 6 | 24 | 0 |
| fosfomycin | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| zithromax | 0 | | 1993 | 2021 | 16.6 | low | 3 | 0 | 5 | 3 | 6 | 1 |
| cyfluthrin | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| abt 492 | 0 | | 2015 | 2022 | 5.9 | high | 6 | 0 | 0 | 0 | 15 | 1 |
| potassium permanganate | 0 | | 1957 | 1957 | 67.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| bromochloroacetic acid | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| stilbenes | 0 | | 2014 | 2017 | 8.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| cannabidiol | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| buprenorphine | 0 | | 2009 | 2015 | 12.7 | low | 0 | 0 | 0 | 2 | 1 | 0 |
| fludarabine | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| urocanic acid | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| curcumin | 0 | | 2010 | 2022 | 6.3 | low | 0 | 0 | 0 | 1 | 0 | 2 |
| terbinafine | 0 | | 2012 | 2013 | 11.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| tamoxifen | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| fusidic acid | 0 | | 1996 | 2018 | 17.8 | low | 4 | 0 | 6 | 6 | 8 | 0 |
| lincomycin | 0 | | 1995 | 1995 | 29.0 | low | 1 | 0 | 1 | 0 | 0 | 0 |
| zinc oxide | 0 | | 1992 | 2017 | 16.0 | low | 1 | 0 | 1 | 0 | 2 | 0 |
| monooctanoin | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| quinine | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| isepamicin | 0 | | 1995 | 1995 | 29.0 | low | 3 | 0 | 3 | 0 | 0 | 0 |
| telavancin | 0 | | 2005 | 2015 | 14.4 | low | 4 | 0 | 0 | 9 | 3 | 0 |
| bilirubin | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cholecalciferol | 0 | | 2006 | 2014 | 14.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| genistein | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| amphotericin b | 0 | | 1998 | 2020 | 19.0 | low | 0 | 0 | 2 | 1 | 1 | 0 |
| clavulanic acid | 0 | | 1994 | 2015 | 15.8 | low | 1 | 0 | 1 | 1 | 2 | 0 |
| cefzil | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| baicalein | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| mycolactone | 0 | | 1999 | 2018 | 16.0 | low | 0 | 0 | 1 | 1 | 1 | 0 |
| miocamycin | 0 | | 1993 | 1993 | 31.0 | low | 1 | 0 | 1 | 0 | 0 | 0 |
| etretinate | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| isotretinoin | 0 | | 2005 | 2014 | 14.5 | low | 1 | 0 | 0 | 1 | 1 | 0 |
| s 1108 | 0 | | 1993 | 2014 | 21.3 | low | 0 | 0 | 1 | 1 | 1 | 0 |
| menaquinone 6 | 0 | | 2013 | 2017 | 9.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| phenylephrine hydrochloride | 0 | | 1998 | 2013 | 19.4 | low | 1 | 0 | 2 | 3 | 2 | 0 |
| vitamin mk 8 | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| bedaquiline | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cysteine | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| heroin | 0 | | 1994 | 2019 | 15.3 | low | 0 | 0 | 1 | 0 | 2 | 0 |
| ceftriaxone | 0 | | 2008 | 2008 | 16.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| cefepime | 0 | | 1996 | 2015 | 16.9 | low | 3 | 0 | 2 | 2 | 3 | 0 |
| hr 810 | 0 | | 1996 | 2015 | 18.5 | low | 1 | 0 | 1 | 0 | 1 | 0 |
| ceftazidime | 0 | | 2008 | 2008 | 16.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| cefotaxime | 0 | | 1994 | 2015 | 19.0 | low | 2 | 0 | 2 | 0 | 2 | 0 |
| selenium | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cefovecin | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| cilastatin | 0 | | 1995 | 2006 | 22.0 | low | 3 | 0 | 1 | 2 | 0 | 0 |
| brl 28500 | 0 | | 1993 | 1997 | 29.0 | low | 1 | 0 | 2 | 0 | 0 | 0 |
| cefpodoxime proxetil | 0 | | 1993 | 1996 | 29.5 | low | 1 | 0 | 2 | 0 | 0 | 0 |
| s-nitroso-n-acetylpenicillamine | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| sitafloxacin | 0 | | 2023 | 2023 | 1.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| retapamulin | 0 | | 2006 | 2009 | 16.5 | low | 0 | 0 | 0 | 6 | 0 | 0 |
| chlorhexidine | 0 | | 1996 | 2021 | 11.8 | low | 6 | 0 | 3 | 2 | 11 | 2 |
| pradofloxacin | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| amoxicillin-potassium clavulanate combination | 0 | | 1993 | 2023 | 17.4 | low | 6 | 0 | 7 | 8 | 9 | 1 |
| avibactam | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ppi-0903 | 0 | | 2009 | 2020 | 10.7 | high | 8 | 0 | 0 | 10 | 45 | 0 |
| ozenoxacin | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| mocetinostat | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cefditoren | 0 | | 1999 | 2009 | 21.2 | low | 0 | 0 | 1 | 3 | 0 | 0 |
| gentamicin sulfate | 0 | | 2008 | 2008 | 16.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| etimicin | 0 | | 2000 | 2000 | 24.0 | low | 1 | 0 | 1 | 0 | 0 | 0 |
| da-7867 | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| oxadiazoles | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| ribose | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| l 749345 | 0 | | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| tedizolid | 0 | | 2014 | 2022 | 5.7 | medium | 3 | 0 | 0 | 0 | 9 | 4 |
| buprenorphine, naloxone drug combination | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| nystatin a1 | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| nimbidiol | 0 | | 2010 | 2010 | 14.0 | high | 0 | 0 | 0 | 1 | 0 | 0 |
| tedizolid phosphate | 0 | | 2011 | 2021 | 8.2 | high | 10 | 0 | 0 | 0 | 27 | 2 |
| cefdinir | 0 | | 2004 | 2006 | 18.8 | low | 1 | 0 | 0 | 5 | 0 | 0 |
| ru 66647 | 0 | | 1998 | 2010 | 20.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| diflucortolone | 0 | | 2006 | 2013 | 12.4 | low | 1 | 0 | 0 | 1 | 4 | 0 |
| dextrothyroxine | 0 | | 2000 | 2019 | 14.0 | low | 0 | 0 | 2 | 1 | 3 | 0 |
| sepharose | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| pituitrin | 0 | | 2005 | 2005 | 19.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| virginiamycin | 0 | | 1996 | 2004 | 23.2 | low | 4 | 0 | 4 | 6 | 0 | 0 |
| nemonoxacin | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| rifamycins | 0 | | 1997 | 2005 | 23.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| clove | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| fluprednidene acetate | 0 | | 1995 | 1995 | 29.0 | medium | 1 | 0 | 1 | 0 | 0 | 0 |
| melitten | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| tannins | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| oritavancin | 0 | | 2005 | 2022 | 8.3 | high | 5 | 0 | 0 | 2 | 30 | 4 |
| pr 39 | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| cellulose | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| ceragenin csa-13 | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cilastatin, imipenem drug combination | 0 | | 1995 | 2006 | 22.0 | low | 3 | 0 | 1 | 2 | 0 | 0 |
| chitosan | 0 | | 2013 | 2021 | 5.4 | low | 0 | 0 | 0 | 0 | 5 | 2 |
| sy 5555 | 0 | | 1995 | 1995 | 29.0 | low | 1 | 0 | 1 | 0 | 0 | 0 |
| sodium hypochlorite | 0 | | 1994 | 2019 | 18.8 | low | 0 | 0 | 3 | 0 | 2 | 0 |
| ro13-9904 | 0 | | 2005 | 2021 | 11.2 | low | 1 | 0 | 0 | 3 | 4 | 1 |
| sodium ethylxanthate | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| piperacillin, tazobactam drug combination | 0 | | 2002 | 2017 | 15.9 | low | 6 | 0 | 0 | 5 | 4 | 0 |
| quinupristin | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| quinupristin-dalfopristin | 0 | | 1999 | 2004 | 22.3 | low | 2 | 0 | 2 | 5 | 0 | 0 |
| pci 32765 | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cardiovascular agents | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| bc-3781 | 0 | | 2015 | 2015 | 9.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| glycolipids | 0 | | 2000 | 2009 | 19.3 | low | 1 | 0 | 1 | 2 | 0 | 0 |
| piperidines | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| interleukin-8 | 0 | | 2002 | 2014 | 15.7 | low | 0 | 0 | 0 | 2 | 1 | 0 |
| tetracycline | 0 | | 1957 | 2021 | 30.9 | low | 0 | 3 | 1 | 1 | 3 | 1 |
| oxytetracycline, anhydrous | 0 | | 1954 | 2016 | 30.4 | low | 2 | 2 | 3 | 2 | 2 | 0 |
| minocycline | 0 | | 1993 | 2021 | 15.7 | high | 10 | 0 | 11 | 41 | 33 | 1 |
| tigecycline | 0 | | 2004 | 2019 | 13.9 | medium | 9 | 0 | 0 | 31 | 27 | 0 |
| omadacycline | 0 | | 2016 | 2023 | 4.1 | high | 3 | 0 | 0 | 0 | 10 | 7 |
| calca protein, human | 0 | | 2012 | 2014 | 11.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| clay | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| pyrethrins | 0 | | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| agar | 0 | | 2017 | 2018 | 6.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| illite | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| bassianolide | 0 | | 2000 | 2001 | 23.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| hyaluronoglucosaminidase | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| daptomycin | 0 | | 2004 | 2023 | 13.2 | medium | 3 | 0 | 0 | 21 | 18 | 1 |
| vitamin b 12 | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| moxidectin | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| dalfopristin | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| cyclosporine | 0 | | 2011 | 2014 | 11.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| muramidase | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| exudates | 0 | | 2005 | 2020 | 12.0 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| acyclovir | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| cyclic gmp | 0 | | 2009 | 2013 | 13.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| guanosine tetraphosphate | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| rifampin | 0 | | 1992 | 2022 | 16.7 | medium | 2 | 0 | 10 | 15 | 13 | 1 |
| ceftobiprole | 0 | | 2007 | 2021 | 12.0 | low | 4 | 0 | 0 | 7 | 2 | 2 |
| ceftobiprole medocaril | 0 | | 2008 | 2008 | 16.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
| bis(3',5')-cyclic diguanylic acid | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| lipoteichoic acid | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| eye | 0 | | 2004 | 2016 | 12.5 | low | 0 | 0 | 0 | 1 | 3 | 0 |
| concanavalin a | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Optimization of optical parameters for improved photodynamic therapy of Staphylococcus aureus using endogenous coproporphyrin III.Photodiagnosis and photodynamic therapy, , Volume: 29, 2020
ALA-PDT combined with antibiotics for the treatment of multiple skin abscesses caused by Mycobacterium fortuitum.Photodiagnosis and photodynamic therapy, , Volume: 15, 2016
A clinical study of photodynamic therapy for chronic skin ulcers in lower limbs infected with Pseudomonas aeruginosa.Archives of dermatological research, , Volume: 307, Issue:1, 2015
Antibacterial effect of photodynamic therapy on infected cutaneous neoplasias.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 22, Issue:10, 2008
Subgaleal abscess and E. coli septicemia following scalp electrode in a preterm newborn: a case report.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, , Volume: 22, Issue:12, 2009
[Cutaneous myiasis by Cochliomyia hominivorax (Coquerel) (Diptera Calliphoridae) in Hospital Universidad del Norte, Soledad, Atlántico].Biomedica : revista del Instituto Nacional de Salud, , Volume: 29, Issue:1, 2009
Rhodococcus equi subcutaneous abscess in a patient with acquired immunodeficiency syndrome.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 22, Issue:1, 2008
[Cylindromatosis].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 57, Issue:4, 2006
Superficial skin infection caused by Streptococcus pneumoniae in children.The Pediatric infectious disease journal, , Volume: 24, Issue:10, 2005
[Pyodermitis vegetans of the scalp and back].Bulletin de la Societe francaise de dermatologie et de syphiligraphie, , Volume: 59, Issue:3
Use of copper sulphate for the treatment of dermatophilosis ('brown spot' disease) in farmed crocodiles.Australian veterinary journal, , Volume: 82, Issue:9, 2004
A new application of BCG antibody for rapid screening of various tissue microorganisms.Journal of the American Academy of Dermatology, , Volume: 38, Issue:1, 1998
Chemotherapy of dermatophilosis--a preliminary study.Tropical animal health and production, , Volume: 28, Issue:2 Suppl, 1996
Dual role of iodine, silver, chlorhexidine and octenidine as antimicrobial and antiprotease agents.PloS one, , Volume: 14, Issue:1, 2019
Skin-Derived C-Terminal Filaggrin-2 Fragments Are Pseudomonas aeruginosa-Directed Antimicrobials Targeting Bacterial Replication.PLoS pathogens, , Volume: 11, Issue:9, 2015
Palmar and digital black pseudochromhidrosis: a case report.International journal of dermatology, , Volume: 49, Issue:5, 2010
Cutaneous nocardiosis by a new pathogenic species: BMJ case reports, , Jun-04, Volume: 2018, 2018
[Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α].Medicina clinica, , Feb-20, Volume: 142, Issue:4, 2014
Fatal disseminated Nocardia farcinica infection in a renal transplant recipient.Pediatric nephrology (Berlin, Germany), , Volume: 14, Issue:2, 2000
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 10-05, Volume: 73, Issue:7, 2021
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-16, Volume: 67, Issue:5, 2018
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.The Journal of antimicrobial chemotherapy, , Dec-01, Volume: 72, Issue:12, 2017
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbiditiesThe Journal of antimicrobial chemotherapy, , Volume: 71, Issue:12, 2016
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections].Deutsche medizinische Wochenschrift (1946), , Volume: 139 Suppl 3, 2014
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , Jun-15, Volume: 70, Issue:12, 2013
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:11, 2012
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:5, 2012
Early endpoints for acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:5, 2012
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, , Volume: 44, Issue:2, 2011
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-15, Volume: 51, Issue:6, 2010
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.Journal of chemotherapy (Florence, Italy), , Volume: 20 Suppl 1, 2008
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:11, 2005
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 9, Issue:5, 2005
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 41 Suppl 5, 2005
PTS phosphorylation of Mga modulates regulon expression and virulence in the group A streptococcus.Molecular microbiology, , Volume: 88, Issue:6, 2013
TrxR, a new CovR-repressed response regulator that activates the Mga virulence regulon in group A Streptococcus.Infection and immunity, , Volume: 76, Issue:10, 2008
Streptococcus pyogenes infection in mouse skin leads to a time-dependent up-regulation of protein H expression.Infection and immunity, , Volume: 71, Issue:10, 2003
Inactivation of single genes within the virulence regulon of an M2 group A streptococcal isolate result in differences in virulence for chicken embryos and for mice.Microbial pathogenesis, , Volume: 23, Issue:6, 1997
[Increase in methicillin-resistant and ciprofloxacin-susceptible Staphylococcus aureus in osteoarticular, skin and soft tissue infections].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, , Volume: 33, Issue:2, 2020
Suspected cutaneous anthrax in rural areas.Journal of infection in developing countries, , 02-28, Volume: 13, Issue:2, 2019
Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis.Diseases of aquatic organisms, , Mar-05, Volume: 127, Issue:3, 2018
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.European journal of medicinal chemistry, , Jul-15, Volume: 155, 2018
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.Annals of the Academy of Medicine, Singapore, , Volume: 45, Issue:10, 2016
A Child With Septic Shock and Purpura.JAMA pediatrics, , Volume: 170, Issue:4, 2016
Cutaneous anthrax: evaluation of 28 cases in the Eastern Anatolian region of Turkey.Cutaneous and ocular toxicology, , Volume: 35, Issue:3, 2016
Unusual cause of fatal anthrax meningitis.Cutaneous and ocular toxicology, , Volume: 34, Issue:1, 2015
Cutaneous anthrax in a school teacher.Mymensingh medical journal : MMJ, , Volume: 23, Issue:2, 2014
Charbon: a classical presentation.International journal of dermatology, , Volume: 53, Issue:7, 2014
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.Infection, , Volume: 41, Issue:2, 2013
A 50-year-old man with blistering skin lesions on both feet.BMJ case reports, , Nov-01, Volume: 2013, 2013
[Four cases of cutaneous anthrax in Diyarbakir, Turkey].Mikrobiyoloji bulteni, , Volume: 47, Issue:3, 2013
Field-based PCR for rapid diagnosis of cutaneous anthrax in the deployed setting using the joint biological agent identification and diagnostic system.Military medicine, , Volume: 178, Issue:8, 2013
Papulopustular eruption after holiday in a 44-year-old man. Whirlpool dermatitis (pseudomonas folliculitis).Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, , Volume: 11, Issue:8, 2013
Evaluation of cutaneous palpebral anthrax.Cutaneous and ocular toxicology, , Volume: 32, Issue:4, 2013
Recent outbreak of cutaneous anthrax in Bangladesh: clinico-demographic profile and treatment outcome of cases attended at Rajshahi Medical College Hospital.BMC research notes, , Aug-28, Volume: 5, 2012
Naturally occurring cutaneous anthrax: antibiotic treatment and outcome.Chemotherapy, , Volume: 58, Issue:1, 2012
Cavitary pneumonia and skin lesions.Respiratory care, , Volume: 57, Issue:3, 2012
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.Emerging infectious diseases, , Volume: 17, Issue:9, 2011
Primary cutaneous infection with Bacillus megaterium mimicking cutaneous anthrax.Journal of the American Academy of Dermatology, , Volume: 65, Issue:2, 2011
Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment.Transplant infectious disease : an official journal of the Transplantation Society, , Volume: 13, Issue:1, 2011
A review of cutaneous anthrax and its outcome.Journal of infection and public health, , Volume: 3, Issue:3, 2010
Ano-genital granulomatosis treated with ciprofloxacin.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 23, Issue:1, 2009
Characteristics of cutaneous anthrax in Turkey.Journal of infection in developing countries, , Sep-15, Volume: 3, Issue:8, 2009
Mesotherapy and cutaneous Mycobacterium fortuitum infection.International journal of dermatology, , Volume: 48, Issue:6, 2009
[Acute dermohypodermitis of the right leg (S. putrefaciens) after sea bathing].Annales de dermatologie et de venereologie, , Volume: 136, Issue:1, 2009
[Cutaneous anthrax: seven cases].Annales de dermatologie et de venereologie, , Volume: 136, Issue:1, 2009
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa.Journal of the American Academy of Dermatology, , Volume: 57, Issue:4, 2007
Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections.Cutis, , Volume: 79, Issue:5, 2007
Paederus dermatitis in Sierra Leone.Dermatology online journal, , Dec-10, Volume: 12, Issue:7, 2006
Cutaneous anthrax as an occupational disease in Central Anatolia, Turkey.Saudi medical journal, , Volume: 27, Issue:5, 2006
An unusually extensive case of cutaneous anthrax in a patient with type II diabetes mellitus.Clinical and experimental dermatology, , Volume: 30, Issue:6, 2005
Impetigo-like vegetating nasal lesions caused by Klebsiella pneumoniae.The American journal of medicine, , Volume: 118, Issue:8, 2005
Cutaneous anthrax: conservative or surgical treatment?Advances in skin & wound care, , Volume: 18, Issue:3, 2005
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 49, Issue:8-9, 2004
Cutaneous infection caused by Salmonella typhi.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 17, Issue:5, 2003
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.Diagnostic microbiology and infectious disease, , Volume: 43, Issue:2, 2002
Cutaneous anthrax: an overview.Dermatology nursing, , Volume: 14, Issue:2, 2002
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].Deutsche medizinische Wochenschrift (1946), , Apr-05, Volume: 127, Issue:14, 2002
Cutaneous anthrax: a concise review.Cutis, , Volume: 69, Issue:1, 2002
The role of fluoroquinolones in skin and skin structure infections.American journal of clinical dermatology, , Volume: 3, Issue:1, 2002
Atypical mycobacterial infection following blepharoplasty and full-face skin resurfacing with CO2 laser.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], , Volume: 28, Issue:8, 2002
Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.MMWR. Morbidity and mortality weekly report, , Nov-30, Volume: 50, Issue:47, 2001
From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.JAMA, , Dec-19, Volume: 286, Issue:23, 2001
From the Centers for Disease Control and Prevention. Recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.JAMA, , Dec-05, Volume: 286, Issue:21, 2001
From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.JAMA, , Nov-28, Volume: 286, Issue:20, 2001
From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.JAMA, , Nov-14, Volume: 286, Issue:18, 2001
From the Centers for Disease Control and Prevention. Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.JAMA, , Nov-07, Volume: 286, Issue:17, 2001
Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.MMWR. Morbidity and mortality weekly report, , Nov-16, Volume: 50, Issue:45, 2001
Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.MMWR. Morbidity and mortality weekly report, , Nov-09, Volume: 50, Issue:44, 2001
Cutaneous Bacillus anthracis infection.The New England journal of medicine, , Nov-29, Volume: 345, Issue:22, 2001
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.MMWR. Morbidity and mortality weekly report, , Oct-26, Volume: 50, Issue:42, 2001
Attempts to stem Anthrax fears stumble.Circulation, , Nov-06, Volume: 104, Issue:19, 2001
Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.MMWR. Morbidity and mortality weekly report, , Oct-19, Volume: 50, Issue:41, 2001
Anthrax. Deadly delivery.Time, , Oct-22, Volume: 158, Issue:18, 2001
Mycobacterium branderi from both a hand infection and a case of pulmonary disease.Journal of clinical microbiology, , Volume: 38, Issue:10, 2000
A rare infection caused by Chryseomonas luteola.The Journal of infection, , Volume: 41, Issue:1, 2000
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.The American journal of tropical medicine and hygiene, , Volume: 61, Issue:5, 1999
[Use of ciprofloxacin in the treatment and prevention of surgical infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 44, Issue:7, 1999
Pacemaker pocket infection.Pacing and clinical electrophysiology : PACE, , Volume: 22, Issue:4 Pt 1, 1999
Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.The Journal of antimicrobial chemotherapy, , Volume: 43 Suppl A, 1999
[Painful nodular lesions].La Revue de medecine interne, , Volume: 19, Issue:9, 1998
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.International journal of clinical practice, , Volume: 52, Issue:2, 1998
An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: successful combined therapy with maternal plasma and ciprofloxacin.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 23, Issue:3, 1996
[Ciprofloxacin in treatment of common bacterial skin infections. Results of an open study in general practice].Fortschritte der Medizin, , Feb-20, Volume: 114, Issue:5, 1996
Cutaneous and pulmonary infections caused by Mycobacterium vaccae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 23, Issue:1, 1996
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.Drugs, , Volume: 49 Suppl 2, 1995
Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 18, Issue:6, 1994
Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.Drugs under experimental and clinical research, , Volume: 20, Issue:5, 1994
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 16, Issue:4, 1993
[Mycobacterium kansasii cutaneous infection].Annales de dermatologie et de venereologie, , Volume: 120, Issue:4, 1993
Rapidly growing members of the genus Mycobacterium affecting dogs and cats.Journal of the American Animal Hospital Association, , Volume: 38, Issue:3
Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen.Acta dermato-venereologica, , Volume: 81, Issue:4
Cutaneous infection caused by Corynebacterium pseudodiphtheriticum: a microbiological report.Revista do Instituto de Medicina Tropical de Sao Paulo, , Volume: 50, Issue:1
Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.Journal of the American Animal Hospital Association, , Volume: 43, Issue:6
Extensive cutaneous anthrax in an immunocompetent patient.European journal of dermatology : EJD, , Volume: 17, Issue:5
Etiology of chronic skin lesions in subjects with peripheral arterial disease.La Clinica terapeutica, , Volume: 169, Issue:2
Molecular confirmation of the circulating Indian journal of medical microbiology, , Volume: 37, Issue:1
Anaplastic large cell lymphoma and lepromatous leprosy: a rare coexistence.Leprosy review, , Volume: 83, Issue:1, 2012
A case of leprosy mistaken for cutaneous sarcoidosis.Acta dermato-venereologica, , Volume: 92, Issue:2, 2012
Question: Can you identify this condition? Tuberculoid leprosy.Canadian family physician Medecin de famille canadien, , Volume: 55, Issue:1, 2009
International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.Tropical medicine & international health : TM & IH, , Volume: 13, Issue:5, 2008
Disseminated Mycobacterium chelonae cutaneous infection: recalcitrant to combined antibiotic therapy.The Journal of dermatology, , Volume: 30, Issue:6, 2003
Dapsone treatment is efficient against persistent cutaneous and gastrointestinal symptoms in children with Henoch-Schönlein purpura.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, , Volume: 162, Issue:2, 2018
A case of leprosy mistaken for cutaneous sarcoidosis.Acta dermato-venereologica, , Volume: 92, Issue:2, 2012
Question: Can you identify this condition? Tuberculoid leprosy.Canadian family physician Medecin de famille canadien, , Volume: 55, Issue:1, 2009
International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.Tropical medicine & international health : TM & IH, , Volume: 13, Issue:5, 2008
Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate.The British journal of dermatology, , Volume: 156, Issue:2, 2007
Perianal actinomycetoma experience of 20 cases.International journal of dermatology, , Volume: 41, Issue:8, 2002
Emergence of leprosy in a patient with mycosis fungoides.Journal of the American Academy of Dermatology, , Volume: 30, Issue:2 Pt 2, 1994
[Chemotherapy of leprosy. I. Effect of 4,4-diaminodiphenylsulfone in rat leprosy].Revista brasileira de leprologia, , Volume: 19, Issue:2, 1951
Guess what! Targetoid erythematous plaques: an unusual morphological presentation of multibacillary Hansen's disease.European journal of dermatology : EJD, , Volume: 11, Issue:1
Photo capsules. Actinomycosis.Skinmed, , Volume: 7, Issue:1
Extending the phenotypic spectrum of keratitis-ichthyosis-deafness syndrome: report of a patient with GJB2 (G12R) Connexin 26 mutation and unusual clinical findings.Pediatric dermatology, , Volume: 29, Issue:3
Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials.Diagnostic microbiology and infectious disease, , Volume: 17, Issue:3, 1993
Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.Chemotherapy, , Volume: 43, Issue:5
First case report of Cryptococcus laurentii knee infection in a previously healthy patient.BMC infectious diseases, , Sep-17, Volume: 20, Issue:1, 2020
Subcutaneous nodules caused by Pseudomonas aeruginosa: healing without incision and drainage.Journal of chemotherapy (Florence, Italy), , Volume: 4, Issue:4, 1992
[Case of the abscess type cutaneous nocardiosis].Medical mycology journal, , Volume: 55, Issue:1, 2014
Mycobacterium marinum infection following contact with reptiles: vivarium granuloma.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 21, 2014
[Antimicrobial activity and frequency of spontaneous gentamicin-resistant mutants in bacteria related skin infections].Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, , Volume: 131, Issue:11, 2011
Cutaneous Listeria infection.British journal of hospital medicine (London, England : 2005), , Volume: 70, Issue:11, 2009
Bullous haemorrhagic cellulitis caused by Enterobacter cloacae.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 19, Issue:6, 2005
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion.The Journal of infectious diseases, , Feb-15, Volume: 187, Issue:4, 2003
Isolation of Dermatophilus congolensis from a cat.Journal of veterinary medicine. B, Infectious diseases and veterinary public health, , Volume: 47, Issue:2, 2000
Bacterial interdigital scaly erythema (Kitamura): a possible new clinical entity.Dermatology (Basel, Switzerland), , Volume: 199, Issue:4, 1999
Subcutaneous nodules with pseudomonas septicaemia in an immunocompetent patient.Anaesthesia and intensive care, , Volume: 27, Issue:2, 1999
Overview of the efficacy of isepamicin in the adult core clinical trial programme.Journal of chemotherapy (Florence, Italy), , Volume: 7 Suppl 2, 1995
Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.Journal of chemotherapy (Florence, Italy), , Volume: 7 Suppl 2, 1995
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.Journal of chemotherapy (Florence, Italy), , Volume: 7 Suppl 2, 1995
Primary cutaneous nocardiosis caused by Nocardia otitidiscaviarum: two cases and a review of the literature.The Journal of tropical medicine and hygiene, , Volume: 98, Issue:6, 1995
A modified two-step treatment for actinomycetoma.Indian journal of dermatology, venereology and leprology, , Volume: 73, Issue:4
Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 62, 2017
Granulomatous lesion on the face successfully treated with antitubercular therapy.Dermatology online journal, , Sep-15, Volume: 16, Issue:9, 2010
Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.Journal of Korean medical science, , Volume: 25, Issue:2, 2010
Severe sporotrichoid fish tank granuloma following infliximab therapy.American journal of clinical dermatology, , Volume: 8, Issue:6, 2007
Central nervous system infection and cutaneous lymphadenitis due to Mycobacterium kansasii in an immunocompetent patient.Infection, , Volume: 35, Issue:4, 2007
Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene.International journal of dermatology, , Volume: 40, Issue:8, 2001
Clinical evaluation of isonicotinic acid hydrazide as an adjuvant in the treatment of lepromatous leprosy; with a note on the detrimental effect of erythema nodosum leprosum reactions.International journal of Leprosy, , Volume: 24, Issue:4, Part 1
Aquarium-borne Mycobacterium marinum skin infection. Report of 15 cases and review of the literature.European journal of dermatology : EJD, , Volume: 23, Issue:4
[Tuberculosis of the breast].Biomedica : revista del Instituto Nacional de Salud, , Volume: 33, Issue:1
[Neonatal accidental burn by isopropyl alcohol].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 11, Issue:8, 2004
Is isopropyl alcohol swabbing before injection really necessary?The Medical journal of Australia, , Sep-17, Volume: 175, Issue:6, 2001
Is isopropyl alcohol swabbing before injection really necessary?The Medical journal of Australia, , Sep-17, Volume: 175, Issue:6, 2001
Staphylococcus pseudintermedius infection associated with nodular skin lesions and systemic inflammatory response syndrome in a dog.The Canadian veterinary journal = La revue veterinaire canadienne, , Volume: 55, Issue:5, 2014
Temporal abscess after tooth extractions.BMJ case reports, , Jul-21, Volume: 2010, 2010
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Helicobacter pylori infection in skin diseases: a critical appraisal.American journal of clinical dermatology, , Volume: 3, Issue:4, 2002
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.The American journal of tropical medicine and hygiene, , Volume: 61, Issue:5, 1999
May Helicobacter pylori be important for dermatologists?Dermatology (Basel, Switzerland), , Volume: 191, Issue:1, 1995
[Buruli ulcer in Angolese refugees in the Kimpese area, Lower Congo, D.R. Congo].Sante (Montrouge, France), , Volume: 13, Issue:1
Cutaneous abscess after Conus textile sting.Journal of travel medicine, , Volume: 18, Issue:3
New insights on the antibacterial efficacy of miconazole in vitro.Mycoses, , Volume: 60, Issue:8, 2017
Effective treatment of tinea corporis due to Trichophyton mentagrophytes with combined isoconazole nitrate and diflucortolone valerate therapy.Mycoses, , Volume: 56 Suppl 1, 2013
Inflammatory tinea pedis with bacterial superinfection effectively treated with isoconazole nitrate and diflucortolone valerate combination therapy.Mycoses, , Volume: 56 Suppl 1, 2013
Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate.Mycoses, , Volume: 56 Suppl 1, 2013
Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids.Mycoses, , Volume: 56 Suppl 1, 2013
The benefits of combination therapy in dermatomycoses.Mycoses, , Volume: 56 Suppl 1, 2013
Novelties in the multifaceted miconazole effects on skin disorders.Expert opinion on pharmacotherapy, , Volume: 9, Issue:11, 2008
Double-blind comparison of miconazole/corticosteroid combination versus miconazole in inflammatory dermatomycoses.International journal of dermatology, , Volume: 34, Issue:2, 1995
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 22, Issue:10, 2016
Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.Chemotherapy, , Volume: 50, Issue:4, 2004
[Fundamental studies on antibacterial activity of clindamycin against Propionibacterium acnes].The Japanese journal of antibiotics, , Volume: 51, Issue:2, 1998
Cutaneous non-tubercular mycobacterial infection in pregnancy and treatment consideration.European journal of obstetrics, gynecology, and reproductive biology, , Volume: 237, 2019
Maximum growth temperature test for cutaneous Mycobacterium chelonae predicts the efficacy of thermal therapy.The Journal of dermatology, , Volume: 39, Issue:2, 2012
[Levofloxacin in complex therapy of patients with skin and soft tissue infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 53, Issue:9-10, 2008
Successful treatment of a widespread cutaneous Mycobacterium fortuitum infection with levofloxacin.International journal of dermatology, , Volume: 45, Issue:9, 2006
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 49, Issue:8-9, 2004
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
The role of fluoroquinolones in skin and skin structure infections.American journal of clinical dermatology, , Volume: 3, Issue:1, 2002
Levofloxacin alone efficiently treated a cutaneous mycobacterium fortuitum infection.The Journal of dermatology, , Volume: 29, Issue:7, 2002
Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.Antimicrobial agents and chemotherapy, , Volume: 45, Issue:8, 2001
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.Drug safety, , Volume: 24, Issue:3, 2001
[Recurrent abscesses in a renal transplant recipient].Enfermedades infecciosas y microbiologia clinica, , Volume: 19, Issue:2, 2001
The fluoroquinolones after ciprofloxacin and ofloxacin.Current clinical topics in infectious diseases, , Volume: 20, 2000
Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:5, 2000
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.Transplant international : official journal of the European Society for Organ Transplantation, , Volume: 12, Issue:1, 1999
Successful triple-antibiotic therapy for cutaneous infection due to Mycobacterium chelonae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 28, Issue:1, 1999
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.International journal of clinical practice, , Volume: 52, Issue:2, 1998
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.JAMA, , Jan-14, Volume: 279, Issue:2, 1998
Mycobacterium marinum skin infection successfully treated with levofloxacin.Archives of dermatology, , Volume: 133, Issue:8, 1997
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.Drugs, , Volume: 49 Suppl 2, 1995
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.Antimicrobial agents and chemotherapy, , Volume: 38, Issue:11, 1994
Ofloxacin treatment of difficult infections of the skin and skin structure.Cutis, , Volume: 51, Issue:1, 1993
Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.Chemotherapy, , Volume: 43, Issue:5
Cutaneous nocardiosis: report of two cases and review of the literature.International journal of dermatology, , Volume: 49, Issue:12, 2010
[Skin penetration of sulfamethoxazole and trimethoprim after oral administration].Annales Academiae Medicae Stetinensis, , Volume: 48, 2002
Clinical and pathologic features of Mycobacterium fortuitum infections. An emerging pathogen in patients with AIDS.American journal of clinical pathology, , Volume: 116, Issue:2, 2001
First Case of Journal of investigative medicine high impact case reports, , Volume: 8
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2002. A 37-year-old man with fever, hepatosplenomegaly, and a cutaneous foot lesion after a trip to Africa.The New England journal of medicine, , Jun-27, Volume: 346, Issue:26, 2002
[Germanin and bismogenol in therapy of pyoderma chronicum vegetans et ulcerans].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 3, Issue:9, 1952
Image Gallery: Acute primary cutaneous nocardiosis due to Nocardia brasiliensis.The British journal of dermatology, , Volume: 176, Issue:5, 2017
CLINICAL DECISIONS. Skin Abscess.The New England journal of medicine, , Mar-03, Volume: 374, Issue:9, 2016
Cutaneous nocardiosis: report of two cases and review of the literature.International journal of dermatology, , Volume: 49, Issue:12, 2010
[Skin penetration of sulfamethoxazole and trimethoprim after oral administration].Annales Academiae Medicae Stetinensis, , Volume: 48, 2002
Clinical and pathologic features of Mycobacterium fortuitum infections. An emerging pathogen in patients with AIDS.American journal of clinical pathology, , Volume: 116, Issue:2, 2001
[Aquarium-borne Mycobacterium marinum infection].Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, , May-20, Volume: 113, Issue:13, 1993
Rapidly growing members of the genus Mycobacterium affecting dogs and cats.Journal of the American Animal Hospital Association, , Volume: 38, Issue:3
First Case of Journal of investigative medicine high impact case reports, , Volume: 8
[Various bacterial dermatoses & their treatment with usnic acid].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 9, Issue:11, 1958
[The treatment of bacterial skin diseases with usnic acid].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 6, Issue:11, 1955
Cutaneous nocardiosis by a new pathogenic species: BMJ case reports, , Jun-04, Volume: 2018, 2018
Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation.Clinical pharmacology and therapeutics, , Volume: 104, Issue:4, 2018
Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions.Acta dermato-venereologica, , Volume: 95, Issue:8, 2015
Maximum growth temperature test for cutaneous Mycobacterium chelonae predicts the efficacy of thermal therapy.The Journal of dermatology, , Volume: 39, Issue:2, 2012
Palisaded neutrophilic granulomatous dermatitis caused by cellulitis in a patient with systemic lupus erythematosus.International journal of dermatology, , Volume: 50, Issue:12, 2011
Something fishy in the immunocompromised.British journal of haematology, , Volume: 153, Issue:2, 2011
[A case of steroid-dependent ulcerative colitis complicated by skin infection of Mycobacterium szulgai].Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, , Volume: 106, Issue:9, 2009
Paederus dermatitis in Sierra Leone.Dermatology online journal, , Dec-10, Volume: 12, Issue:7, 2006
Primary cutaneous nocardiosis in 2 patients on immunosuppressants.Scandinavian journal of infectious diseases, , Volume: 37, Issue:6-7, 2005
Disseminated cutaneous infection with Mycobacterium chelonae in a patient with steroid-dependent rheumatoid arthritis.Clinical and experimental dermatology, , Volume: 29, Issue:3, 2004
Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases.Acta medica Okayama, , Volume: 57, Issue:5, 2003
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].Deutsche medizinische Wochenschrift (1946), , Apr-05, Volume: 127, Issue:14, 2002
Polyarteritis nodosa associated with streptococcus.Archives of disease in childhood, , Volume: 69, Issue:6, 1993
Atypical Ulcerated Lesions in a Patient With Cogan Syndrome.Actas dermo-sifiliograficas, , Volume: 108, Issue:4, 2017
Sporotrichoid fluctuant nodules.Cutis, , Volume: 98, Issue:2, 2016
[Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α].Medicina clinica, , Feb-20, Volume: 142, Issue:4, 2014
Epithelioid histiocytic infiltrate caused by Mycobacterium scrofulaceum infection: a potential mimic of various neoplastic entities.The American Journal of dermatopathology, , Volume: 35, Issue:2, 2013
Nocardia neocaledoniensis [corrected] as a cause of skin and soft tissue infection.Journal of clinical microbiology, , Volume: 50, Issue:9, 2012
Sub-polar lepromatous leprosy localized to the face.Dermatology online journal, , Sep-15, Volume: 16, Issue:9, 2010
"MAC" attack.The American journal of medicine, , Volume: 122, Issue:12, 2009
Suppurative inflammation with microabscess and pseudocyst formation is a characteristic histologic manifestation of cutaneous infections with rapid-growing Mycobacterium species.American journal of clinical pathology, , Volume: 130, Issue:4, 2008
An 80-year-old man with a nonhealing glabellar lesion. Primary cutaneous nocardiosis.Archives of pathology & laboratory medicine, , Volume: 130, Issue:10, 2006
Primary cutaneous nocardiosis in 2 patients on immunosuppressants.Scandinavian journal of infectious diseases, , Volume: 37, Issue:6-7, 2005
Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, , Oct-26, Volume: 171, Issue:9, 2004
[Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia].Annales de dermatologie et de venereologie, , Volume: 128, Issue:5, 2001
What is your diagnosis? Canine eosinophilic furunculosis (folliculitis) of the face.The Journal of small animal practice, , Volume: 41, Issue:11, 2000
Fatal disseminated Nocardia farcinica infection in a renal transplant recipient.Pediatric nephrology (Berlin, Germany), , Volume: 14, Issue:2, 2000
[Primary cutaneous nocardia asteroides nocardiosis in an immunocompromised patient].Annales de dermatologie et de venereologie, , Volume: 122, Issue:10, 1995
Phaeohyphomycosis and Mycobacterium fortuitum abscesses in a patient receiving corticosteroids for sarcoidosis.Journal of the American Academy of Dermatology, , Volume: 33, Issue:2 Pt 1, 1995
Infections in systemic lupus erythematosus.Singapore medical journal, , Volume: 34, Issue:5, 1993
Pulmonary and cutaneous nocardiosis in a patient treated with corticosteroids.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, , Volume: 32, Issue:6
[Cervical malignant pustule treated with a combination of penicillin, streptomycin & cortancyl; recovery from an immediate relapse in the presternal region with magnamycin].Bulletins et memoires de la Societe medicale des hopitaux de Paris, , Volume: 73, Issue:27-28
Study of dermatoses in kidney transplant patients.Anais brasileiros de dermatologia, , Volume: 88, Issue:3
Cutaneous Anthrax Outbreak in the Trakya Region of TurkeyBalkan medical journal, , 05-10, Volume: 36, Issue:3, 2019
[Cutaneous anthrax, the last outbreak diagnosed in Chile].Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, , Volume: 35, Issue:2, 2018
Is flucloxacillin monotherapy sufficient for the treatment of skin and soft tissue infections in plastic surgery?Journal of plastic, reconstructive & aesthetic surgery : JPRAS, , Volume: 71, Issue:6, 2018
Two cases of human cutaneous anthrax with massive tissue damage, severe edema, and slight injury to the liver.International journal of dermatology, , Volume: 57, Issue:3, 2018
Cutaneous Anthrax.The Journal of emergency medicine, , Volume: 52, Issue:2, 2017
Unusual cause of fatal anthrax meningitis.Cutaneous and ocular toxicology, , Volume: 34, Issue:1, 2015
Imported toxigenic cutaneous diphtheria in a young male returning from Mozambique to Norway, March 2014.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, , Jun-19, Volume: 19, Issue:24, 2014
Three eyelid localized cutaneous anthrax cases.Cutaneous and ocular toxicology, , Volume: 33, Issue:4, 2014
[A severe cutaneous anthrax case complicated with sepsis in Bursa, Turkey].Mikrobiyoloji bulteni, , Volume: 47, Issue:3, 2013
Cutaneous Listeria infection.British journal of hospital medicine (London, England : 2005), , Volume: 70, Issue:11, 2009
[Bacteriology of cutaneous infections of the child].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 15 Suppl 2, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
[Skin abscesses and a mediastinal mass in a young male].Enfermedades infecciosas y microbiologia clinica, , Volume: 24, Issue:5, 2006
An unusually extensive case of cutaneous anthrax in a patient with type II diabetes mellitus.Clinical and experimental dermatology, , Volume: 30, Issue:6, 2005
Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases.Acta medica Okayama, , Volume: 57, Issue:5, 2003
[Cutaneous palpebral anthrax].Journal francais d'ophtalmologie, , Volume: 25, Issue:9, 2002
Two familial cases of perianal streptococcal dermatitis.Cutis, , Volume: 68, Issue:3, 2001
Anthrax: an overview within the Indian subcontinent.International journal of dermatology, , Volume: 40, Issue:3, 2001
[Erysipelas, cellulitis and other severe Streptococcus pyogenes skin infections].Presse medicale (Paris, France : 1983), , Nov-13, Volume: 28, Issue:35, 1999
Primary cutaneous actinomycosis.JPMA. The Journal of the Pakistan Medical Association, , Volume: 48, Issue:11, 1998
Diagnosis: cutaneous anthrax.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 25, Issue:3, 1997
Cutaneous anthrax on eyelids.Japanese journal of ophthalmology, , Volume: 48, Issue:3
Reaction or infection: topical chloramphenicol treatment.Annals of the Royal College of Surgeons of England, , Volume: 95, Issue:1, 2013
[Antimicrobial activity and frequency of spontaneous gentamicin-resistant mutants in bacteria related skin infections].Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, , Volume: 131, Issue:11, 2011
Cervicofacial nocardiosis in an immunocompetent child.Acta paediatrica (Oslo, Norway : 1992), , Volume: 94, Issue:9, 2005
Typhoid in the highlands of Papua New Guinea 1984-1990: a hospital-based perspective.Papua and New Guinea medical journal, , Volume: 38, Issue:4, 1995
[Local treatment of bacterial dermatosis with leukomycin].Zeitschrift fur Haut- und Geschlechtskrankheiten, , Feb-01, Volume: 20, Issue:3, 1956
Chloramphenicol in treatment of cutaneous anthrax.British medical journal, , Jan-12, Volume: 1, Issue:4749, 1952
Pyoderma vegetans successfully treated with chloramphenicol.A.M.A. archives of dermatology and syphilology, , Volume: 66, Issue:5, 1952
[Acrodermatitis chronica atrophicans Herxheimer; a new indication for chloromycetin].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 3, Issue:7, 1952
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 22, Issue:10, 2016
The potential role of nemonoxacin for treatment of common infections.Expert opinion on pharmacotherapy, , Volume: 16, Issue:2, 2015
Novel antibacterial agents for skin and skin structure infections.Journal of the American Academy of Dermatology, , Volume: 50, Issue:3, 2004
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).Diagnostic microbiology and infectious disease, , Volume: 43, Issue:4, 2002
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.Clinical therapeutics, , Volume: 21, Issue:1, 1999
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.Antimicrobial agents and chemotherapy, , Volume: 41, Issue:7, 1997
Use of enrofloxacin.The Veterinary record, , Jun-12, Volume: 132, Issue:24, 1993
Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.Journal of the American Animal Hospital Association, , Volume: 43, Issue:6
Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis.Expert review of anti-infective therapy, , Volume: 20, Issue:11, 2022
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.European journal of medicinal chemistry, , Jul-15, Volume: 155, 2018
Zinc-resistance gene CzrC identified in methicillin-resistant Staphylococcus hyicus isolated from pigs with exudative epidermitis.The Canadian veterinary journal = La revue veterinaire canadienne, , Volume: 55, Issue:5, 2014
In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs.Veterinary dermatology, , Volume: 24, Issue:4, 2013
Frequency of panton-valentine leukocidin-producing methicillin-sensitive Staphylococcus strains in patients with complicated skin and soft tissue infection in bronx, new york.Journal of clinical microbiology, , Volume: 49, Issue:8, 2011
Disseminated cutaneous and pulmonary abscesses in an injecting drug user caused by a Panton-Valentine leucocidin-positive, methicillin-susceptible Staphylococcus aureus strain.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 27, Issue:10, 2008
Suspected methicillin-resistant Staphylococcus aureus infections at sea.International maritime health, , Volume: 58, Issue:1-4, 2007
Skin disease presenting as an outbreak of pseudobacteremia in a laboratory worker.Journal of clinical microbiology, , Volume: 39, Issue:1, 2001
[Multiresistant bacteria in dermatology].Annales de dermatologie et de venereologie, , Volume: 125, Issue:10, 1998
Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.Pediatric dermatology, , Volume: 28, Issue:1
Skin and soft-tissue infections caused by Actinobaculum schaalii: report of two cases and literature review.Anaerobe, , Volume: 28, 2014
A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid.American journal of surgery, , Volume: 185, Issue:4, 2003
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.The American journal of tropical medicine and hygiene, , Volume: 61, Issue:5, 1999
Bacterial skin infections at a tertiary dermatological centre.Singapore medical journal, , Volume: 39, Issue:8, 1998
Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:6, 2011
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
[Contribution of linezolid to the treatment of complicated infections of the skin and soft tissues].Presse medicale (Paris, France : 1983), , Apr-05, Volume: 32, Issue:13 Pt 2, 2003
Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:12, 2000
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection GrThe Journal of antimicrobial chemotherapy, , Volume: 44, Issue:2, 1999
[Oxacillin plus clindamycin: a useful combination?]Revista peruana de medicina experimental y salud publica, , Volume: 35, Issue:1
Cutaneous anthrax in an unusual location: case report.Le infezioni in medicina, , Volume: 23, Issue:4, 2015
Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 17, Issue:12, 2013
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).Current medical research and opinion, , Volume: 29, Issue:7, 2013
Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate.Mycoses, , Volume: 56 Suppl 1, 2013
Evaluation of cutaneous palpebral anthrax.Cutaneous and ocular toxicology, , Volume: 32, Issue:4, 2013
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.BMC infectious diseases, , Nov-12, Volume: 12, 2012
Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 31, Issue:2, 2000
Isolation of Dermatophilus congolensis from a cat.Journal of veterinary medicine. B, Infectious diseases and veterinary public health, , Volume: 47, Issue:2, 2000
Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.The Pediatric infectious disease journal, , Volume: 18, Issue:7, 1999
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 15, Issue:12, 1996
[Sultamicillin in treatment of suppurative skin disorders].Polski tygodnik lekarski (Warsaw, Poland : 1960), , Volume: 48 Suppl 2, 1993
Low-dose sultamicillin oral suspension in the treatment of mild to moderate paediatric infections in Turkey.The Journal of international medical research, , Volume: 20 Suppl 1, 1992
A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.Advances in therapy, , Volume: 11, Issue:4
Cutaneous Mycobacterium chelonae infection in a patient with rheumatoid arthritis treated with glucocorticoids.Joint bone spine, , Volume: 86, Issue:1, 2019
Two cases of human cutaneous anthrax with massive tissue damage, severe edema, and slight injury to the liver.International journal of dermatology, , Volume: 57, Issue:3, 2018
Childhood-onset eosinophilic granulomatosis with polyangiitis: a rare childhood vasculitis mimicking anthrax and eosinophilic leukaemia.BMJ case reports, , Feb-17, Volume: 2016, 2016
New rash, old foe.The American journal of medicine, , Volume: 121, Issue:3, 2008
Skin and joint infection by Mycobacterium chelonae: rescue treatment with interferon gamma.Joint bone spine, , Volume: 74, Issue:4, 2007
Fatal disseminated Nocardia farcinica infection in a renal transplant recipient.Pediatric nephrology (Berlin, Germany), , Volume: 14, Issue:2, 2000
[Nocardia otitidiscaviarum, cutaneous infection in a patient receiving long-term corticosteroid treatment].Annales de biologie clinique, , Volume: 61, Issue:2
Is flucloxacillin monotherapy sufficient for the treatment of skin and soft tissue infections in plastic surgery?Journal of plastic, reconstructive & aesthetic surgery : JPRAS, , Volume: 71, Issue:6, 2018
Imported toxigenic cutaneous diphtheria in a young male returning from Mozambique to Norway, March 2014.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, , Jun-19, Volume: 19, Issue:24, 2014
Dermacase. Perianal streptococcal dermatitis.Canadian family physician Medecin de famille canadien, , Volume: 45, 1999
Therapy of Lyme borreliosis in children.Infection, , Volume: 24, Issue:2
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.International journal of antimicrobial agents, , Volume: 51, Issue:3, 2018
Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.The Journal of antimicrobial chemotherapy, , 04-01, Volume: 72, Issue:4, 2017
Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.Expert opinion on pharmacotherapy, , Volume: 18, Issue:10, 2017
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.Infection control and hospital epidemiology, , Volume: 36, Issue:8, 2015
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).Current medical research and opinion, , Volume: 29, Issue:7, 2013
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 66, Issue:11, 2011
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.International journal of antimicrobial agents, , Volume: 26, Issue:5, 2005
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.International journal of antimicrobial agents, , Volume: 23, Issue:3, 2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.The Journal of antimicrobial chemotherapy, , Volume: 53 Suppl 2, 2004
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 35, Issue:Suppl 1, 2002
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, , Issue:573, 1994
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.Antimicrobial agents and chemotherapy, , Volume: 37, Issue:8, 1993
Randomized, controlled trial testing the effectiveness and safety of 2.5% and 5% benzoyl peroxide for the treatment of pitted keratolysis.The Journal of dermatological treatment, , Volume: 32, Issue:7, 2021
Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens.The Journal of investigative dermatology, , Volume: 133, Issue:5, 2013
Comparison of two shampoos as sole treatment for canine bacterial overgrowth syndrome.The Veterinary record, , Jun-30, Volume: 170, Issue:26, 2012
[Bacterial resistance in acne? A meta-analysis of the controversy].Cirugia y cirujanos, , Volume: 84, Issue:3
Climber's knuckle excoriation.The Journal of dermatology, , Volume: 45, Issue:9, 2018
[Antimicrobial activity and frequency of spontaneous gentamicin-resistant mutants in bacteria related skin infections].Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, , Volume: 131, Issue:11, 2011
Effect of cream containing Melia azedarach flowers on skin diseases in children.Phytomedicine : international journal of phytotherapy and phytopharmacology, , Volume: 15, Issue:4, 2008
Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective.Expert review of anti-infective therapy, , Volume: 5, Issue:5, 2007
Topical antimicrobial agents in dermatology.Disease-a-month : DM, , Volume: 50, Issue:7, 2004
A rare infection caused by Chryseomonas luteola.The Journal of infection, , Volume: 41, Issue:1, 2000
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:2, 2000
[Baneocin -- a drug of choice in prophylaxis and treatment of bacterial infections of the skin].Voenno-meditsinskii zhurnal, , Volume: 321, Issue:7, 2000
Neomycin lotion in treatment of cutaneous bacterial infections.A.M.A. archives of dermatology and syphilology, , Volume: 68, Issue:6, 1953
Neomycin.Dermatitis : contact, atopic, occupational, drug, , Volume: 19, Issue:2
Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.International journal of clinical pharmacology and therapeutics, , Volume: 59, Issue:9, 2021
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-02, Volume: 73, Issue:3, 2021
Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity.AAPS PharmSciTech, , Feb-02, Volume: 22, Issue:2, 2021
Safety and Tolerability of More than Six Days of Tedizolid Treatment.Antimicrobial agents and chemotherapy, , 06-23, Volume: 64, Issue:7, 2020
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.Antimicrobial agents and chemotherapy, , Volume: 63, Issue:7, 2019
Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 24, Issue:6, 2018
Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections.Expert opinion on drug safety, , Volume: 17, Issue:4, 2018
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.Antimicrobial agents and chemotherapy, , Volume: 61, Issue:5, 2017
Antibiotics.Nursing, , Volume: 47, Issue:3, 2017
Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.Expert opinion on drug metabolism & toxicology, , Volume: 13, Issue:3, 2017
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled Trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-15, Volume: 64, Issue:2, 2017
Outpatient treatment of acute bacterial skin and skin structure infections (ABSSSI) with tedizolid phosphate and linezolid in patients in the United States: Subgroup analysis of 2 randomized phase 3 trials.Medicine, , Volume: 96, Issue:52, 2017
In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China.Journal of medical microbiology, , Volume: 65, Issue:10, 2016
Clinician-reported lesion measurements in skin infection trials: Definitions, reliability, and association with patient-reported pain.Contemporary clinical trials, , Volume: 50, 2016
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections.Connecticut medicine, , Volume: 80, Issue:3, 2016
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 22 Suppl 2, 2016
Tedizolid for treatment of acute bacterial skin and skin structure infections.Expert review of anti-infective therapy, , Volume: 13, Issue:9, 2015
Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections.The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, , Volume: 30, Issue:7, 2015
Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Oct-15, Volume: 61, Issue:8, 2015
A closer inspection of tedizolid - authors' reply.The Lancet. Infectious diseases, , Volume: 15, Issue:4, 2015
A closer inspection of tedizolid.The Lancet. Infectious diseases, , Volume: 15, Issue:4, 2015
A closer inspection of tedizolid.The Lancet. Infectious diseases, , Volume: 15, Issue:4, 2015
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.Drugs, , Volume: 75, Issue:3, 2015
Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections.Drugs of today (Barcelona, Spain : 1998), , Volume: 50, Issue:11, 2014
Tedizolid population pharmacokinetics, exposure response, and target attainment.Antimicrobial agents and chemotherapy, , Volume: 58, Issue:11, 2014
Two new drugs for skin and skin structure infections.The Medical letter on drugs and therapeutics, , Aug-18, Volume: 56, Issue:1449, 2014
New antibiotics for skin and skin-structure infections.The Lancet. Infectious diseases, , Volume: 14, Issue:8, 2014
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.The Lancet. Infectious diseases, , Volume: 14, Issue:8, 2014
Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study.Surgical infections, , Volume: 15, Issue:2, 2014
End points in trials of treatments for skin infections--reply.JAMA, , May-22, Volume: 309, Issue:20, 2013
End points in trials of treatments for skin infections.JAMA, , May-22, Volume: 309, Issue:20, 2013
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.Drug design, development and therapy, , Volume: 7, 2013
Antibiotics for skin infections: new study design and a step toward shorter course therapy.JAMA, , Feb-13, Volume: 309, Issue:6, 2013
Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.JAMA, , Feb-13, Volume: 309, Issue:6, 2013
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:2, 2011
Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 20, Issue:2
A cutaneous Anthrax outbreak in Koraput District of Odisha-India 2015.BMC public health, , May-10, Volume: 19, Issue:Suppl 3, 2019
Trichomycosis axillaris: Clinical, Wood lamp, and dermoscopic diagnostic images.Actas dermo-sifiliograficas, , Volume: 108, Issue:3, 2017
Prevalence and pathology of dermatophilosis in camels (Camelus dromedaries) in Iran.Tropical animal health and production, , Volume: 44, Issue:1, 2012
Disseminated subcutaneous nocardiosis caused by Nocardia farcinica diagnosed by FNA biopsy and 16S ribosomal gene sequencing.Diagnostic cytopathology, , Volume: 36, Issue:4, 2008
[Diagnostic value of Gram staining of peri-catheter skin and the connection in the prediction of intravascular-catheter-related bacteremia].Enfermedades infecciosas y microbiologia clinica, , Volume: 16, Issue:5, 1998
Bacillus thuringiensis: a causative agent of pitted keratolysis.The Australasian journal of dermatology, , Volume: 62, Issue:4, 2021
50 Years Ago in The Journal of Pediatrics: Erythromycin versus Penicillin for the Treatment of Streptococcal Skin Infections.The Journal of pediatrics, , Volume: 225, 2020
A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.BMC pediatrics, , 06-05, Volume: 19, Issue:1, 2019
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.European journal of medicinal chemistry, , Jul-15, Volume: 155, 2018
Combined photodynamic and antibiotic therapy for skin disorder via lipase-sensitive liposomes with enhanced antimicrobial performance.Biomaterials, , Volume: 141, 2017
Oral erythromycin therapy in epidermolysis bullosa simplex generalized severe.The British journal of dermatology, , Volume: 173, Issue:2, 2015
Two cases of cutaneous diphtheria associated with occupational pig contact in Germany.Zoonoses and public health, , Volume: 60, Issue:8, 2013
A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma.The Journal of dermatological treatment, , Volume: 24, Issue:1, 2013
Follicular spicules associated with Propionibacterium acnes with response to erythromycin: Lack of evidence for the species?The Journal of dermatology, , Volume: 39, Issue:6, 2012
Follicular spicules associated with Propionibacterium acnes in response to erythromycin.The Journal of dermatology, , Volume: 38, Issue:4, 2011
Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria.Anaerobe, , Volume: 16, Issue:4, 2010
Palmar and digital black pseudochromhidrosis: a case report.International journal of dermatology, , Volume: 49, Issue:5, 2010
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study.The Journal of antimicrobial chemotherapy, , Volume: 55, Issue:6, 2005
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center.Archives of dermatology, , Volume: 138, Issue:7, 2002
Cutaneous granulomas caused by corynebacterium minutissimum in an HIV-infected man.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 16, Issue:6, 2002
[Acute generalized cat scratch disease in myelodysplastic syndrome].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 52, Issue:10 Pt 2, 2001
Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:9, 2000
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:2, 2000
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
Bacterial skin infections at a tertiary dermatological centre.Singapore medical journal, , Volume: 39, Issue:8, 1998
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated fAntimicrobial agents and chemotherapy, , Volume: 42, Issue:5, 1998
Replicate plating: does it increase reliability?Letters in applied microbiology, , Volume: 23, Issue:2, 1996
Propionibacterium: resistance of acne to antibiotics.The New Zealand medical journal, , Feb-08, Volume: 108, Issue:993, 1995
Invasive streptococci.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 14 Suppl 1, 1995
Comparative studies of cefprozil in the management of skin and soft-tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 13, Issue:10, 1994
Dirithromycin in the treatment of skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl C, 1993
Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
Once-daily azithromycin in the treatment of adult skin and skin-structure infections.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease.Journal of medical microbiology, , Volume: 39, Issue:3, 1993
[Boutonneuse fever in childhood: a pathology often underdiagnosed. A report of 2 clinical cases].Minerva pediatrica, , Volume: 45, Issue:4, 1993
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group.International journal of dermatology, , Volume: 32, Issue:7, 1993
Erythromycin propionate ointment in the treatment of cutaneous bacterial infections in children.Antibiotic medicine & clinical therapy (New York, NY), , Volume: 7, 1960
Erythromycin in local treatment of cutaneous bacterial infections.Journal of the American Medical Association, , Dec-05, Volume: 153, Issue:14, 1953
Rapidly growing members of the genus Mycobacterium affecting dogs and cats.Journal of the American Animal Hospital Association, , Volume: 38, Issue:3
Topical antimicrobial agents in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Macrolides in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
[Bacterial resistance in acne? A meta-analysis of the controversy].Cirugia y cirujanos, , Volume: 84, Issue:3
Pitted keratolysis, erythromycin, and hyperhidrosis.Dermatologic therapy, , Volume: 27, Issue:2
Image Gallery: Fish tank granuloma on the face with sporotrichoid cervicofacial lymphadenitis and abscesses due to Mycobacterium marinum infection.The British journal of dermatology, , Volume: 180, Issue:6, 2019
Mycobacterium marinum infections in Denmark from 2004 to 2017: A retrospective study of incidence, patient characteristics, treatment regimens and outcome.Scientific reports, , 04-30, Volume: 8, Issue:1, 2018
A fast-growing cold skin abscess revealing disseminated Mycobacterium intracellulare infection in an HIV-infected patient.International journal of STD & AIDS, , Volume: 29, Issue:7, 2018
Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 62, 2017
Sporotrichoid fluctuant nodules.Cutis, , Volume: 98, Issue:2, 2016
Cutaneous Mycobacterium intracellulare infection in an immuno-competent person.Acta dermato-venereologica, , Volume: 93, Issue:6, 2013
A rifampicin-resistant Mycobacterium marinum infection in a newly diagnosed HIV-1 individual.International journal of STD & AIDS, , Volume: 24, Issue:1, 2013
Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents.Journal of the American Academy of Dermatology, , Volume: 65, Issue:5, 2011
Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man.BMC dermatology, , Jan-26, Volume: 11, 2011
Granulomatous lesion on the face successfully treated with antitubercular therapy.Dermatology online journal, , Sep-15, Volume: 16, Issue:9, 2010
"MAC" attack.The American journal of medicine, , Volume: 122, Issue:12, 2009
Subcutaneous nodules with sporotrichoid spread.Dermatology online journal, , May-15, Volume: 15, Issue:5, 2009
Central nervous system infection and cutaneous lymphadenitis due to Mycobacterium kansasii in an immunocompetent patient.Infection, , Volume: 35, Issue:4, 2007
Mycobacterium marinum infection: a case report and review of the literature.Cutis, , Volume: 79, Issue:1, 2007
Mycobacterium avium infection involving skin and soft tissue of the hand treated by radical debridement and reconstruction in addition to multidrug chemotherapy.Journal of hand surgery (Edinburgh, Scotland), , Volume: 31, Issue:6, 2006
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].Deutsche medizinische Wochenschrift (1946), , Apr-05, Volume: 127, Issue:14, 2002
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.The American journal of tropical medicine and hygiene, , Volume: 61, Issue:5, 1999
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum].Deutsche medizinische Wochenschrift (1946), , Oct-15, Volume: 124, Issue:41, 1999
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.Transplant international : official journal of the European Society for Organ Transplantation, , Volume: 12, Issue:1, 1999
Successful triple-antibiotic therapy for cutaneous infection due to Mycobacterium chelonae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 28, Issue:1, 1999
Recurrent disseminated infection with Mycobacterium avium complex identified in tissues by molecular analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 22, Issue:4, 1996
Mycobacterium marinum skin infections. Report of 31 cases and review of the literature.Archives of internal medicine, , Jun-27, Volume: 154, Issue:12, 1994
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.Antimicrobial agents and chemotherapy, , Volume: 38, Issue:11, 1994
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 16, Issue:4, 1993
A case of disseminated Mycobacterium marinum infection in an immunocompetent patient.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 11, Issue:10, 1992
Mycobacterium intracellulare soft tissue infection.Journal of the American Academy of Dermatology, , Volume: 27, Issue:6 Pt 1, 1992
[Tuberculosis of the breast].Biomedica : revista del Instituto Nacional de Salud, , Volume: 33, Issue:1
Trichomycosis axillaris: Clinical, Wood lamp, and dermoscopic diagnostic images.Actas dermo-sifiliograficas, , Volume: 108, Issue:3, 2017
The diagnostic value of a KOH.JAAPA : official journal of the American Academy of Physician Assistants, , Volume: 14, Issue:4, 2001
Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis.Expert review of anti-infective therapy, , Volume: 20, Issue:11, 2022
Oritavancin versus oral antibiotics for treatment of skin and skin structure infections in the emergency department.The American journal of emergency medicine, , Volume: 60, 2022
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 10-05, Volume: 73, Issue:7, 2021
Characterization of Pathogens Isolated from Cutaneous Abscesses in Patients Evaluated by the Dermatology Service at an Emergency Department.Puerto Rico health sciences journal, , Volume: 39, Issue:3, 2020
A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.BMC pediatrics, , 06-05, Volume: 19, Issue:1, 2019
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies.Clinical therapeutics, , Volume: 41, Issue:6, 2019
Treatment of chronic osteomyelitis with multidose oritavancin: A case series and literature review.International journal of antimicrobial agents, , Volume: 53, Issue:4, 2019
Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.Antimicrobial agents and chemotherapy, , Volume: 63, Issue:11, 2019
MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis.The Journal of infection, , Volume: 77, Issue:6, 2018
Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections.International journal of antimicrobial agents, , Volume: 52, Issue:2, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive PathAntimicrobial agents and chemotherapy, , Volume: 62, Issue:5, 2018
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-16, Volume: 67, Issue:5, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive PathClinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 04-03, Volume: 66, Issue:8, 2018
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections.Expert opinion on drug metabolism & toxicology, , Volume: 14, Issue:2, 2018
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.European journal of medicinal chemistry, , Jul-15, Volume: 155, 2018
Daptomycin for Complicated Skin Infections: A Randomized Trial.Pediatrics, , Volume: 139, Issue:3, 2017
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, , Volume: 25, Issue:4, 2017
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.The Journal of antimicrobial chemotherapy, , Dec-01, Volume: 72, Issue:12, 2017
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbiditiesThe Journal of antimicrobial chemotherapy, , Volume: 71, Issue:12, 2016
Linezolid versus vancomycin for skin and soft tissue infections.The Cochrane database of systematic reviews, , Jan-07, Issue:1, 2016
Economic Impact of Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in the Emergency Department or Observation Setting: Cost Savings Associated with Avoidable Hospitalizations.Clinical therapeutics, , Jan-01, Volume: 38, Issue:1, 2016
Can We Better Optimize Vancomycin Monotherapy?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Mar-15, Volume: 62, Issue:6, 2016
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.The Journal of antimicrobial chemotherapy, , Volume: 71, Issue:3, 2016
In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.International journal of antimicrobial agents, , Volume: 46, Issue:6, 2015
Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Oct-01, Volume: 61, Issue:7, 2015
Editorial Commentary: Double Gram-Positive Coverage for Acute Bacterial Skin and Skin Structure Infections: Has the Eagle Landed?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Oct-01, Volume: 61, Issue:7, 2015
Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis.Current medical research and opinion, , Volume: 31, Issue:8, 2015
Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?International journal of antimicrobial agents, , Volume: 46, Issue:1, 2015
Vancomycin Use in Patients Discharged From the Emergency Department: A Retrospective Observational Cohort Study.The Journal of emergency medicine, , Volume: 49, Issue:1, 2015
Trials and tribulations of noninferiority: caveat emptor.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Apr-15, Volume: 60, Issue:8, 2015
Reply to DiNubile.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Apr-15, Volume: 60, Issue:8, 2015
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-15, Volume: 60, Issue:2, 2015
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections].Deutsche medizinische Wochenschrift (1946), , Volume: 139 Suppl 3, 2014
Cochrane in context: Linezolid versus vancomycin for skin and soft tissue infections.Evidence-based child health : a Cochrane review journal, , Volume: 9, Issue:1, 2014
Weekly dalbavancin was noninferior to daily vancomycin for acute bacterial skin infection in adults.Annals of internal medicine, , Oct-21, Volume: 161, Issue:8, 2014
Dalbavancin or oritavancin for skin infections.The New England journal of medicine, , 09-18, Volume: 371, Issue:12, 2014
Dalbavancin or oritavancin for skin infections.The New England journal of medicine, , 09-18, Volume: 371, Issue:12, 2014
Dalbavancin or oritavancin for skin infections.The New England journal of medicine, , 09-18, Volume: 371, Issue:12, 2014
Dalbavancin or oritavancin for skin infections.The New England journal of medicine, , 09-18, Volume: 371, Issue:12, 2014
Dalbavancin or oritavancin for skin infections.The New England journal of medicine, , 09-18, Volume: 371, Issue:12, 2014
What's new in the treatment of serious MRSA infection?Current opinion in infectious diseases, , Volume: 27, Issue:6, 2014
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.Journal of medical economics, , Volume: 17, Issue:10, 2014
Pharmacology and the treatment of complicated skin and skin-structure infections.The New England journal of medicine, , Jun-05, Volume: 370, Issue:23, 2014
Single-dose oritavancin in the treatment of acute bacterial skin infections.The New England journal of medicine, , Jun-05, Volume: 370, Issue:23, 2014
Once-weekly dalbavancin versus daily conventional therapy for skin infection.The New England journal of medicine, , Jun-05, Volume: 370, Issue:23, 2014
Trends of Staphylococcus aureus bloodstream infections in a neonatal intensive care unit from 2000-2009.BMC pediatrics, , May-09, Volume: 14, 2014
Does vancomycin have a future in the treatment of skin infections?Current opinion in infectious diseases, , Volume: 27, Issue:2, 2014
Comparative analysis of empiric antimicrobial treatments for skin and soft tissue infections in newly hospitalized patients.Journal of pharmacy practice, , Volume: 27, Issue:1, 2014
Linezolid versus vancomycin for skin and soft tissue infections.The Cochrane database of systematic reviews, , Jul-12, Issue:7, 2013
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , Jun-15, Volume: 70, Issue:12, 2013
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).Current medical research and opinion, , Volume: 29, Issue:7, 2013
Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 57, Issue:5, 2013
TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:11, 2012
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:5, 2012
Early endpoints for acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:5, 2012
Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:3, 2012
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 16, Issue:1, 2012
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, , Volume: 44, Issue:2, 2011
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:3, 2011
The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.Clinical pediatrics, , Volume: 50, Issue:11, 2011
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.Journal of chemotherapy (Florence, Italy), , Volume: 22, Issue:5, 2010
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections.Future microbiology, , Volume: 5, Issue:12, 2010
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.Diagnostic microbiology and infectious disease, , Volume: 68, Issue:2, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-15, Volume: 51, Issue:6, 2010
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.Current medical research and opinion, , Volume: 26, Issue:3, 2010
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.International journal of antimicrobial agents, , Volume: 35, Issue:1, 2010
Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections.PharmacoEconomics, , Volume: 27, Issue:5, 2009
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-15, Volume: 48, Issue:2, 2009
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Mar-01, Volume: 46, Issue:5, 2008
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.Journal of chemotherapy (Florence, Italy), , Volume: 20 Suppl 1, 2008
When less is more: high-dose, short duration regimens and antibiotic resistance.International journal of clinical practice, , Volume: 62, Issue:9, 2008
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.International journal of antimicrobial agents, , Volume: 32, Issue:3, 2008
Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibiotic.Journal of clinical pharmacology, , Volume: 48, Issue:9, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:1, 2008
Dalbavancin: a review for dermatologists.Dermatology online journal, , May-30, Volume: 12, Issue:4, 2006
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study.Antimicrobial agents and chemotherapy, , Volume: 50, Issue:3, 2006
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?Antimicrobial agents and chemotherapy, , Volume: 49, Issue:11, 2005
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:11, 2005
Update on linezolid: the first oxazolidinone antibiotic.Expert opinion on pharmacotherapy, , Volume: 6, Issue:13, 2005
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 9, Issue:5, 2005
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 41 Suppl 5, 2005
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:6, 2005
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jun-01, Volume: 40, Issue:11, 2005
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
Linezolid for the treatment of complicated skin and skin structure infections in children.The Pediatric infectious disease journal, , Volume: 22, Issue:9 Suppl, 2003
Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.Surgical infections, ,Spring, Volume: 4, Issue:1, 2003
Cutaneous Bacillus cereus infection in an immunocompetent patient.Journal of the American Academy of Dermatology, , Volume: 47, Issue:2, 2002
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection GrThe Journal of antimicrobial chemotherapy, , Volume: 44, Issue:2, 1999
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.European journal of cancer (Oxford, England : 1990), , Volume: 32A, Issue:8, 1996
Rapidly growing members of the genus Mycobacterium affecting dogs and cats.Journal of the American Animal Hospital Association, , Volume: 38, Issue:3
A pharmacoeconomic model to evaluate antibiotic costs.Pharmacotherapy, , Volume: 14, Issue:4
Intraperitoneal antibiotics effectively treat non-dialysis-related infections.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, , Volume: 15, Issue:6
Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:12, 2000
Once-daily azithromycin in the treatment of adult skin and skin-structure infections.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.Journal of clinical microbiology, , Volume: 56, Issue:4, 2018
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:8, 2005
Buruli ulcer recurrence, Benin.Emerging infectious diseases, , Volume: 11, Issue:4, 2005
Acute brucellosis presenting with erythema nodosum.European journal of epidemiology, , Volume: 18, Issue:9, 2003
Perianal actinomycetoma experience of 20 cases.International journal of dermatology, , Volume: 41, Issue:8, 2002
Isolation of Dermatophilus congolensis from a cat.Journal of veterinary medicine. B, Infectious diseases and veterinary public health, , Volume: 47, Issue:2, 2000
[Cervical malignant pustule treated with a combination of penicillin, streptomycin & cortancyl; recovery from an immediate relapse in the presternal region with magnamycin].Bulletins et memoires de la Societe medicale des hopitaux de Paris, , Volume: 73, Issue:27-28
Is flucloxacillin monotherapy sufficient for the treatment of skin and soft tissue infections in plastic surgery?Journal of plastic, reconstructive & aesthetic surgery : JPRAS, , Volume: 71, Issue:6, 2018
Recent outbreak of cutaneous anthrax in Bangladesh: clinico-demographic profile and treatment outcome of cases attended at Rajshahi Medical College Hospital.BMC research notes, , Aug-28, Volume: 5, 2012
Necrotizing black tattoo reaction: what's in a name?American journal of clinical dermatology, , Volume: 10, Issue:2, 2009
Flucloxacillin-induced aplastic anaemia and liver failure.Transplant international : official journal of the European Society for Organ Transplantation, , Volume: 18, Issue:4, 2005
[Diagnostic image (202). A newborn with subfebrile temperature and skin lesions. Staphylococcal scalded skin syndrome].Nederlands tijdschrift voor geneeskunde, , Aug-14, Volume: 148, Issue:33, 2004
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:2, 2000
A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
Synthesis and Biological Evaluation of Amoxicillin Loaded Hybrid Material Composite Spheres Against Methicillin-Resistant Staphylococcus aureus.Current pharmaceutical biotechnology, , Volume: 22, Issue:5, 2021
Dual role of iodine, silver, chlorhexidine and octenidine as antimicrobial and antiprotease agents.PloS one, , Volume: 14, Issue:1, 2019
Silver nanoparticles in situ synthesized by polysaccharides from Sanghuangporus sanghuang and composites with chitosan to prepare scaffolds for the regeneration of infected full-thickness skin defects.International journal of biological macromolecules, , Mar-15, Volume: 125, 2019
Current State of Nanomedicines in the Treatment of Topical Infectious Disorders.Recent patents on anti-infective drug discovery, , Volume: 13, Issue:2, 2018
Incorporation of a Theranostic "Two-Tone" Luminescent Silver Complex into Biocompatible Agar Hydrogel Composite for the Eradication of ESKAPE Pathogens in a Skin and Soft Tissue Infection Model.Inorganic chemistry, , Jun-04, Volume: 57, Issue:11, 2018
Antibacterial activity of silver nanoparticle-coated fabric and leather against odor and skin infection causing bacteria.Applied microbiology and biotechnology, , Volume: 98, Issue:19, 2014
[Wounds and infections: "speaking about silver"].Revista de enfermeria (Barcelona, Spain), , Volume: 28, Issue:1, 2005
Ultrasound imaging for the follow-up of patients with leprosy: a pictorial essay.The British journal of dermatology, , Volume: 172, Issue:1, 2015
Clinical manifestations and diagnosis of lyme borreliosis.Current problems in dermatology, , Volume: 37, 2009
Fulminant bowel-associated dermatosis-arthritis syndrome that clinically showed necrotizing fasciitis-like severe skin and systemic manifestations.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 20, Issue:6, 2006
Bacterial complications of primary varicella in children.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 23, Issue:4, 1996
Orthopedic symptoms in pustular bacterid (pustulosis palmaris et plantaris): Tietze's syndrome and arthritis of manubriosternal joint due to focal infection.The Journal of dermatology, , Volume: 4, Issue:2, 1977
Gonnorrheal arthritis with keratodermia blennorrhagicum.Medical bulletin. United States. Army. Forces in the European Theater. Office of the Theater Chief Surgeon, , Volume: 2, Issue:1, 1947
[Cutaneous eruption and acute monoarthritis in a young woman with systemic lupus erythematosus].Annales de dermatologie et de venereologie, , Volume: 131, Issue:6-7 Pt 1
Necrobiosis lipoidica with superimposed pyoderma vegetans.Cutis, , Volume: 103, Issue:1, 2019
Effect of prophylactic cefalexin treatment on the development of bacterial infection in acute radiation-induced dermatitis in dogs: a blinded randomized controlled prospective clinical trial.Veterinary dermatology, , Volume: 29, Issue:1, 2018
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.Annals of the Academy of Medicine, Singapore, , Volume: 45, Issue:10, 2016
Wolf's isotopic response manifesting as a furuncle on the forehead of an Indian man.International journal of dermatology, , Volume: 52, Issue:1, 2013
Painful blisters on the hand.BMJ (Clinical research ed.), , Mar-26, Volume: 346, 2013
Pustular dermatitis caused by Dermatophilus congolensis.Journal of clinical microbiology, , Volume: 45, Issue:5, 2007
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.Current medical research and opinion, , Volume: 22, Issue:12, 2006
A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema.Clinical and experimental dermatology, , Volume: 27, Issue:1, 2002
Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.International journal of clinical practice, , Volume: 54, Issue:8, 2000
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:2, 2000
Primary cutaneous nocardiosis caused by Nocardia otitidiscaviarum: two cases and a review of the literature.The Journal of tropical medicine and hygiene, , Volume: 98, Issue:6, 1995
Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
Factors that affect the duration of antimicrobial therapy for cellulitis.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 24, Issue:4, 2018
Trials and tribulations of noninferiority: caveat emptor.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Apr-15, Volume: 60, Issue:8, 2015
Reply to DiNubile.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Apr-15, Volume: 60, Issue:8, 2015
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).Current medical research and opinion, , Volume: 29, Issue:7, 2013
Evaluation of cutaneous palpebral anthrax.Cutaneous and ocular toxicology, , Volume: 32, Issue:4, 2013
Palisaded neutrophilic granulomatous dermatitis caused by cellulitis in a patient with systemic lupus erythematosus.International journal of dermatology, , Volume: 50, Issue:12, 2011
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection GrThe Journal of antimicrobial chemotherapy, , Volume: 44, Issue:2, 1999
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.Drugs, , Volume: 49 Suppl 2, 1995
Randomized comparison trial of teicoplanin i.v., teicoplanin i.m., and cefazolin therapy for skin and soft tissue infections caused by gram-positive bacteria.Southern medical journal, , Volume: 87, Issue:9, 1994
Synthesis and Biological Evaluation of Amoxicillin Loaded Hybrid Material Composite Spheres Against Methicillin-Resistant Staphylococcus aureus.Current pharmaceutical biotechnology, , Volume: 22, Issue:5, 2021
Treatment of penile actinomycosis.Dermatologic therapy, , Volume: 31, Issue:5, 2018
Clinical Perineal Streptococcal Infection in Children: Epidemiologic Features, Low Symptomatic Recurrence Rate after Treatment, and Risk Factors for Recurrence.The Journal of pediatrics, , Volume: 167, Issue:3, 2015
Cutaneous nocardiosis: an underdiagnosed pathogenic infection.BMJ case reports, , Mar-02, Volume: 2015, 2015
Streptococcal intertrigo.The Journal of pediatrics, , Volume: 166, Issue:5, 2015
[Multifocal invasive infection due to Streptococcus pyogenes in a 20 month-old infant: case report].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 21 Suppl 2, 2014
Naturally occurring cutaneous anthrax: antibiotic treatment and outcome.Chemotherapy, , Volume: 58, Issue:1, 2012
Strategies to prevent, treat, and provoke Corynebacterium-associated hyperkeratosis in athymic nude mice.Journal of the American Association for Laboratory Animal Science : JAALAS, , Volume: 50, Issue:3, 2011
A review of cutaneous anthrax and its outcome.Journal of infection and public health, , Volume: 3, Issue:3, 2010
Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections.Infection, , Volume: 37, Issue:5, 2009
[Skin abscesses and a mediastinal mass in a young male].Enfermedades infecciosas y microbiologia clinica, , Volume: 24, Issue:5, 2006
Actinomycosis presenting as a large facial mass.Dermatology online journal, , Feb-28, Volume: 12, Issue:2, 2006
Primary cutaneous actinomycosis of the forehead.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 17, Issue:3, 2003
Helicobacter pylori infection in skin diseases: a critical appraisal.American journal of clinical dermatology, , Volume: 3, Issue:4, 2002
Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.MMWR. Morbidity and mortality weekly report, , Nov-16, Volume: 50, Issue:45, 2001
Isolation of Dermatophilus congolensis from a cat.Journal of veterinary medicine. B, Infectious diseases and veterinary public health, , Volume: 47, Issue:2, 2000
Perianal streptococcal dermatitis.American family physician, , Jan-15, Volume: 61, Issue:2, 2000
[Group A beta-hemolytic Streptococcus: an unusual etiology of perianal dermatitis in an adult?].Annales de dermatologie et de venereologie, , Volume: 125, Issue:12, 1998
Erysipelothrix rhusiopathiae: an uncommon but ever present zoonosis.Pathology, , Volume: 30, Issue:4, 1998
Comparative studies of cefprozil in the management of skin and soft-tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 13, Issue:10, 1994
Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Primary cutaneous nocardiosis in an immune-competent patient.European journal of dermatology : EJD, , Volume: 11, Issue:6
[Pasteurella pneumotropica skin infection in a child].Presse medicale (Paris, France : 1983), , Volume: 23, Issue:26
Skin infiltration of pelvic actinomycosis after total gastrectomy.European journal of dermatology : EJD, , Volume: 21, Issue:2
Case of atypical cutaneous BMJ case reports, , Dec-08, Volume: 12, Issue:12, 2019
Panton-valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:4, 2011
Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.Clinical and experimental dermatology, , Volume: 35, Issue:3, 2010
Rapidly growing members of the genus Mycobacterium affecting dogs and cats.Journal of the American Animal Hospital Association, , Volume: 38, Issue:3
Intraperitoneal antibiotics effectively treat non-dialysis-related infections.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, , Volume: 15, Issue:6
Suspected drug-induced destructive cholangitis in a young dog.The Journal of small animal practice, , Volume: 47, Issue:6, 2006
Generalised demodicosis in the dog: the unresponsive or recurrent case.Australian veterinary journal, , Volume: 78, Issue:4, 2000
Generalised demodicosis in dogs, clinical perspective.Australian veterinary journal, , Volume: 78, Issue:4, 2000
[Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 42, Issue:12, 1997
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, , Issue:573, 1994
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.Antimicrobial agents and chemotherapy, , Volume: 37, Issue:8, 1993
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.BMC infectious diseases, , May-24, Volume: 20, Issue:1, 2020
[no title available]BMJ case reports, , Feb-22, Volume: 2018, 2018
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.The Journal of antimicrobial chemotherapy, , 10-01, Volume: 72, Issue:10, 2017
Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria.Archives of pathology & laboratory medicine, , Volume: 138, Issue:8, 2014
[Case report; a case of lung and skin nocardiosis in a non-immunocompromised patient].Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, , Oct-10, Volume: 102, Issue:10, 2013
Nocardiosis: a 15-year experience in a tertiary medical center in Israel.European journal of internal medicine, , Volume: 24, Issue:6, 2013
Facial ecthyma gangrenosum in 2 preterm neonates.Actas dermo-sifiliograficas, , Volume: 103, Issue:7, 2012
An unusual presentation of primary cutaneous nocardiosis at a rare site: succesful treatment with a modified Welsh regimen.Dermatology online journal, , Dec-15, Volume: 17, Issue:12, 2011
Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 17, Issue:7, 2011
[Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation].[Rinsho ketsueki] The Japanese journal of clinical hematology, , Volume: 49, Issue:2, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Gangrenous ecthyma in infancy.Saudi medical journal, , Volume: 28, Issue:4, 2007
Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate.The British journal of dermatology, , Volume: 156, Issue:2, 2007
Iatrogenic Mycobacterium abscessus infection associated with acupuncture: clinical manifestations and its treatment.International journal of dermatology, , Volume: 44, Issue:10, 2005
Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa.Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, ,Spring, Volume: 26, Issue:1, 1999
The use of amikacin in the treatment of primary cutaneous mycobacteriosis due to Mycobacterium fortuitum.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 12, Issue:1, 1999
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 24, Issue:1, 1997
[Effects of hyperbaric oxygenation in skin and pulmonary infections caused by Pseudomonas aeruginosa].Minerva anestesiologica, , Volume: 62, Issue:9, 1996
Overview of the efficacy of isepamicin in the adult core clinical trial programme.Journal of chemotherapy (Florence, Italy), , Volume: 7 Suppl 2, 1995
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.Journal of chemotherapy (Florence, Italy), , Volume: 7 Suppl 2, 1995
Miliary liver abscesses and skin infection due to Yersinia enterocolitica in a patient with unsuspected hemochromatosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 21, Issue:1, 1995
Cutaneous Nocardia farcinica infection in a nonimmunocompromised patient: case report and review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 16, Issue:6, 1993
Subcutaneous nodules caused by Pseudomonas aeruginosa: healing without incision and drainage.Journal of chemotherapy (Florence, Italy), , Volume: 4, Issue:4, 1992
Rapidly growing members of the genus Mycobacterium affecting dogs and cats.Journal of the American Animal Hospital Association, , Volume: 38, Issue:3
An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy.Enfermedades infecciosas y microbiologia clinica, , Volume: 29, Issue:7
Cutaneous infection with Mycobacterium fortuitum: an unusual presentation.Indian journal of medical microbiology, , Volume: 26, Issue:4
[Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].Annales de dermatologie et de venereologie, , Volume: 135, Issue:8-9
A Review of Scabies: An Infestation More than Skin Deep.Dermatology (Basel, Switzerland), , Volume: 235, Issue:2, 2019
Ignoring the "Itch": The Global Health Problem of Scabies.The American journal of tropical medicine and hygiene, , Volume: 97, Issue:6, 2017
A case report of crusted scabies in an adult patient with Down syndrome.Dermatology online journal, , Aug-15, Volume: 21, Issue:8, 2015
Treatment of bacterial, fungal, and parasitic infections in the HIV-infected host.Seminars in dermatology, , Volume: 12, Issue:4, 1993
Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.Expert opinion on pharmacotherapy, , Volume: 18, Issue:10, 2017
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.Infection control and hospital epidemiology, , Volume: 36, Issue:8, 2015
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).Current medical research and opinion, , Volume: 29, Issue:7, 2013
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 66, Issue:11, 2011
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.International journal of antimicrobial agents, , Volume: 26, Issue:5, 2005
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.International journal of antimicrobial agents, , Volume: 23, Issue:3, 2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.The Journal of antimicrobial chemotherapy, , Volume: 53 Suppl 2, 2004
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 35, Issue:Suppl 1, 2002
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, , Issue:573, 1994
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.Antimicrobial agents and chemotherapy, , Volume: 37, Issue:8, 1993
Isolation of Dermatophilus congolensis from a cat.Journal of veterinary medicine. B, Infectious diseases and veterinary public health, , Volume: 47, Issue:2, 2000
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 24, Issue:3, 1997
[A trial of using Cefobid (cefoperazone) in treating infections of the skin and soft tissues].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 39, Issue:2-3
Link between cutaneous infection, stress and depression.Journal of biological regulators and homeostatic agents, , Volume: 31, Issue:4
Safety and tolerability of linezolid in children.The Pediatric infectious disease journal, , Volume: 22, Issue:9 Suppl, 2003
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group.International journal of dermatology, , Volume: 32, Issue:7, 1993
Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children.The Pediatric infectious disease journal, , Volume: 12, Issue:12 Suppl 3, 1993
Cefadroxil in skin and skin-structure foot infections: a retrospective review.Advances in therapy, , Volume: 12, Issue:1
Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.Medicine, , Volume: 98, Issue:6, 2019
Comparative studies of cefprozil in the management of skin and soft-tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 13, Issue:10, 1994
Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.Diagnostic microbiology and infectious disease, , Volume: 16, Issue:2, 1993
Comprehensive safety profile of cefaclor AF in respiratory, urinary tract and skin infections.Postgraduate medical journal, , Volume: 68 Suppl 3, 1992
Cefaclor AF: correlation of microbiology and clinical outcome.Postgraduate medical journal, , Volume: 68 Suppl 3, 1992
[Tinea capitis in elderly women: a report of 4 cases].Actas dermo-sifiliograficas, , Volume: 103, Issue:2, 2012
Synchronous infection with Mycobacterium chelonae and Paecilomyces in a heart transplant patient.Transplant infectious disease : an official journal of the Transplantation Society, , Volume: 13, Issue:1, 2011
Lymphocutaneous nocardiosis and cutaneous pheohyphomycosis in a liver transplant recipient.International journal of dermatology, , Volume: 47, Issue:6, 2008
The fluoroquinolones after ciprofloxacin and ofloxacin.Current clinical topics in infectious diseases, , Volume: 20, 2000
Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections.Clinical therapeutics, , Volume: 21, Issue:5, 1999
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.Clinical therapeutics, , Volume: 21, Issue:1, 1999
Mycobacterium nebraskense infection in a dog in Switzerland with disseminated skin lesions.Veterinary dermatology, , Volume: 30, Issue:3, 2019
Antibiotic susceptibility of bacteria isolated from infections in cats and dogs throughout Europe (2002-2009).Comparative immunology, microbiology and infectious diseases, , Volume: 37, Issue:2, 2014
Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.Journal of the American Animal Hospital Association, , Volume: 43, Issue:6
Efficacy and safety of ceftobiprole in patients aged 65 years or older: a Future microbiology, , Volume: 16, 2021
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 10-05, Volume: 73, Issue:7, 2021
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATInternational journal of antimicrobial agents, , Volume: 56, Issue:1, 2020
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience.Infection, , Volume: 48, Issue:2, 2020
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.Journal of global antimicrobial resistance, , Volume: 21, 2020
Possible clinical indications of ceftobiprole.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, , Volume: 32 Suppl 3, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.International journal of antimicrobial agents, , Volume: 53, Issue:6, 2019
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.International journal of antimicrobial agents, , Volume: 53, Issue:4, 2019
Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.Antimicrobial agents and chemotherapy, , Volume: 63, Issue:11, 2019
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.International journal of antimicrobial agents, , Volume: 51, Issue:3, 2018
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.The Journal of antimicrobial chemotherapy, , 04-01, Volume: 72, Issue:4, 2017
Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.Journal of clinical pharmacology, , Volume: 57, Issue:3, 2017
Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens.International journal of antimicrobial agents, , Volume: 50, Issue:6, 2017
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.Journal of global antimicrobial resistance, , Volume: 9, 2017
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.The Pediatric infectious disease journal, , Volume: 36, Issue:5, 2017
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbiditiesThe Journal of antimicrobial chemotherapy, , Volume: 71, Issue:12, 2016
In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012-2014.Diagnostic microbiology and infectious disease, , Volume: 86, Issue:2, 2016
A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection.The Pediatric infectious disease journal, , Volume: 35, Issue:8, 2016
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.Surgical infections, , Volume: 17, Issue:4, 2016
In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.The Journal of antimicrobial chemotherapy, , Volume: 71, Issue:1, 2016
Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP).Journal of chemotherapy (Florence, Italy), , Volume: 28, Issue:3, 2016
Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline.The Journal of antimicrobial chemotherapy, , Volume: 70, Issue:10, 2015
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.Pakistan journal of pharmaceutical sciences, , Volume: 28, Issue:3, 2015
Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.Antimicrobial agents and chemotherapy, , Volume: 59, Issue:8, 2015
Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013.Diagnostic microbiology and infectious disease, , Volume: 82, Issue:1, 2015
Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function.International journal of antimicrobial agents, , Volume: 45, Issue:4, 2015
Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency.Expert review of clinical pharmacology, , Volume: 8, Issue:1, 2015
[Therapy of skin and soft tissue infections from surgeon's point of view].Deutsche medizinische Wochenschrift (1946), , Volume: 139 Suppl 3, 2014
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections].Deutsche medizinische Wochenschrift (1946), , Volume: 139 Suppl 3, 2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections in obese patients.Postgraduate medicine, , Volume: 126, Issue:5, 2014
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patients.Hospital practice (1995), , Volume: 42, Issue:3, 2014
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).The Pediatric infectious disease journal, , Volume: 33, Issue:8, 2014
What's new in the treatment of serious MRSA infection?Current opinion in infectious diseases, , Volume: 27, Issue:6, 2014
[Role of ceftaroline in skin and soft tissue infections].Enfermedades infecciosas y microbiologia clinica, , Volume: 32 Suppl 2, 2014
[Case of the abscess type cutaneous nocardiosis].Medical mycology journal, , Volume: 55, Issue:1, 2014
Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.Antimicrobial agents and chemotherapy, , Volume: 58, Issue:5, 2014
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012).Diagnostic microbiology and infectious disease, , Volume: 78, Issue:4, 2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.Expert review of clinical pharmacology, , Volume: 7, Issue:2, 2014
Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).Diagnostic microbiology and infectious disease, , Volume: 78, Issue:4, 2014
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.Infection, , Volume: 41, Issue:2, 2013
Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.Journal of chemotherapy (Florence, Italy), , Volume: 25, Issue:6, 2013
Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia.Journal of clinical pharmacology, , Volume: 53, Issue:11, 2013
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , Jun-15, Volume: 70, Issue:12, 2013
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).Diagnostic microbiology and infectious disease, , Volume: 76, Issue:1, 2013
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).International journal of antimicrobial agents, , Volume: 41, Issue:4, 2013
TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:11, 2012
In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.International journal of antimicrobial agents, , Volume: 40, Issue:3, 2012
Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Drugs, , Jul-30, Volume: 72, Issue:11, 2012
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.Expert opinion on pharmacotherapy, , Volume: 13, Issue:8, 2012
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:5, 2012
Early endpoints for acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:5, 2012
[Ceftaroline fosamil, a broad spectrum cephalosporin antibiotic for the treatment of community-acquired pneumonia and complicated skin and skin structure infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 56, Issue:7-8, 2011
MRSA new treatments on the horizon: current status.Injury, , Volume: 42 Suppl 5, 2011
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.The Annals of pharmacotherapy, , Volume: 45, Issue:11, 2011
Ceftaroline (Teflaro): a new cephalosporin.The Nurse practitioner, , Volume: 36, Issue:11, 2011
Ceftaroline fosamil: a new broad-spectrum cephalosporin.The Journal of antimicrobial chemotherapy, , Volume: 66 Suppl 3, 2011
Is cefepime safe for clinical use? A Bayesian viewpoint.The Journal of antimicrobial chemotherapy, , Volume: 66, Issue:6, 2011
Ceftaroline: a comprehensive update.International journal of antimicrobial agents, , Volume: 37, Issue:5, 2011
Ceftaroline fosamil (Teflaro) - a new IV cephalosporin.The Medical letter on drugs and therapeutics, , Jan-24, Volume: 53, Issue:1356, 2011
Ceftaroline fosamil: drug profile and clinical data.Future microbiology, , Volume: 6, Issue:1, 2011
Pharmacokinetics of Cefovecin in squirrel monkey (Saimiri sciureus), rhesus macaques (Macaca mulatta), and cynomolgus macaques (Macaca fascicularis).Journal of the American Association for Laboratory Animal Science : JAALAS, , Volume: 49, Issue:6, 2010
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
The problem of complicated skin and skin structure infections: the need for new agents.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-15, Volume: 51, Issue:6, 2010
Meta-analysis of a possible signal of increased mortality associated with cefepime use.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Aug-15, Volume: 51, Issue:4, 2010
Ceftaroline for complicated skin and skin-structure infections.Expert opinion on pharmacotherapy, , Volume: 11, Issue:7, 2010
Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.Expert review of anti-infective therapy, , Volume: 7, Issue:7, 2009
Antimicrobial development in the era of emerging resistance.Mini reviews in medicinal chemistry, , Volume: 9, Issue:8, 2009
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.Diagnostic microbiology and infectious disease, , Volume: 64, Issue:2, 2009
Ceftaroline: a cephalosporin with expanded Gram-positive activity.Future microbiology, , Volume: 4, Issue:1, 2009
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.Diagnostic microbiology and infectious disease, , Volume: 61, Issue:1, 2008
Pharmacokinetic and pharmacodynamic profile of ceftobiprole.Diagnostic microbiology and infectious disease, , Volume: 61, Issue:1, 2008
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Mar-01, Volume: 46, Issue:5, 2008
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:1, 2008
[Managing children skin and soft tissue infections].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 15 Suppl 2, 2008
[Bacteriology of cutaneous infections of the child].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 15 Suppl 2, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 13 Suppl 2, 2007
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.Current medical research and opinion, , Volume: 22, Issue:12, 2006
Cephalosporins for uncomplicated skin and skin structure infections in emerging community-acquired MRSA.Expert opinion on pharmacotherapy, , Volume: 7, Issue:15, 2006
Therapeutic experience with cefdinir in the treatment of uSSSIs.International journal of clinical practice, , Volume: 60, Issue:10, 2006
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?Diagnostic microbiology and infectious disease, , Volume: 55, Issue:4, 2006
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.Diagnostic microbiology and infectious disease, , Volume: 49, Issue:4, 2004
Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections.Cutis, , Volume: 73, Issue:5 Suppl, 2004
A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema.Clinical and experimental dermatology, , Volume: 27, Issue:1, 2002
Cefditoren, a new aminothiazolyl cephalosporin.Pharmacotherapy, , Volume: 22, Issue:10, 2002
Oral prodrug enters cephalosporin market.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , Nov-01, Volume: 58, Issue:21, 2001
Attempts to stem Anthrax fears stumble.Circulation, , Nov-06, Volume: 104, Issue:19, 2001
Drug eruption induced by cefcapene pivoxil hydrochloride.Contact dermatitis, , Volume: 44, Issue:3, 2001
Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.International journal of clinical practice, , Volume: 54, Issue:8, 2000
Isolation of Dermatophilus congolensis from a cat.Journal of veterinary medicine. B, Infectious diseases and veterinary public health, , Volume: 47, Issue:2, 2000
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection GrThe Journal of antimicrobial chemotherapy, , Volume: 44, Issue:2, 1999
Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.The Pediatric infectious disease journal, , Volume: 18, Issue:7, 1999
Subcutaneous nodules with pseudomonas septicaemia in an immunocompetent patient.Anaesthesia and intensive care, , Volume: 27, Issue:2, 1999
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
Neonatal Pseudomonas putida infection presenting as staphylococcal scalded skin syndrome.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 17, Issue:9, 1998
Antibiotics in the management of pediatric skin disease.Dermatologic clinics, , Volume: 16, Issue:3, 1998
[Vibrio vulnificus infections].Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, , May-10, Volume: 87, Issue:5, 1998
Antimicrobial agents for the dermatologist. I. Beta-lactam antibiotics and related compounds.Journal of the American Academy of Dermatology, , Volume: 37, Issue:2 Pt 1, 1997
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 24, Issue:3, 1997
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 24, Issue:1, 1997
[Use of cefpirome in the treatment of patients with skin and soft tissue infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 41, Issue:12, 1996
Current and future management of serious skin and skin-structure infections.The American journal of medicine, , Jun-24, Volume: 100, Issue:6A, 1996
Primary cutaneous nocardiosis caused by Nocardia otitidiscaviarum: two cases and a review of the literature.The Journal of tropical medicine and hygiene, , Volume: 98, Issue:6, 1995
Comparative studies of cefprozil in the management of skin and soft-tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 13, Issue:10, 1994
[Clinical evaluation of S-1108 in children].The Japanese journal of antibiotics, , Volume: 46, Issue:11, 1993
Therapy of Lyme borreliosis in children.Infection, , Volume: 24, Issue:2
Cefepime.Pharmacotherapy, , Volume: 14, Issue:6
Intraperitoneal antibiotics effectively treat non-dialysis-related infections.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, , Volume: 15, Issue:6
Update on treating uncomplicated skin and skin structure infections.Journal of drugs in dermatology : JDD, , Volume: 4, Issue:6 Suppl
Cephalosporins in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America - results of AWARE surveillance 2012.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 19, Issue:6
Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 17, Issue:5
Antimicrobial development in the era of emerging resistance.Mini reviews in medicinal chemistry, , Volume: 9, Issue:8, 2009
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.The Journal of antimicrobial chemotherapy, , Volume: 50, Issue:3, 2002
Profound skin infection with bone involvement due to Nocardia asteroides in a patient with myelodysplastic syndrome.The Journal of dermatology, , Volume: 28, Issue:10, 2001
[Significant role of penem antibiotics: focused on faropenem (discussion)].The Japanese journal of antibiotics, , Volume: 50, Issue:7, 1997
Pathology in practice. Bacterial pseudomycetoma.Journal of the American Veterinary Medical Association, , Sep-01, Volume: 239, Issue:5, 2011
Use of enrofloxacin.The Veterinary record, , Jun-12, Volume: 132, Issue:24, 1993
Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.Journal of the American Animal Hospital Association, , Volume: 43, Issue:6
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response.The Journal of antimicrobial chemotherapy, , 10-28, Volume: 77, Issue:11, 2022
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing tedJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 28, Issue:9, 2022
Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.International journal of clinical pharmacology and therapeutics, , Volume: 59, Issue:9, 2021
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.The Pediatric infectious disease journal, , 03-01, Volume: 40, Issue:3, 2021
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.Antimicrobial agents and chemotherapy, , 11-17, Volume: 65, Issue:12, 2021
Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections.Expert review of clinical pharmacology, , Volume: 13, Issue:6, 2020
Safety and Tolerability of More than Six Days of Tedizolid Treatment.Antimicrobial agents and chemotherapy, , 06-23, Volume: 64, Issue:7, 2020
Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study.Acta medica portuguesa, , Jun-28, Volume: 32, Issue:6, 2019
Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials.Diagnostic microbiology and infectious disease, , Volume: 94, Issue:3, 2019
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.Drug design, development and therapy, , Volume: 11, 2017
Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity InfectionsJournal of the American Podiatric Medical Association, , Volume: 107, Issue:4, 2017
Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-15, Volume: 61 Suppl 2, 2015
A closer inspection of tedizolid - authors' reply.The Lancet. Infectious diseases, , Volume: 15, Issue:4, 2015
A closer inspection of tedizolid.The Lancet. Infectious diseases, , Volume: 15, Issue:4, 2015
A closer inspection of tedizolid.The Lancet. Infectious diseases, , Volume: 15, Issue:4, 2015
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 59, Issue:2, 2015
Cochrane in context: Linezolid versus vancomycin for skin and soft tissue infections.Evidence-based child health : a Cochrane review journal, , Volume: 9, Issue:1, 2014
What's new in the treatment of serious MRSA infection?Current opinion in infectious diseases, , Volume: 27, Issue:6, 2014
Tedizolid population pharmacokinetics, exposure response, and target attainment.Antimicrobial agents and chemotherapy, , Volume: 58, Issue:11, 2014
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.Journal of medical economics, , Volume: 17, Issue:10, 2014
New antibiotics for skin and skin-structure infections.The Lancet. Infectious diseases, , Volume: 14, Issue:8, 2014
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.The Lancet. Infectious diseases, , Volume: 14, Issue:8, 2014
Once-weekly dalbavancin versus daily conventional therapy for skin infection.The New England journal of medicine, , Jun-05, Volume: 370, Issue:23, 2014
Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study.Surgical infections, , Volume: 15, Issue:2, 2014
Linezolid versus vancomycin for skin and soft tissue infections.The Cochrane database of systematic reviews, , Jul-12, Issue:7, 2013
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:11, 2012
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 16, Issue:1, 2012
Mycobacterium chelonae infection involving the auricle.QJM : monthly journal of the Association of Physicians, , Volume: 105, Issue:10, 2012
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:12, 2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 52 Suppl 7, 2011
Linezolid: safety and efficacy in special populations.The Journal of antimicrobial chemotherapy, , Volume: 66 Suppl 4, 2011
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:2, 2011
The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.Clinical pediatrics, , Volume: 50, Issue:11, 2011
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Expert review of anti-infective therapy, , Volume: 8, Issue:9, 2010
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.Current medical research and opinion, , Volume: 26, Issue:3, 2010
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.International journal of antimicrobial agents, , Volume: 35, Issue:1, 2010
[Therapy of SSTI and role of tigecycline].Le infezioni in medicina, , Volume: 17 Suppl 4, 2009
Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study".Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jul-15, Volume: 49, Issue:2, 2009
Noninferiority of linezolid for skin and bloodstream infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jul-15, Volume: 49, Issue:2, 2009
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-15, Volume: 48, Issue:2, 2009
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.International journal of antimicrobial agents, , Volume: 32, Issue:3, 2008
Dalbavancin: a review for dermatologists.Dermatology online journal, , May-30, Volume: 12, Issue:4, 2006
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?Antimicrobial agents and chemotherapy, , Volume: 49, Issue:11, 2005
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Nov-15, Volume: 41, Issue:10, 2005
Update on linezolid: the first oxazolidinone antibiotic.Expert opinion on pharmacotherapy, , Volume: 6, Issue:13, 2005
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:6, 2005
Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.The Annals of pharmacotherapy, , Volume: 39, Issue:3, 2005
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.The British journal of dermatology, , Volume: 151, Issue:5, 2004
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Disease-a-month : DM, , Volume: 50, Issue:7, 2004
Efficacy and tolerability of linezolid in treating severe skin and soft tissue infections caused by Gram-positive pathogens.Journal of the Formosan Medical Association = Taiwan yi zhi, , Volume: 103, Issue:5, 2004
Antibiotics: what's new?Cutis, , Volume: 73, Issue:5 Suppl, 2004
Novel antibacterial agents for skin and skin structure infections.Journal of the American Academy of Dermatology, , Volume: 50, Issue:3, 2004
In vitro activities of new antimicrobials against Nocardia brasiliensis.Antimicrobial agents and chemotherapy, , Volume: 48, Issue:2, 2004
Safety and tolerability of linezolid in children.The Pediatric infectious disease journal, , Volume: 22, Issue:9 Suppl, 2003
Linezolid for the treatment of complicated skin and skin structure infections in children.The Pediatric infectious disease journal, , Volume: 22, Issue:9 Suppl, 2003
Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.Journal of drugs in dermatology : JDD, , Volume: 2, Issue:4, 2003
[Contribution of linezolid to the treatment of complicated infections of the skin and soft tissues].Presse medicale (Paris, France : 1983), , Apr-05, Volume: 32, Issue:13 Pt 2, 2003
Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.Surgical infections, ,Spring, Volume: 4, Issue:1, 2003
A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid.American journal of surgery, , Volume: 185, Issue:4, 2003
Therapeutic efficacy of linezolid in extended clinical practice.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 22, Issue:2, 2003
[Linezolide--an antibiotic with new action mechanism].Lakartidningen, , Mar-14, Volume: 99, Issue:11, 2002
Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 21, Issue:7, 2002
Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:12, 2000
Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 31 Suppl 4, 2000
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Diagnosis and therapy of Mycobacterium marinum: a single-center 21-year retrospective analysis.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, , Volume: 20, Issue:9, 2022
Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.Nature communications, , 05-03, Volume: 13, Issue:1, 2022
A case of cutaneous nodules in a sporotrichoid pattern.Dermatology online journal, , Mar-15, Volume: 25, Issue:3, 2019
Case of atypical cutaneous BMJ case reports, , Dec-08, Volume: 12, Issue:12, 2019
[no title available]BMJ case reports, , Dec-08, Volume: 12, Issue:12, 2019
Mycobacterium marinum infections in Denmark from 2004 to 2017: A retrospective study of incidence, patient characteristics, treatment regimens and outcome.Scientific reports, , 04-30, Volume: 8, Issue:1, 2018
Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis.Diseases of aquatic organisms, , Mar-05, Volume: 127, Issue:3, 2018
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.Journal of clinical microbiology, , Volume: 56, Issue:4, 2018
Cutaneous infection due to Mycobacterium immunogenum: an European case report and review of the literature.Dermatology online journal, , Oct-15, Volume: 23, Issue:10, 2017
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.The Journal of antimicrobial chemotherapy, , 10-01, Volume: 72, Issue:10, 2017
Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection.The British journal of dermatology, , Volume: 177, Issue:1, 2017
Cutaneous Mycobacterium chelonae in a 95-year-old woman.Dermatology online journal, , Feb-15, Volume: 23, Issue:2, 2017
Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 30, Issue:1, 2016
Cutaneous infection with Mycobacterium kansasii in a patient with myelodysplastic syndrome and Sweet syndrome.Cutis, , Volume: 96, Issue:1, 2015
Treatment of sporotrichoid fish tank granuloma with pulsed clarithromycin.Dermatology (Basel, Switzerland), , Volume: 229, Issue:2, 2014
Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria.Archives of pathology & laboratory medicine, , Volume: 138, Issue:8, 2014
Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis.The Journal of dermatology, , Volume: 41, Issue:5, 2014
Mycobacterium marinum infection following contact with reptiles: vivarium granuloma.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 21, 2014
[Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α].Medicina clinica, , Feb-20, Volume: 142, Issue:4, 2014
Epithelioid histiocytic infiltrate caused by Mycobacterium scrofulaceum infection: a potential mimic of various neoplastic entities.The American Journal of dermatopathology, , Volume: 35, Issue:2, 2013
A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma.The Journal of dermatological treatment, , Volume: 24, Issue:1, 2013
Mycobacteria infection in an immunocompetent patient with no risk factors: evaluation and management of non-healing majocchi granuloma-type nodule.Dermatology online journal, , Aug-15, Volume: 19, Issue:8, 2013
Cutaneous Mycobacterium intracellulare infection in an immuno-competent person.Acta dermato-venereologica, , Volume: 93, Issue:6, 2013
A rifampicin-resistant Mycobacterium marinum infection in a newly diagnosed HIV-1 individual.International journal of STD & AIDS, , Volume: 24, Issue:1, 2013
Mycobacterium chelonae infection involving the auricle.QJM : monthly journal of the Association of Physicians, , Volume: 105, Issue:10, 2012
Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents.Journal of the American Academy of Dermatology, , Volume: 65, Issue:5, 2011
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.Emerging infectious diseases, , Volume: 17, Issue:9, 2011
[Development of subcutaneous nodules after mesotherapy].Enfermedades infecciosas y microbiologia clinica, , Volume: 29, Issue:10, 2011
Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man.BMC dermatology, , Jan-26, Volume: 11, 2011
Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 17, Issue:7, 2011
Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment.Transplant infectious disease : an official journal of the Transplantation Society, , Volume: 13, Issue:1, 2011
Synchronous infection with Mycobacterium chelonae and Paecilomyces in a heart transplant patient.Transplant infectious disease : an official journal of the Transplantation Society, , Volume: 13, Issue:1, 2011
Mycobacterium abscessus infection complicating a professional tattoo.The Australasian journal of dermatology, , Volume: 51, Issue:4, 2010
Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.Clinical and experimental dermatology, , Volume: 35, Issue:3, 2010
Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.Journal of Korean medical science, , Volume: 25, Issue:2, 2010
An outbreak of Mycobacterium chelonae infections in tattoos.Journal of the American Academy of Dermatology, , Volume: 62, Issue:3, 2010
Cutaneous Mycobacterium chelonae infection presenting as symmetrical plaques on both shins in an immunocompetent patient.Acta dermato-venereologica, , Volume: 89, Issue:6, 2009
Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Nov-01, Volume: 49, Issue:9, 2009
Rapidly growing mycobacteria: emerging pathogens in cosmetic procedures of the skin.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Nov-01, Volume: 49, Issue:9, 2009
Nontuberculous mycobacterial skin infections: recognition and management.American journal of clinical dermatology, , Volume: 10, Issue:5, 2009
Subcutaneous nodules with sporotrichoid spread.Dermatology online journal, , May-15, Volume: 15, Issue:5, 2009
Cutaneous nontuberculous mycobacterial infection: a clinicopathological study of 7 cases.The American Journal of dermatopathology, , Volume: 31, Issue:3, 2009
Unresolving furunculosis in a diabetic patient: cutaneous Mycobacterium abscessus infection.Annals of the Academy of Medicine, Singapore, , Volume: 38, Issue:2, 2009
'Fish-tank' granuloma: a diagnostic dilemma.Internal medicine journal, , Volume: 39, Issue:5, 2009
[Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation].[Rinsho ketsueki] The Japanese journal of clinical hematology, , Volume: 49, Issue:2, 2008
Mycobacterium mucogenicum: report of a skin infection associated with etanercept.Dermatology online journal, , Jan-15, Volume: 14, Issue:1, 2008
Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases.Journal of the American Academy of Dermatology, , Volume: 57, Issue:3, 2007
Mycobacterium marinum infection: a case report and review of the literature.Cutis, , Volume: 79, Issue:1, 2007
Comparative tolerability, safety and efficacy of tablet formulations of twice-daily clarithromycin 250 mg versus once-daily extended-release clarithromycin 500 mg in pediatric and adolescent patients.Clinical pediatrics, , Volume: 45, Issue:7, 2006
Case report of non-healing wounds presenting to a DGH, South East London.Emergency medicine journal : EMJ, , Volume: 23, Issue:8, 2006
Cutaneous infection with rapidly-growing mycobacterial infection following heart transplant: a case report and review of the literature.Transplantation proceedings, , Volume: 38, Issue:5, 2006
Iatrogenic Mycobacterium abscessus infection associated with acupuncture: clinical manifestations and its treatment.International journal of dermatology, , Volume: 44, Issue:10, 2005
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.The British journal of dermatology, , Volume: 151, Issue:5, 2004
Macrolides in dermatology.Disease-a-month : DM, , Volume: 50, Issue:7, 2004
Subcutaneous infection with Mycobacterium abscessus in a renal transplant recipient.Dermatology (Basel, Switzerland), , Volume: 208, Issue:3, 2004
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
[Cutaneous infection with Mycobacterium marinum. successful therapy with rifampicin and clarithromycin].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:1, 2004
Disseminated Mycobacterium chelonae cutaneous infection: recalcitrant to combined antibiotic therapy.The Journal of dermatology, , Volume: 30, Issue:6, 2003
Helicobacter pylori infection in skin diseases: a critical appraisal.American journal of clinical dermatology, , Volume: 3, Issue:4, 2002
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].Deutsche medizinische Wochenschrift (1946), , Apr-05, Volume: 127, Issue:14, 2002
Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review.The Journal of infection, , Volume: 43, Issue:3, 2001
Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene.International journal of dermatology, , Volume: 40, Issue:8, 2001
[Cutaneous nodular infection with hemopathy].Annales de pathologie, , Volume: 20, Issue:4, 2000
Mycobacterium branderi from both a hand infection and a case of pulmonary disease.Journal of clinical microbiology, , Volume: 38, Issue:10, 2000
Successful treatment using clarithromycin for a cutaneous lesion caused by Mycobacterium szulgai.The British journal of dermatology, , Volume: 142, Issue:4, 2000
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.The American journal of tropical medicine and hygiene, , Volume: 61, Issue:5, 1999
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum].Deutsche medizinische Wochenschrift (1946), , Oct-15, Volume: 124, Issue:41, 1999
Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells.International journal of dermatology, , Volume: 38, Issue:10, 1999
Fish tank granuloma: response to treatment with clarithromycin.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 12, Issue:1, 1999
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.Transplant international : official journal of the European Society for Organ Transplantation, , Volume: 12, Issue:1, 1999
[Painful nodular lesions].La Revue de medecine interne, , Volume: 19, Issue:9, 1998
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated fAntimicrobial agents and chemotherapy, , Volume: 42, Issue:5, 1998
Isolated cutaneous Mycobacterium avium complex infection in AIDS.International journal of dermatology, , Volume: 36, Issue:4, 1997
Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection.Journal of the American Academy of Dermatology, , Volume: 36, Issue:3 Pt 1, 1997
Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient.The British journal of dermatology, , Volume: 134, Issue:4, 1996
Recurrent disseminated infection with Mycobacterium avium complex identified in tissues by molecular analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 22, Issue:4, 1996
Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 20, Issue:2, 1995
Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 18, Issue:6, 1994
Clarithromycin: a potent agent against infections due to Mycobacterium marinum.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 18, Issue:4, 1994
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.Antimicrobial agents and chemotherapy, , Volume: 38, Issue:11, 1994
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 16, Issue:4, 1993
Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin.Journal of the American Academy of Dermatology, , Volume: 28, Issue:6, 1993
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.Annals of internal medicine, , Sep-15, Volume: 119, Issue:6, 1993
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group.International journal of dermatology, , Volume: 32, Issue:7, 1993
Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children.The Pediatric infectious disease journal, , Volume: 12, Issue:12 Suppl 3, 1993
Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults.The Pediatric infectious disease journal, , Volume: 12, Issue:12 Suppl 3, 1993
Rapidly growing members of the genus Mycobacterium affecting dogs and cats.Journal of the American Animal Hospital Association, , Volume: 38, Issue:3
Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen.Acta dermato-venereologica, , Volume: 81, Issue:4
Disseminated cutaneous Mycobacterium chelonae infection.Cancer control : journal of the Moffitt Cancer Center, , Volume: 7, Issue:2
Cutaneous Infection with Mycobacterium abscessus in a child.Pediatric dermatology, , Volume: 23, Issue:2
Successful treatment of localized cutaneous infection caused by Mycobacterium scrofulaceum with clarithromycin.Pediatric dermatology, , Volume: 22, Issue:5
Nocardia otitidiscaviarum: an unusual Nocardia species causing a primary lymphocutaneous infectious process in a mildly immunosuppressed patient.Skinmed, , Volume: 1, Issue:1
Macrolides in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy.Enfermedades infecciosas y microbiologia clinica, , Volume: 29, Issue:7
Cutaneous infection with Mycobacterium fortuitum: an unusual presentation.Indian journal of medical microbiology, , Volume: 26, Issue:4
[Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].Annales de dermatologie et de venereologie, , Volume: 135, Issue:8-9
Surgical Site Infection Caused by Mycobacterium Septicum Following Blepharoplasty.The Journal of craniofacial surgery, , Volume: 31, Issue:3
Prevalence and factors related to antibiotic prescription in Benin: a school-based study.Acta tropica, , Volume: 127, Issue:2, 2013
BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.The American journal of tropical medicine and hygiene, , Volume: 75, Issue:4, 2006
Buruli ulcer recurrence, Benin.Emerging infectious diseases, , Volume: 11, Issue:4, 2005
Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity.Tropical medicine & international health : TM & IH, , Volume: 9, Issue:12, 2004
[Histopathological findings of Buruli ulcer: cases from Benin in west Africa].Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association, , Volume: 71, Issue:3, 2002
Insects in the transmission of Mycobacterium ulcerans infection.Lancet (London, England), , Mar-20, Volume: 353, Issue:9157, 1999
[Buruli's ulcer, a pathology little known in Benin. Apropos of 227 cases].Bulletin de la Societe de pathologie exotique (1990), , Volume: 87, Issue:3, 1994
The multifunctional LigB adhesin binds homeostatic proteins with potential roles in cutaneous infection by pathogenic Leptospira interrogans.PloS one, , Feb-09, Volume: 6, Issue:2, 2011
A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans.The Journal of infectious diseases, , Mar-01, Volume: 199, Issue:5, 2009
Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection.Infection and immunity, , Volume: 72, Issue:1, 2004
Inactivation of single genes within the virulence regulon of an M2 group A streptococcal isolate result in differences in virulence for chicken embryos and for mice.Microbial pathogenesis, , Volume: 23, Issue:6, 1997
Effective treatment of tinea corporis due to Trichophyton mentagrophytes with combined isoconazole nitrate and diflucortolone valerate therapy.Mycoses, , Volume: 56 Suppl 1, 2013
Inflammatory tinea pedis with bacterial superinfection effectively treated with isoconazole nitrate and diflucortolone valerate combination therapy.Mycoses, , Volume: 56 Suppl 1, 2013
Paederus dermatitis in Sierra Leone.Dermatology online journal, , Dec-10, Volume: 12, Issue:7, 2006
Macrococcus canis sp. nov., a skin bacterium associated with infections in dogs.International journal of systematic and evolutionary microbiology, , Volume: 67, Issue:3, 2017
Arsenicicoccus dermatophilus sp. nov., a hypha-forming bacterium isolated from the skin of greater flamingos (Phoenicopterus roseus) with pododermatitis.International journal of systematic and evolutionary microbiology, , Volume: 63, Issue:Pt 11, 2013
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.BMC infectious diseases, , May-24, Volume: 20, Issue:1, 2020
Case of atypical cutaneous BMJ case reports, , Dec-08, Volume: 12, Issue:12, 2019
A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.Clinical therapeutics, , Volume: 28, Issue:8, 2006
Chromobacterium violaceum infection.British journal of hospital medicine (London, England : 2005), , Volume: 67, Issue:4, 2006
Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.Surgical infections, ,Fall, Volume: 6, Issue:3, 2005
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature.The Journal of infection, , Volume: 51, Issue:2, 2005
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
Primary cutaneous nocardiosis.European journal of dermatology : EJD, , Volume: 8, Issue:6, 1998
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.Drugs, , Volume: 49 Suppl 2, 1995
Miliary liver abscesses and skin infection due to Yersinia enterocolitica in a patient with unsuspected hemochromatosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 21, Issue:1, 1995
[Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].Annales de dermatologie et de venereologie, , Volume: 135, Issue:8-9
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience.Infection, , Volume: 48, Issue:2, 2020
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.Journal of global antimicrobial resistance, , Volume: 21, 2020
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.International journal of antimicrobial agents, , Volume: 53, Issue:4, 2019
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.International journal of antimicrobial agents, , Volume: 51, Issue:3, 2018
Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.The Journal of antimicrobial chemotherapy, , 04-01, Volume: 72, Issue:4, 2017
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.Journal of global antimicrobial resistance, , Volume: 9, 2017
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 35, Issue:Suppl 1, 2002
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, , Issue:573, 1994
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.Antimicrobial agents and chemotherapy, , Volume: 37, Issue:8, 1993
Outcome, complications and future fertility in women treated with uterine artery embolization and methotrexate for non-tubal ectopic pregnancy.European journal of obstetrics, gynecology, and reproductive biology, , Volume: 182, 2014
Nocardia neocaledoniensis [corrected] as a cause of skin and soft tissue infection.Journal of clinical microbiology, , Volume: 50, Issue:9, 2012
[A rare complication in a patient with rheumatoid arthritis: sudden appearance of nodules on the forearm].MMW Fortschritte der Medizin, , Feb-09, Volume: 154, Issue:2, 2012
Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents.Journal of the American Academy of Dermatology, , Volume: 65, Issue:5, 2011
Primary cutaneous nocardiosis in 2 patients on immunosuppressants.Scandinavian journal of infectious diseases, , Volume: 37, Issue:6-7, 2005
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].Deutsche medizinische Wochenschrift (1946), , Apr-05, Volume: 127, Issue:14, 2002
Cutaneous anthrax in an unusual location: case report.Le infezioni in medicina, , Volume: 23, Issue:4, 2015
Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 17, Issue:12, 2013
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).Current medical research and opinion, , Volume: 29, Issue:7, 2013
Evaluation of cutaneous palpebral anthrax.Cutaneous and ocular toxicology, , Volume: 32, Issue:4, 2013
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.BMC infectious diseases, , Nov-12, Volume: 12, 2012
Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 31, Issue:2, 2000
Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.The Pediatric infectious disease journal, , Volume: 18, Issue:7, 1999
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 24, Issue:3, 1997
Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 15, Issue:12, 1996
[Sultamicillin in treatment of suppurative skin disorders].Polski tygodnik lekarski (Warsaw, Poland : 1960), , Volume: 48 Suppl 2, 1993
Low-dose sultamicillin oral suspension in the treatment of mild to moderate paediatric infections in Turkey.The Journal of international medical research, , Volume: 20 Suppl 1, 1992
A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.Advances in therapy, , Volume: 11, Issue:4
Link between cutaneous infection, stress and depression.Journal of biological regulators and homeostatic agents, , Volume: 31, Issue:4
The role of carbapenem-resistant pathogens in cSSTI and how to manage them.Current opinion in infectious diseases, , Volume: 32, Issue:2, 2019
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.Infection control and hospital epidemiology, , Volume: 36, Issue:8, 2015
[Case report; a case of lung and skin nocardiosis in a non-immunocompromised patient].Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, , Oct-10, Volume: 102, Issue:10, 2013
Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 17, Issue:12, 2013
Klebsiella necrotizing soft tissue infections in liver transplant recipients: a case series.Transplant infectious disease : an official journal of the Transplantation Society, , Volume: 15, Issue:4, 2013
Nocardiosis: a 15-year experience in a tertiary medical center in Israel.European journal of internal medicine, , Volume: 24, Issue:6, 2013
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 16, Issue:1, 2012
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Expert review of anti-infective therapy, , Volume: 8, Issue:9, 2010
Acinetobacter baumannii skin and soft-tissue infection associated with war trauma.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Aug-15, Volume: 47, Issue:4, 2008
Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.The Journal of antimicrobial chemotherapy, , Volume: 48, Issue:5, 2001
[Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].The Japanese journal of antibiotics, , Volume: 48, Issue:1, 1995
NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India.Journal of medical microbiology, , Volume: 61, Issue:Pt 3, 2012
[Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections].Le infezioni in medicina, , Volume: 17 Suppl 4, 2009
Antimicrobial development in the era of emerging resistance.Mini reviews in medicinal chemistry, , Volume: 9, Issue:8, 2009
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.Pediatrics, , Volume: 123, Issue:6, 2009
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.International journal of antimicrobial agents, , Volume: 33, Issue:2, 2009
[Bacteriology of cutaneous infections of the child].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 15 Suppl 2, 2008
[Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 15 Suppl 2, 2008
Oral beta-lactams applied to uncomplicated infections of skin and skin structures.Diagnostic microbiology and infectious disease, , Volume: 57, Issue:3 Suppl, 2007
Fluoroquinolones vs beta-lactams for empirical treatment of immunocompetent patients with skin and soft tissue infections: a meta-analysis of randomized controlled trials.Mayo Clinic proceedings, , Volume: 81, Issue:12, 2006
Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.The Journal of antimicrobial chemotherapy, , Volume: 58, Issue:3, 2006
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.International journal of antimicrobial agents, , Volume: 23, Issue:3, 2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.The Journal of antimicrobial chemotherapy, , Volume: 53 Suppl 2, 2004
Complicated infections of skin and skin structures: when the infection is more than skin deep.The Journal of antimicrobial chemotherapy, , Volume: 53 Suppl 2, 2004
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.Diagnostic microbiology and infectious disease, , Volume: 43, Issue:2, 2002
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.The Journal of antimicrobial chemotherapy, , Volume: 50, Issue:3, 2002
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 35, Issue:Suppl 1, 2002
Profound skin infection with bone involvement due to Nocardia asteroides in a patient with myelodysplastic syndrome.The Journal of dermatology, , Volume: 28, Issue:10, 2001
Combating bacterial resistance in skin and skin-structure infection: importance of beta-lactamase inhibition.American journal of therapeutics, , Volume: 6, Issue:1, 1999
Antimicrobial agents for the dermatologist. I. Beta-lactam antibiotics and related compounds.Journal of the American Academy of Dermatology, , Volume: 38, Issue:5 Pt 1, 1998
[Significant role of penem antibiotics: focused on faropenem (discussion)].The Japanese journal of antibiotics, , Volume: 50, Issue:7, 1997
Successful treatment of cutaneous Mycobacterium chelonae infection by switching from levofloxacin to sitafloxacin.The Journal of dermatology, , Volume: 50, Issue:6, 2023
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.BMC infectious diseases, , May-24, Volume: 20, Issue:1, 2020
Acute retiform purpura caused by BMJ case reports, , Dec-23, Volume: 12, Issue:12, 2019
Two cases of human cutaneous anthrax with massive tissue damage, severe edema, and slight injury to the liver.International journal of dermatology, , Volume: 57, Issue:3, 2018
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 22, Issue:10, 2016
The potential role of nemonoxacin for treatment of common infections.Expert opinion on pharmacotherapy, , Volume: 16, Issue:2, 2015
[Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 59, Issue:11-12, 2014
Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis.The Journal of dermatology, , Volume: 41, Issue:5, 2014
[Levofloxacin in complex therapy of patients with skin and soft tissue infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 53, Issue:9-10, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Successful treatment of a widespread cutaneous Mycobacterium fortuitum infection with levofloxacin.International journal of dermatology, , Volume: 45, Issue:9, 2006
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 49, Issue:8-9, 2004
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
Levofloxacin alone efficiently treated a cutaneous mycobacterium fortuitum infection.The Journal of dermatology, , Volume: 29, Issue:7, 2002
Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.Antimicrobial agents and chemotherapy, , Volume: 45, Issue:8, 2001
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.Drug safety, , Volume: 24, Issue:3, 2001
Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:5, 2000
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.International journal of clinical practice, , Volume: 52, Issue:2, 1998
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.JAMA, , Jan-14, Volume: 279, Issue:2, 1998
Mycobacterium marinum skin infection successfully treated with levofloxacin.Archives of dermatology, , Volume: 133, Issue:8, 1997
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.International journal of antimicrobial agents, , Volume: 33, Issue:2, 2009
Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.The Journal of antimicrobial chemotherapy, , Volume: 58, Issue:3, 2006
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.International journal of antimicrobial agents, , Volume: 23, Issue:3, 2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.The Journal of antimicrobial chemotherapy, , Volume: 53 Suppl 2, 2004
Complicated infections of skin and skin structures: when the infection is more than skin deep.The Journal of antimicrobial chemotherapy, , Volume: 53 Suppl 2, 2004
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.Diagnostic microbiology and infectious disease, , Volume: 43, Issue:2, 2002
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 35, Issue:Suppl 1, 2002
Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.Expert opinion on pharmacotherapy, , Volume: 18, Issue:10, 2017
A Meta-analysis of Sequential Intravenous/Oral Moxifloxacin Monotherapy for Treatment of Skin and Skin Structure Infections.Drug research, , Volume: 65, Issue:12, 2015
Mycobacterium fortuitum Complex Skin Infection in a Healthy Adolescent.Infectious disorders drug targets, , Volume: 14, Issue:3, 2014
[A severe cutaneous anthrax case complicated with sepsis in Bursa, Turkey].Mikrobiyoloji bulteni, , Volume: 47, Issue:3, 2013
Sequential intravenous/oral moxifloxacin monotherapy for complicated skin and skin structure infections: a meta-analysis of randomised controlled trials.International journal of clinical practice, , Volume: 67, Issue:9, 2013
Switch and gain - sequential moxifloxacin monotherapy.International journal of clinical practice, , Volume: 67, Issue:9, 2013
Moxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study.Advances in therapy, , Volume: 30, Issue:6, 2013
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 66, Issue:11, 2011
[Development of subcutaneous nodules after mesotherapy].Enfermedades infecciosas y microbiologia clinica, , Volume: 29, Issue:10, 2011
Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 17, Issue:7, 2011
Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections.Infection, , Volume: 37, Issue:5, 2009
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.International journal of antimicrobial agents, , Volume: 26, Issue:5, 2005
The role of fluoroquinolones in skin and skin structure infections.American journal of clinical dermatology, , Volume: 3, Issue:1, 2002
[Moxifloxacin: results of clinical use].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 47, Issue:10, 2002
Moxifloxacin (Avelox) for the treatment of bacterial skin infections.Skin therapy letter, , Volume: 6, Issue:11, 2001
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.Antimicrobial agents and chemotherapy, , Volume: 41, Issue:7, 1997
[Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].Annales de dermatologie et de venereologie, , Volume: 135, Issue:8-9
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies.Clinical therapeutics, , Volume: 41, Issue:6, 2019
Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections.International journal of antimicrobial agents, , Volume: 52, Issue:2, 2018
Iclaprim, a dihydrofolate reductase inhibitor antibiotic in Phase III of clinical development: a review of its pharmacology, microbiology and clinical efficacy and safety.Future microbiology, , Volume: 13, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive PathAntimicrobial agents and chemotherapy, , Volume: 62, Issue:5, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive PathClinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 04-03, Volume: 66, Issue:8, 2018
Antimicrobial development in the era of emerging resistance.Mini reviews in medicinal chemistry, , Volume: 9, Issue:8, 2009
Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections.Future microbiology, , Volume: 4, Issue:2, 2009
[Various bacterial dermatoses & their treatment with usnic acid].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 9, Issue:11, 1958
[The treatment of bacterial skin diseases with usnic acid].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 6, Issue:11, 1955
Case of cutaneous botryomycosis in an 8-year-old immunocompetent boy with a review of the published work.The Journal of dermatology, , Volume: 47, Issue:5, 2020
Impact of Trimethoprim-sulfamethoxazole Urinary Tract Infection Prophylaxis on Non-UTI Infections.The Pediatric infectious disease journal, , Volume: 38, Issue:4, 2019
Cutaneous melioidosis: a review of the literature.International journal of dermatology, , Volume: 58, Issue:2, 2019
[no title available]BMJ case reports, , Dec-08, Volume: 12, Issue:12, 2019
Subgroup Analysis of Antibiotic Treatment for Skin Abscesses.Annals of emergency medicine, , Volume: 71, Issue:1, 2018
Image Gallery: Cutaneous botryomycosis at an unusual site in an immunocompetent patient.The British journal of dermatology, , Volume: 176, Issue:1, 2017
A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.The New England journal of medicine, , 06-29, Volume: 376, Issue:26, 2017
Successful Short-Term Intravenous Treatment of Disseminated Nocardia farcinica Infection with Severe Hyponatremia After Kidney Transplantation: A Case Report.Transplantation proceedings, , Volume: 48, Issue:9, 2016
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.Annals of the Academy of Medicine, Singapore, , Volume: 45, Issue:10, 2016
Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.AIDS (London, England), , 11-28, Volume: 30, Issue:18, 2016
Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Abscess.The New England journal of medicine, , 07-21, Volume: 375, Issue:3, 2016
Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Abscess.The New England journal of medicine, , 07-21, Volume: 375, Issue:3, 2016
Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Abscess.The New England journal of medicine, , 07-21, Volume: 375, Issue:3, 2016
Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Abscess.The New England journal of medicine, , 07-21, Volume: 375, Issue:3, 2016
Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess.The New England journal of medicine, , Mar-03, Volume: 374, Issue:9, 2016
Clindamycin and trimethoprim-sulfamethoxazole equally effective in treating skin infection.The Journal of pediatrics, , Volume: 167, Issue:3, 2015
ACP Journal Club. Clindamycin did not differ from trimethoprim-sulfamethoxazole for curing uncomplicated skin infections.Annals of internal medicine, , Jul-21, Volume: 163, Issue:2, 2015
Antibacterial Treatment for Uncomplicated Skin Infections.The New England journal of medicine, , 06-18, Volume: 372, Issue:25, 2015
Antibacterial Treatment for Uncomplicated Skin Infections.The New England journal of medicine, , 06-18, Volume: 372, Issue:25, 2015
Antibacterial Treatment for Uncomplicated Skin Infections.The New England journal of medicine, , 06-18, Volume: 372, Issue:25, 2015
Choosing an antibiotic for skin infections.The New England journal of medicine, , Mar-19, Volume: 372, Issue:12, 2015
Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.The New England journal of medicine, , Mar-19, Volume: 372, Issue:12, 2015
Mycobacterium fortuitum Complex Skin Infection in a Healthy Adolescent.Infectious disorders drug targets, , Volume: 14, Issue:3, 2014
Trimethoprim-sulfamethoxazole for skin and soft tissue infections--let us not forget the risks.Annals of emergency medicine, , Volume: 63, Issue:6, 2014
[Case of the abscess type cutaneous nocardiosis].Medical mycology journal, , Volume: 55, Issue:1, 2014
Cutaneous Serratia marcescens infection in an immunocompetent patient after filler injection.Acta dermato-venereologica, , Mar-27, Volume: 93, Issue:2, 2013
Nocardiosis: a 15-year experience in a tertiary medical center in Israel.European journal of internal medicine, , Volume: 24, Issue:6, 2013
Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:11, 2012
An unusual presentation of primary cutaneous nocardiosis at a rare site: succesful treatment with a modified Welsh regimen.Dermatology online journal, , Dec-15, Volume: 17, Issue:12, 2011
Primary cutaneous actinomycosis caused by Actinomyces meyeri as first manifestation of HIV infection.Dermatology online journal, , Nov-15, Volume: 17, Issue:11, 2011
Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections.Pediatrics, , Volume: 128, Issue:3, 2011
Nocardia infection in kidney transplant recipients: case report and analysis of 66 published cases.Transplant infectious disease : an official journal of the Transplantation Society, , Volume: 13, Issue:4, 2011
Lymphocutaneous type of nocardiosis caused by Nocardia vinacea in a patient with polymyositis.Mycopathologia, , Volume: 172, Issue:1, 2011
Streptomyces bacteremia in a patient with actinomycotic mycetoma.Journal of infection in developing countries, , May-01, Volume: 4, Issue:4, 2010
Lack of antibiotic efficacy for simple abscesses: have matters come to a head?Annals of emergency medicine, , Volume: 55, Issue:5, 2010
Are we looking for superiority, equivalence, or noninferiority? Asking the right question and answering it correctly.Annals of emergency medicine, , Volume: 55, Issue:5, 2010
Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient.Annals of emergency medicine, , Volume: 55, Issue:5, 2010
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.Pediatrics, , Volume: 123, Issue:6, 2009
Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature.Diagnostic microbiology and infectious disease, , Volume: 63, Issue:3, 2009
Lymphocutaneous nocardiosis and cutaneous pheohyphomycosis in a liver transplant recipient.International journal of dermatology, , Volume: 47, Issue:6, 2008
Disseminated subcutaneous nocardiosis caused by Nocardia farcinica diagnosed by FNA biopsy and 16S ribosomal gene sequencing.Diagnostic cytopathology, , Volume: 36, Issue:4, 2008
A 39-year-old man with a skin infection.JAMA, , Jan-02, Volume: 299, Issue:1, 2008
The history holds the key in this gardener with a skin infection.JAAPA : official journal of the American Academy of Physician Assistants, , Volume: 21, Issue:9, 2008
Cutaneous actinomycosis: a rare case.Indian journal of medical microbiology, , Volume: 25, Issue:4, 2007
Iatrogenic actinomycetoma of neck and back successfully treated with sulphonamides.Clinical and experimental dermatology, , Volume: 32, Issue:1, 2007
Disseminated cutaneous nocardiosis mimicking cellulitis and erythema nodosum.Dermatology online journal, , Dec-10, Volume: 12, Issue:7, 2006
[Cutaneous melioidosis: report of a case].Zhonghua bing li xue za zhi = Chinese journal of pathology, , Volume: 35, Issue:12, 2006
Skin manifestation of Stenotrophomonas maltophilia infection--a case report and review article.Annals of the Academy of Medicine, Singapore, , Volume: 35, Issue:12, 2006
Lymphocutaneous nocardiosis from commercially treated lumber: a case report.Cutis, , Volume: 78, Issue:4, 2006
Cervicofacial nocardiosis in an immunocompetent child.Acta paediatrica (Oslo, Norway : 1992), , Volume: 94, Issue:9, 2005
[Abdominal actinomycetoma reaching the gut].Presse medicale (Paris, France : 1983), , Aug-27, Volume: 34, Issue:14, 2005
Primary cutaneous nocardiosis in 2 patients on immunosuppressants.Scandinavian journal of infectious diseases, , Volume: 37, Issue:6-7, 2005
Primary Nocardia brasiliensis of the eyelid.American journal of ophthalmology, , Volume: 138, Issue:3, 2004
[Cutaneous nocardiosis as an opportunistic infection].Nederlands tijdschrift voor geneeskunde, , Mar-13, Volume: 148, Issue:11, 2004
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
Lymphocutaneous nocardiosis due to Nocardia brasiliensis.Diagnostic microbiology and infectious disease, , Volume: 47, Issue:1, 2003
Reactive cutaneous cytophagocytosis in nocardiosis.Journal of Korean medical science, , Volume: 17, Issue:2, 2002
Primary lymphocutaneous nocardiosis caused by Nocardia otitidiscaviarum.Hand surgery : an international journal devoted to hand and upper limb surgery and related research : journal of the Asia-Pacific Federation of Societies for Surgery of the Hand, , Volume: 7, Issue:2, 2002
Perianal actinomycetoma experience of 20 cases.International journal of dermatology, , Volume: 41, Issue:8, 2002
Attempts to stem Anthrax fears stumble.Circulation, , Nov-06, Volume: 104, Issue:19, 2001
Nocardia asteroides abscess after heart transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, , Volume: 20, Issue:7, 2001
[Recurrent abscesses in a renal transplant recipient].Enfermedades infecciosas y microbiologia clinica, , Volume: 19, Issue:2, 2001
Cutaneous infection caused by Serratia marcescens.Cutis, , Volume: 66, Issue:6, 2000
Skin disease and nontuberculous atypical mycobacteria.International journal of dermatology, , Volume: 39, Issue:9, 2000
Mycobacterium branderi from both a hand infection and a case of pulmonary disease.Journal of clinical microbiology, , Volume: 38, Issue:10, 2000
Subretinal abscess due to Nocardia farcinica infection.Retina (Philadelphia, Pa.), , Volume: 20, Issue:3, 2000
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.The American journal of tropical medicine and hygiene, , Volume: 61, Issue:5, 1999
Superficial cutaneous abscess and multiple brain abscesses from Nocardia asteroides in an immunocompetent patient.Journal of the American Academy of Dermatology, , Volume: 39, Issue:5 Pt 1, 1998
Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin.Journal of the American Academy of Dermatology, , Volume: 37, Issue:3 Pt 1, 1997
Cutaneous and pulmonary infections caused by Mycobacterium vaccae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 23, Issue:1, 1996
[Primary cutaneous nocardia asteroides nocardiosis in an immunocompromised patient].Annales de dermatologie et de venereologie, , Volume: 122, Issue:10, 1995
[Clinical and bacteriological aspects of nocardiasis. 9 cases].Presse medicale (Paris, France : 1983), , Jun-24, Volume: 24, Issue:23, 1995
Cutaneous Nocardia farcinica infection in a nonimmunocompromised patient: case report and review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 16, Issue:6, 1993
Fever and skin lesions in a five-year-old boy.The Pediatric infectious disease journal, , Volume: 12, Issue:10, 1993
Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen.Acta dermato-venereologica, , Volume: 81, Issue:4
Photo capsules. Actinomycosis.Skinmed, , Volume: 7, Issue:1
A modified two-step treatment for actinomycetoma.Indian journal of dermatology, venereology and leprology, , Volume: 73, Issue:4
Pulmonary and cutaneous nocardiosis in a patient treated with corticosteroids.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, , Volume: 32, Issue:6
[Nocardia otitidiscaviarum, cutaneous infection in a patient receiving long-term corticosteroid treatment].Annales de biologie clinique, , Volume: 61, Issue:2
Current treatment options for Expert opinion on pharmacotherapy, , Volume: 24, Issue:10
Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, , Volume: 17, Issue:7, 2015
Antiseptic efficacy of local disinfecting povidone-iodine (Betadine) therapy in chronic wounds of lymphedematous patients.Dermatology (Basel, Switzerland), , Volume: 204 Suppl 1, 2002
[Antiseptics in skin diseases].Annales de dermatologie et de venereologie, , Volume: 123, Issue:5, 1996
Topical antimicrobial agents in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
A fibrin biofilm covers blood clots and protects from microbial invasion.The Journal of clinical investigation, , 08-01, Volume: 128, Issue:8, 2018
The multifunctional LigB adhesin binds homeostatic proteins with potential roles in cutaneous infection by pathogenic Leptospira interrogans.PloS one, , Feb-09, Volume: 6, Issue:2, 2011
Rational use of antibacterials and drug sensitivity analysis in the repair of large lip defect with skin flap.Pakistan journal of pharmaceutical sciences, , Volume: 31, Issue:5(Special), 2018
[Necrotic lesion of the lip and cough with fever: cutaneous and pulmonary anthrax].Medecine tropicale : revue du Corps de sante colonial, , Volume: 71, Issue:6, 2011
[Primary cutaneous actinomycosis due to Actinomyces griseus globisporus].Dermatologica, , Volume: 109, Issue:4, 1954
Glutathione-Conjugated Hydrogels: Flexible Vehicles for Personalized Treatment of Bacterial Infections.Pharmaceutical research, , Volume: 38, Issue:7, 2021
Cutaneous melioidosis: a review of the literature.International journal of dermatology, , Volume: 58, Issue:2, 2019
A Child With Septic Shock and Purpura.JAMA pediatrics, , Volume: 170, Issue:4, 2016
Testicular nocardiosis accompanied by cutaneous lesions in an immunocompetent man.Internal medicine (Tokyo, Japan), , Volume: 52, Issue:1, 2013
Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 17, Issue:12, 2013
Exuberant cutaneous ulcers on the buttocks caused by multi-resistant Klebsiella pneumoniae.Dermatology online journal, , Aug-15, Volume: 18, Issue:8, 2012
Facial ecthyma gangrenosum in 2 preterm neonates.Actas dermo-sifiliograficas, , Volume: 103, Issue:7, 2012
Lymphocutaneous type of nocardiosis caused by Nocardia vinacea in a patient with polymyositis.Mycopathologia, , Volume: 172, Issue:1, 2011
Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-15, Volume: 47 Suppl 1, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
[Nocardia farcinica infection of a vascular prosthesis].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 58, Issue:4, 2007
A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.Clinical therapeutics, , Volume: 28, Issue:8, 2006
Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.Surgical infections, ,Fall, Volume: 6, Issue:3, 2005
Comparison of the activity of meropenem with that of other agents in the treatment of intraabdominal, obstetric/gynecologic, and skin and soft tissue.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 20 Suppl 2, 1995
Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.Clinical therapeutics, , Jan-01, Volume: 38, Issue:1, 2016
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 31, Issue:2, 2000
Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 15, Issue:12, 1996
Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.Antimicrobial agents and chemotherapy, , Volume: 37, Issue:7, 1993
Rapidly growing members of the genus Mycobacterium affecting dogs and cats.Journal of the American Animal Hospital Association, , Volume: 38, Issue:3
A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.Advances in therapy, , Volume: 11, Issue:4
Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis.Expert review of anti-infective therapy, , Volume: 20, Issue:11, 2022
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response.The Journal of antimicrobial chemotherapy, , 10-28, Volume: 77, Issue:11, 2022
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing tedJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 28, Issue:9, 2022
Linezolid versus omadacycline in diabetic soft tissue infections: a signal of different adjunctive immunological properties?The Journal of antimicrobial chemotherapy, , 05-29, Volume: 77, Issue:6, 2022
Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.International journal of clinical pharmacology and therapeutics, , Volume: 59, Issue:9, 2021
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-02, Volume: 73, Issue:3, 2021
Linezolid as a treatment option for cutaneous non-tuberculous mycobacterial infections.Dermatology online journal, , Sep-15, Volume: 26, Issue:9, 2020
Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections.Expert review of clinical pharmacology, , Volume: 13, Issue:6, 2020
Omadacycline for Acute Bacterial Skin and Skin Structure Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-01, Volume: 69, Issue:Suppl 1, 2019
Cutaneous non-tubercular mycobacterial infection in pregnancy and treatment consideration.European journal of obstetrics, gynecology, and reproductive biology, , Volume: 237, 2019
Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials.Diagnostic microbiology and infectious disease, , Volume: 94, Issue:3, 2019
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections.The New England journal of medicine, , 02-07, Volume: 380, Issue:6, 2019
Enriching the antibiotic armamentarium for acute bacterial skin and skin structure infections.The Lancet. Infectious diseases, , Volume: 19, Issue:10, 2019
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.The Lancet. Infectious diseases, , Volume: 19, Issue:10, 2019
Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 24, Issue:6, 2018
Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections.Expert opinion on drug safety, , Volume: 17, Issue:4, 2018
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.European journal of medicinal chemistry, , Jul-15, Volume: 155, 2018
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.Antimicrobial agents and chemotherapy, , Volume: 61, Issue:5, 2017
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled Trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-15, Volume: 64, Issue:2, 2017
Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity InfectionsJournal of the American Podiatric Medical Association, , Volume: 107, Issue:4, 2017
Outpatient treatment of acute bacterial skin and skin structure infections (ABSSSI) with tedizolid phosphate and linezolid in patients in the United States: Subgroup analysis of 2 randomized phase 3 trials.Medicine, , Volume: 96, Issue:52, 2017
Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.Antimicrobial agents and chemotherapy, , Volume: 60, Issue:10, 2016
Linezolid versus vancomycin for skin and soft tissue infections.The Cochrane database of systematic reviews, , Jan-07, Issue:1, 2016
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.The Journal of antimicrobial chemotherapy, , Volume: 71, Issue:3, 2016
Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 30, Issue:1, 2016
In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.International journal of antimicrobial agents, , Volume: 46, Issue:6, 2015
Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Oct-15, Volume: 61, Issue:8, 2015
Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis.Current medical research and opinion, , Volume: 31, Issue:8, 2015
Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.Antimicrobial agents and chemotherapy, , Volume: 59, Issue:8, 2015
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 59, Issue:2, 2015
What's new in the treatment of serious MRSA infection?Current opinion in infectious diseases, , Volume: 27, Issue:6, 2014
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.Journal of medical economics, , Volume: 17, Issue:10, 2014
New antibiotics for skin and skin-structure infections.The Lancet. Infectious diseases, , Volume: 14, Issue:8, 2014
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.The Lancet. Infectious diseases, , Volume: 14, Issue:8, 2014
Once-weekly dalbavancin versus daily conventional therapy for skin infection.The New England journal of medicine, , Jun-05, Volume: 370, Issue:23, 2014
Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study.Surgical infections, , Volume: 15, Issue:2, 2014
Linezolid versus vancomycin for skin and soft tissue infections.The Cochrane database of systematic reviews, , Jul-12, Issue:7, 2013
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:11, 2012
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 16, Issue:1, 2012
Mycobacterium chelonae infection involving the auricle.QJM : monthly journal of the Association of Physicians, , Volume: 105, Issue:10, 2012
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:12, 2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 52 Suppl 7, 2011
Linezolid: safety and efficacy in special populations.The Journal of antimicrobial chemotherapy, , Volume: 66 Suppl 4, 2011
The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.Clinical pediatrics, , Volume: 50, Issue:11, 2011
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Expert review of anti-infective therapy, , Volume: 8, Issue:9, 2010
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.Current medical research and opinion, , Volume: 26, Issue:3, 2010
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.International journal of antimicrobial agents, , Volume: 35, Issue:1, 2010
[Therapy of SSTI and role of tigecycline].Le infezioni in medicina, , Volume: 17 Suppl 4, 2009
Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study".Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jul-15, Volume: 49, Issue:2, 2009
Noninferiority of linezolid for skin and bloodstream infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jul-15, Volume: 49, Issue:2, 2009
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-15, Volume: 48, Issue:2, 2009
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.International journal of antimicrobial agents, , Volume: 32, Issue:3, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Dalbavancin: a review for dermatologists.Dermatology online journal, , May-30, Volume: 12, Issue:4, 2006
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?Antimicrobial agents and chemotherapy, , Volume: 49, Issue:11, 2005
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Nov-15, Volume: 41, Issue:10, 2005
Update on linezolid: the first oxazolidinone antibiotic.Expert opinion on pharmacotherapy, , Volume: 6, Issue:13, 2005
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:6, 2005
Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.The Annals of pharmacotherapy, , Volume: 39, Issue:3, 2005
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.The British journal of dermatology, , Volume: 151, Issue:5, 2004
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Disease-a-month : DM, , Volume: 50, Issue:7, 2004
Efficacy and tolerability of linezolid in treating severe skin and soft tissue infections caused by Gram-positive pathogens.Journal of the Formosan Medical Association = Taiwan yi zhi, , Volume: 103, Issue:5, 2004
Novel antibacterial agents for skin and skin structure infections.Journal of the American Academy of Dermatology, , Volume: 50, Issue:3, 2004
Safety and tolerability of linezolid in children.The Pediatric infectious disease journal, , Volume: 22, Issue:9 Suppl, 2003
Linezolid for the treatment of complicated skin and skin structure infections in children.The Pediatric infectious disease journal, , Volume: 22, Issue:9 Suppl, 2003
Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.Journal of drugs in dermatology : JDD, , Volume: 2, Issue:4, 2003
[Contribution of linezolid to the treatment of complicated infections of the skin and soft tissues].Presse medicale (Paris, France : 1983), , Apr-05, Volume: 32, Issue:13 Pt 2, 2003
Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.Surgical infections, ,Spring, Volume: 4, Issue:1, 2003
A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid.American journal of surgery, , Volume: 185, Issue:4, 2003
Therapeutic efficacy of linezolid in extended clinical practice.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 22, Issue:2, 2003
[Linezolide--an antibiotic with new action mechanism].Lakartidningen, , Mar-14, Volume: 99, Issue:11, 2002
Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 21, Issue:7, 2002
Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:12, 2000
Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 31 Suppl 4, 2000
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 20, Issue:2
Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 17, Issue:12, 2013
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).Current medical research and opinion, , Volume: 29, Issue:7, 2013
Evaluation of cutaneous palpebral anthrax.Cutaneous and ocular toxicology, , Volume: 32, Issue:4, 2013
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.BMC infectious diseases, , Nov-12, Volume: 12, 2012
Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 31, Issue:2, 2000
Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.The Pediatric infectious disease journal, , Volume: 18, Issue:7, 1999
[Sultamicillin in treatment of suppurative skin disorders].Polski tygodnik lekarski (Warsaw, Poland : 1960), , Volume: 48 Suppl 2, 1993
Low-dose sultamicillin oral suspension in the treatment of mild to moderate paediatric infections in Turkey.The Journal of international medical research, , Volume: 20 Suppl 1, 1992
Resistin-like Molecule α Provides Vitamin-A-Dependent Antimicrobial Protection in the Skin.Cell host & microbe, , Jun-12, Volume: 25, Issue:6, 2019
Acne pathogenesis: history of concepts.Dermatology (Basel, Switzerland), , Volume: 229, Issue:1, 2014
Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions.Acta dermato-venereologica, , Volume: 95, Issue:8, 2015
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.Experimental dermatology, , Volume: 20, Issue:10, 2011
[Use of topical tacrolimus and its side-effects].Atencion primaria, , Jun-15, Volume: 36, Issue:1, 2005
Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506).The Journal of investigative dermatology, , Volume: 116, Issue:3, 2001
Subcutaneous nodules attributed to nocardiosis in a renal transplant recipient on tacrolimus therapy.American journal of nephrology, , Volume: 20, Issue:2
Mycobacterium haemophilum in an immunosuppressed child.Pediatric dermatology, , Volume: 23, Issue:5
Sporotrichoid fluctuant nodules.Cutis, , Volume: 98, Issue:2, 2016
Disseminated Mycobacterium avium Complex With Cutaneous Lesions.Journal of cutaneous medicine and surgery, , Volume: 20, Issue:3, 2016
Mycobacterium haemophilum in an immunosuppressed child.Pediatric dermatology, , Volume: 23, Issue:5
Necrobiosis lipoidica with superimposed pyoderma vegetans.Cutis, , Volume: 103, Issue:1, 2019
Anti-biofilm properties of a mupirocin spray formulation against Escherichia coli wound infections.Biofouling, , Volume: 33, Issue:7, 2017
Chlorhexidine for routine PD catheter exit-site care.International urology and nephrology, , Volume: 48, Issue:9, 2016
Pitted keratolysis: successful management with mupirocin 2% ointment monotherapy.Dermatology online journal, , Aug-15, Volume: 21, Issue:8, 2015
Perianal and periumbilical dermatitis: Report of a woman with group G streptococcal infection and review of perianal and periumbilical dermatoses.Dermatology online journal, , Apr-15, Volume: 19, Issue:4, 2013
Ecthyma gangrenosum in a neonate: not always pseudomonas.BMJ case reports, , May-27, Volume: 2013, 2013
Superficial community-acquired skin infections: prevalence of bacteria and antibiotic susceptibility in France.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 23, Issue:12, 2009
Thematic review series: skin lipids. Antimicrobial lipids at the skin surface.Journal of lipid research, , Volume: 49, Issue:1, 2008
[Managing children skin and soft tissue infections].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 15 Suppl 2, 2008
Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:11, 2008
Direct economic effect following mupirocin therapy failure among patients with uncomplicated skin and skin-structure infections in a large population-based cohort.Managed care interface, , Volume: 20, Issue:7, 2007
Selection of retapamulin, a novel pleuromutilin for topical use.Antimicrobial agents and chemotherapy, , Volume: 50, Issue:11, 2006
Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.Scandinavian journal of infectious diseases, , Volume: 35, Issue:2, 2003
A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema.Clinical and experimental dermatology, , Volume: 27, Issue:1, 2002
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:2, 2000
Dermacase. Perianal streptococcal dermatitis.Canadian family physician Medecin de famille canadien, , Volume: 45, 1999
[Comment on the contribution by P. H. Höger: "Topical antibiotics and antiseptics"].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 50, Issue:5, 1999
Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, , Volume: 13, Issue:7, 1998
Infection with methicillin-resistant Staphylococcus aureus after carbon dioxide resurfacing of the face. Successful treatment with minocycline, rifampin, and mupiricin ointment.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], , Volume: 24, Issue:2, 1998
[Mupirocin (Bactroban)--a new antibiotic for local use in bacterial infections].Ugeskrift for laeger, , Nov-29, Volume: 155, Issue:48, 1993
An open study of mupirocin in Libyan patients with skin infections.The Journal of international medical research, , Volume: 23, Issue:6
Treatment of uncomplicated skin and skin structure infections in the diabetic patient.Journal of drugs in dermatology : JDD, , Volume: 4, Issue:6 Suppl
Topical antimicrobial agents in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Characterization of Pathogens Isolated from Cutaneous Abscesses in Patients Evaluated by the Dermatology Service at an Emergency Department.Puerto Rico health sciences journal, , Volume: 39, Issue:3, 2020
A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.BMC pediatrics, , 06-05, Volume: 19, Issue:1, 2019
Treatment of penile actinomycosis.Dermatologic therapy, , Volume: 31, Issue:5, 2018
Daptomycin for Complicated Skin Infections: A Randomized Trial.Pediatrics, , Volume: 139, Issue:3, 2017
Trichomycosis axillaris: Clinical, Wood lamp, and dermoscopic diagnostic images.Actas dermo-sifiliograficas, , Volume: 108, Issue:3, 2017
A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.The New England journal of medicine, , 06-29, Volume: 376, Issue:26, 2017
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.Annals of the Academy of Medicine, Singapore, , Volume: 45, Issue:10, 2016
Can We Better Optimize Vancomycin Monotherapy?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Mar-15, Volume: 62, Issue:6, 2016
Clindamycin and trimethoprim-sulfamethoxazole equally effective in treating skin infection.The Journal of pediatrics, , Volume: 167, Issue:3, 2015
ACP Journal Club. Clindamycin did not differ from trimethoprim-sulfamethoxazole for curing uncomplicated skin infections.Annals of internal medicine, , Jul-21, Volume: 163, Issue:2, 2015
Antibacterial Treatment for Uncomplicated Skin Infections.The New England journal of medicine, , 06-18, Volume: 372, Issue:25, 2015
Antibacterial Treatment for Uncomplicated Skin Infections.The New England journal of medicine, , 06-18, Volume: 372, Issue:25, 2015
Antibacterial Treatment for Uncomplicated Skin Infections.The New England journal of medicine, , 06-18, Volume: 372, Issue:25, 2015
Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Oct-01, Volume: 61, Issue:7, 2015
Editorial Commentary: Double Gram-Positive Coverage for Acute Bacterial Skin and Skin Structure Infections: Has the Eagle Landed?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Oct-01, Volume: 61, Issue:7, 2015
Risk factors for recurrent colonization with methicillin-resistant Staphylococcus aureus in community-dwelling adults and children.Infection control and hospital epidemiology, , Volume: 36, Issue:7, 2015
Choosing an antibiotic for skin infections.The New England journal of medicine, , Mar-19, Volume: 372, Issue:12, 2015
Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.The New England journal of medicine, , Mar-19, Volume: 372, Issue:12, 2015
[Multifocal invasive infection due to Streptococcus pyogenes in a 20 month-old infant: case report].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 21 Suppl 2, 2014
Trends of Staphylococcus aureus bloodstream infections in a neonatal intensive care unit from 2000-2009.BMC pediatrics, , May-09, Volume: 14, 2014
Chronic dermatitis caused by Lactobacillus jensenii infection in a blue and gold macaw (Ara ararauna).Journal of the American Veterinary Medical Association, , Oct-01, Volume: 243, Issue:7, 2013
Field-based PCR for rapid diagnosis of cutaneous anthrax in the deployed setting using the joint biological agent identification and diagnostic system.Military medicine, , Volume: 178, Issue:8, 2013
Management of necrotizing skin and soft tissue infections.Expert review of anti-infective therapy, , Volume: 10, Issue:7, 2012
Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections.Pediatrics, , Volume: 128, Issue:3, 2011
Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria.Anaerobe, , Volume: 16, Issue:4, 2010
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.Pediatrics, , Volume: 123, Issue:6, 2009
Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.Journal of child and adolescent psychopharmacology, , Volume: 18, Issue:2, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Bullous haemorrhagic cellulitis caused by Enterobacter cloacae.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 19, Issue:6, 2005
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
[Fundamental studies on antibacterial activity of clindamycin against Propionibacterium acnes].The Japanese journal of antibiotics, , Volume: 51, Issue:2, 1998
Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin.Journal of the American Academy of Dermatology, , Volume: 37, Issue:3 Pt 1, 1997
Propionibacterium: resistance of acne to antibiotics.The New Zealand medical journal, , Feb-08, Volume: 108, Issue:993, 1995
Extensive cutaneous anthrax in an immunocompetent patient.European journal of dermatology : EJD, , Volume: 17, Issue:5
Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.Pediatric dermatology, , Volume: 28, Issue:1
[Bacterial resistance in acne? A meta-analysis of the controversy].Cirugia y cirujanos, , Volume: 84, Issue:3
A forgotten disease in a returning traveler from Thailand.Acta clinica Belgica, , Volume: 68, Issue:5
[Oxacillin plus clindamycin: a useful combination?]Revista peruana de medicina experimental y salud publica, , Volume: 35, Issue:1
Disseminated Gonococcal Infection in an Immunosuppressed Patient.The American journal of medicine, , Volume: 134, Issue:2, 2021
Azithromycin-loaded liposomes for enhanced topical treatment of methicillin-resistant Staphyloccocus aureus (MRSA) infections.International journal of pharmaceutics, , Dec-20, Volume: 553, Issue:1-2, 2018
[no title available]BMJ case reports, , Feb-22, Volume: 2018, 2018
Cutaneous Diphtheria Mimicking Pyoderma Gangrenosum.JAMA dermatology, , 02-01, Volume: 154, Issue:2, 2018
Azithromycin in Labor Lowers Clinical Infections in Mothers and Newborns: A Double-Blind Trial.Pediatrics, , Volume: 139, Issue:2, 2017
Sporotrichoid fluctuant nodules.Cutis, , Volume: 98, Issue:2, 2016
Cutaneous gonococcal abscess of the abdomen in a child.Pediatric emergency care, , Volume: 27, Issue:9, 2011
"MAC" attack.The American journal of medicine, , Volume: 122, Issue:12, 2009
Macrolides in dermatology.Disease-a-month : DM, , Volume: 50, Issue:7, 2004
Impact of single dose azithromycin on group A streptococci in the upper respiratory tract and skin of Aboriginal children.The Pediatric infectious disease journal, , Volume: 21, Issue:5, 2002
[Azithromycin in the field of dermatology].The Japanese journal of antibiotics, , Volume: 53 Suppl B, 2000
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated fAntimicrobial agents and chemotherapy, , Volume: 42, Issue:5, 1998
Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
Once-daily azithromycin in the treatment of adult skin and skin-structure infections.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.The Journal of antimicrobial chemotherapy, , Volume: 31 Suppl E, 1993
Macrolides in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Mycobacterium marinum cutaneous infection with sporotrichoid distribution treated with azithromycin monotherapy.Skinmed, , Volume: 10, Issue:1
Atypical cutaneous mycobacteriosis caused by Mycobacterium avium complex.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 14, Issue:3
Author Reply.Indian journal of pharmacology, , Volume: 48, Issue:1
Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections.Indian journal of pharmacology, , Volume: 48, Issue:1
Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections.Indian journal of pharmacology, , Volume: 47, Issue:4
Early Clinical Experience with Delafloxacin: A Case Series.The American journal of the medical sciences, , Volume: 363, Issue:4, 2022
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections.Drugs, , Volume: 80, Issue:12, 2020
Analysis of Pooled Phase 3 Safety Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 04-08, Volume: 68, Issue:Suppl 3, 2019
Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 04-08, Volume: 68, Issue:Suppl 3, 2019
Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 04-08, Volume: 68, Issue:Suppl 3, 2019
Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin.European journal of drug metabolism and pharmacokinetics, , Volume: 44, Issue:3, 2019
Delafloxacin meglumine for the treatment of acute bacterial skin and skin structure infections (ABSSSI).Drugs of today (Barcelona, Spain : 1998), , Volume: 54, Issue:11, 2018
Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.Expert review of anti-infective therapy, , Volume: 16, Issue:7, 2018
Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineering.Future microbiology, , Volume: 13, 2018
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-16, Volume: 67, Issue:5, 2018
Clinical review of delafloxacin: a novel anionic fluoroquinolone.The Journal of antimicrobial chemotherapy, , 06-01, Volume: 73, Issue:6, 2018
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.The Journal of antimicrobial chemotherapy, , Dec-01, Volume: 72, Issue:12, 2017
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections.Expert opinion on drug metabolism & toxicology, , Volume: 13, Issue:11, 2017
Delafloxacin: First Global Approval.Drugs, , Volume: 77, Issue:13, 2017
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.The Journal of antimicrobial chemotherapy, , Volume: 71, Issue:3, 2016
Delafloxacin for the treatment of respiratory and skin infections.Expert opinion on investigational drugs, , Volume: 24, Issue:3, 2015
Correlates of Skin and Soft Tissue Infections in Injection Drug Users in a Syringe-Exchange Program in Malmö, Sweden.Substance use & misuse, , Volume: 50, Issue:12, 2015
Penile and scrotal skin necrosis after injection of crushed buprenorphine tablets.Presse medicale (Paris, France : 1983), , Volume: 39, Issue:5, 2010
Cutaneous complications among i.v. buprenorphine users.The Journal of dermatology, , Volume: 36, Issue:1, 2009
Photodisinfection of material surfaces and bacterial skin infections by a detergent loaded with curcumin.Photodiagnosis and photodynamic therapy, , Volume: 39, 2022
Antimicrobial photodynamic therapy (aPDT) with curcumin controls intradermal infection by Staphylococcus aureus in mice with type 1 diabetes mellitus: a pilot study.Journal of photochemistry and photobiology. B, Biology, , Volume: 224, 2021
Phytotherapy of ulcerative dermatitis induced by Aeromonas hydrophila infection in goldfish ( Carassius auratus ).Acta veterinaria Hungarica, , Volume: 58, Issue:1, 2010
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.European journal of medicinal chemistry, , Jul-15, Volume: 155, 2018
Antibiotic therapy in the management of atopic dermatitis.Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, , Volume: 150, Issue:3, 2015
Streptococcal intertrigo.The Journal of pediatrics, , Volume: 166, Issue:5, 2015
Fusidic acid in skin infections and infected atopic eczema.Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, , Volume: 149, Issue:4, 2014
A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma.The Journal of dermatological treatment, , Volume: 24, Issue:1, 2013
Smelly foot rash.Australian family physician, , Volume: 40, Issue:3, 2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 52 Suppl 7, 2011
Introduction: fusidic acid enters the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 52 Suppl 7, 2011
[Managing children skin and soft tissue infections].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 15 Suppl 2, 2008
Pits on the soles of the feet.The Journal of family practice, , Volume: 54, Issue:7, 2005
Fusidic acid suspension twice daily: a new treatment schedule for skin and soft tissue infection in children, with improved tolerability.The Journal of dermatological treatment, , Volume: 15, Issue:3, 2004
Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.Scandinavian journal of infectious diseases, , Volume: 35, Issue:2, 2003
Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center.Archives of dermatology, , Volume: 138, Issue:7, 2002
[Superficial pyoderma requiring oral antibiotic therapy: fusidic acid versus pristinamycin]].Presse medicale (Paris, France : 1983), , Mar-03, Volume: 30, Issue:8, 2001
Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK.Clinical and experimental dermatology, , Volume: 25, Issue:4, 2000
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.Antimicrobial agents and chemotherapy, , Volume: 44, Issue:2, 2000
In vitro activity of fusidic acid against streptococci isolated from skin and soft tissue infections.The Journal of antimicrobial chemotherapy, , Volume: 45, Issue:1, 2000
Fusidic acid in skin and soft tissue infections.International journal of antimicrobial agents, , Volume: 12 Suppl 2, 1999
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
Cutaneous infection caused by Tsukamurella paurometabolum.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 23, Issue:4, 1996
Topical fusidic acid.Nursing times, , Volume: 101, Issue:3
Pitted keratolysis in an adolescent, diagnosed using conventional and molecular microbiology and successfully treated with fusidic acid.European journal of dermatology : EJD, , Volume: 24, Issue:4
Neonatal skin care: what should we do? A four-week follow-up randomized controlled trial at Zagazig University Hospitals.International journal of dermatology, , Volume: 56, Issue:11, 2017
[Diaper dermatitis].Annales de dermatologie et de venereologie, , Volume: 142, Issue:1, 2015
Microbiology of secondarily infected diaper dermatitis.International journal of dermatology, , Volume: 31, Issue:10, 1992
Overview of the efficacy of isepamicin in the adult core clinical trial programme.Journal of chemotherapy (Florence, Italy), , Volume: 7 Suppl 2, 1995
Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.Journal of chemotherapy (Florence, Italy), , Volume: 7 Suppl 2, 1995
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.Journal of chemotherapy (Florence, Italy), , Volume: 7 Suppl 2, 1995
Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-15, Volume: 61 Suppl 2, 2015
MRSA new treatments on the horizon: current status.Injury, , Volume: 42 Suppl 5, 2011
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia.Expert opinion on pharmacotherapy, , Volume: 12, Issue:17, 2011
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.Journal of chemotherapy (Florence, Italy), , Volume: 22, Issue:5, 2010
ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections.Future microbiology, , Volume: 5, Issue:12, 2010
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.Diagnostic microbiology and infectious disease, , Volume: 68, Issue:2, 2010
Telavancin (Vibativ) for gram-positive skin infections.The Medical letter on drugs and therapeutics, , Jan-11, Volume: 52, Issue:1329, 2010
Telavancin.Nature reviews. Drug discovery, , Volume: 8, Issue:12, 2009
Antimicrobial development in the era of emerging resistance.Mini reviews in medicinal chemistry, , Volume: 9, Issue:8, 2009
Telavancin: a novel lipoglycopeptide antibiotic.The Annals of pharmacotherapy, , Volume: 43, Issue:5, 2009
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study.Antimicrobial agents and chemotherapy, , Volume: 50, Issue:3, 2006
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jun-01, Volume: 40, Issue:11, 2005
First case report of Cryptococcus laurentii knee infection in a previously healthy patient.BMC infectious diseases, , Sep-17, Volume: 20, Issue:1, 2020
Primary cutaneous mucormycosis in an immunocompetent host: report of a case.Surgery today, , Volume: 33, Issue:4, 2003
Eyelid nodule: a sentinel lesion of disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome.Archives of ophthalmology (Chicago, Ill. : 1960), , Volume: 117, Issue:2, 1999
Antibiotic use in the critical care unit.Critical care clinics, , Volume: 14, Issue:2, 1998
Cutaneous nocardiosis: an underdiagnosed pathogenic infection.BMJ case reports, , Mar-02, Volume: 2015, 2015
Streptococcal intertrigo.The Journal of pediatrics, , Volume: 166, Issue:5, 2015
Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections.Infection, , Volume: 37, Issue:5, 2009
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, , Issue:573, 1994
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.Journal of clinical microbiology, , Volume: 56, Issue:4, 2018
Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.Infection and immunity, , Volume: 75, Issue:2, 2007
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.Science (New York, N.Y.), , Feb-05, Volume: 283, Issue:5403, 1999
[Case of the abscess type cutaneous nocardiosis].Medical mycology journal, , Volume: 55, Issue:1, 2014
Drug eruption induced by cefcapene pivoxil hydrochloride.Contact dermatitis, , Volume: 44, Issue:3, 2001
[Clinical evaluation of S-1108 in children].The Japanese journal of antibiotics, , Volume: 46, Issue:11, 1993
Macrococcus canis sp. nov., a skin bacterium associated with infections in dogs.International journal of systematic and evolutionary microbiology, , Volume: 67, Issue:3, 2017
Arsenicicoccus dermatophilus sp. nov., a hypha-forming bacterium isolated from the skin of greater flamingos (Phoenicopterus roseus) with pododermatitis.International journal of systematic and evolutionary microbiology, , Volume: 63, Issue:Pt 11, 2013
Ulcerated plaque in the nasal dorsum in a patient with multiple myeloma.Clinical and experimental dermatology, , Volume: 38, Issue:6, 2013
Genetic relatedness of methicillin-resistant Staphylococcus pseudintermedius (MRSP) isolated from a dog and the dog owner.Research in veterinary science, , Volume: 91, Issue:3, 2011
Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne.The British journal of dermatology, , Volume: 153, Issue:6, 2005
Infections and some other conditions affecting the skin and subcutis of the naso-ocular region of cats--clinical experience 1987-2003.Journal of feline medicine and surgery, , Volume: 6, Issue:6, 2004
Nasal tip ulceration from infection and extrusion of a nasal alloplastic implant.Journal of the American Academy of Dermatology, , Volume: 44, Issue:2 Suppl, 2001
An epidemiological study on the occurrence of Staphylococcus aureus in superficial abscesses of patients presenting for surgery in a teaching hospital in Khartoum, Sudan.FEMS immunology and medical microbiology, , Volume: 29, Issue:2, 2000
A painful spot on the nose.Lancet (London, England), , Feb-21, Volume: 351, Issue:9102, 1998
Primary cutaneous actinomycosis on the nose.European journal of dermatology : EJD, , Volume: 17, Issue:2
The Heroin Epidemic in America: A Surgeon's Perspective.Surgical infections, , Volume: 20, Issue:5, 2019
Fatal cutaneous anthrax in a heroin user.The Journal of laryngology and otology, , Volume: 127, Issue:4, 2013
Wound botulism.Annals of emergency medicine, , Volume: 24, Issue:6, 1994
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.Pakistan journal of pharmaceutical sciences, , Volume: 28, Issue:3, 2015
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.Infection, , Volume: 41, Issue:2, 2013
Is cefepime safe for clinical use? A Bayesian viewpoint.The Journal of antimicrobial chemotherapy, , Volume: 66, Issue:6, 2011
Meta-analysis of a possible signal of increased mortality associated with cefepime use.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Aug-15, Volume: 51, Issue:4, 2010
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 24, Issue:1, 1997
Current and future management of serious skin and skin-structure infections.The American journal of medicine, , Jun-24, Volume: 100, Issue:6A, 1996
Cefepime.Pharmacotherapy, , Volume: 14, Issue:6
Nonpseudomonal ecthyma gangrenosum of the upper lid treated with lid reconstruction.Indian journal of ophthalmology, , Volume: 63, Issue:10, 2015
Staphylococcus pseudintermedius infection associated with nodular skin lesions and systemic inflammatory response syndrome in a dog.The Canadian veterinary journal = La revue veterinaire canadienne, , Volume: 55, Issue:5, 2014
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 24, Issue:3, 1997
Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group.The American journal of medicine, , Aug-15, Volume: 97, Issue:2A, 1994
A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.Clinical therapeutics, , Volume: 28, Issue:8, 2006
Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.Surgical infections, ,Fall, Volume: 6, Issue:3, 2005
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.Drugs, , Volume: 49 Suppl 2, 1995
[Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 42, Issue:12, 1997
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.Antimicrobial agents and chemotherapy, , Volume: 37, Issue:8, 1993
[Treatment of infectious complications affecting the skin and soft tissues with cefpodoxime proxetil].Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, , Volume: 45, Issue:2, 1996
Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.Diagnostic microbiology and infectious disease, , Volume: 16, Issue:2, 1993
Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.Expert review of anti-infective therapy, , Volume: 7, Issue:3, 2009
Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.Drugs, , Volume: 68, Issue:6, 2008
Retapamulin for impetigo and other infections.Drug and therapeutics bulletin, , Volume: 46, Issue:10, 2008
Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:11, 2008
Molecule of the month. Retapamulin.Drug news & perspectives, , Volume: 19, Issue:10, 2006
Selection of retapamulin, a novel pleuromutilin for topical use.Antimicrobial agents and chemotherapy, , Volume: 50, Issue:11, 2006
Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial.Archives of disease in childhood. Fetal and neonatal edition, , Volume: 106, Issue:6, 2021
Liposomes-in-chitosan hydrogel boosts potential of chlorhexidine in biofilm eradication in vitro.Carbohydrate polymers, , Jun-15, Volume: 262, 2021
Dual role of iodine, silver, chlorhexidine and octenidine as antimicrobial and antiprotease agents.PloS one, , Volume: 14, Issue:1, 2019
Safety of Biweekly Chlorhexidine Gluconate Bathing in Infants 36 To 48 Weeks' Postmenstrual Age.American journal of critical care : an official publication, American Association of Critical-Care Nurses, , Volume: 28, Issue:6, 2019
Can community health workers identify omphalitis? A validation study from Southern Province, Zambia.Tropical medicine & international health : TM & IH, , Volume: 23, Issue:7, 2018
Chlorhexidine use in adult patients on ICU.Intensive care medicine, , Volume: 44, Issue:12, 2018
Chlorhexidine for routine PD catheter exit-site care.International urology and nephrology, , Volume: 48, Issue:9, 2016
Recurrent Methicillin-Resistant Staphylococcus aureus Cutaneous Abscesses and Selection of Reduced Chlorhexidine Susceptibility during Chlorhexidine Use.Journal of clinical microbiology, , Volume: 53, Issue:11, 2015
Reduction in acute gastroenteritis among military trainees: secondary effects of a hygiene-based cluster-randomized trial for skin and soft tissue infection prevention.Infection control and hospital epidemiology, , Volume: 36, Issue:3, 2015
Perianal and periumbilical dermatitis: Report of a woman with group G streptococcal infection and review of perianal and periumbilical dermatoses.Dermatology online journal, , Apr-15, Volume: 19, Issue:4, 2013
In vitro comparison of the effectiveness of polihexanide and chlorhexidine against canine isolates of Staphylococcus pseudintermedius, Pseudomonas aeruginosa and Malassezia pachydermatis.Veterinary dermatology, , Volume: 24, Issue:4, 2013
Evaluation of the antiseptic efficacy and local tolerability of a polihexanide-based antiseptic on resident skin flora.Advances in skin & wound care, , Volume: 25, Issue:9, 2012
Comparison of two shampoos as sole treatment for canine bacterial overgrowth syndrome.The Veterinary record, , Jun-30, Volume: 170, Issue:26, 2012
A randomized controlled trial of the impact of chlorhexidine skin cleansing on bacterial colonization of hospital-born infants in Nepal.The Pediatric infectious disease journal, , Volume: 27, Issue:6, 2008
Increased susceptibility to Staphylococcus aureus colonization of the skin of the NOA mouse: a potentially useful animal model for evaluating antiseptic effects.Experimental animals, , Volume: 55, Issue:1, 2006
A rare infection caused by Chryseomonas luteola.The Journal of infection, , Volume: 41, Issue:1, 2000
[Antisepsis in children].Annales de dermatologie et de venereologie, , Volume: 125, Issue:12, 1998
[Antiseptics in skin diseases].Annales de dermatologie et de venereologie, , Volume: 123, Issue:5, 1996
Topical antimicrobial agents in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Successful treatment with amoxicillin-clavulanic acid: cutaneous nocardiosis caused by The Journal of dermatological treatment, , Volume: 34, Issue:1, 2023
Cutaneous melioidosis: a review of the literature.International journal of dermatology, , Volume: 58, Issue:2, 2019
Treatment of cutaneous actinomycosis with amoxicillin/clavulanic acid.The Journal of dermatological treatment, , Volume: 28, Issue:1, 2017
Primary cutaneous nocardiosis: a pitfall in the diagnosis of skin infection.Infection, , Volume: 45, Issue:6, 2017
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.Annals of the Academy of Medicine, Singapore, , Volume: 45, Issue:10, 2016
Unusual presentation of Streptococcus pneumoniae in human immunodeficiency virus infection.The Journal of the Association of Physicians of India, , Volume: 61, Issue:3, 2013
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.BMC infectious diseases, , Nov-12, Volume: 12, 2012
Primary actinomycosis of hand: A rare soft tissue infection.The Journal of dermatology, , Volume: 39, Issue:8, 2012
Cavitary pneumonia and skin lesions.Respiratory care, , Volume: 57, Issue:3, 2012
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 66, Issue:11, 2011
[Managing children skin and soft tissue infections].Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, , Volume: 15 Suppl 2, 2008
Imported melioidosis with an isolated cutaneous presentation in a 90-year-old traveller from Bangladesh.Bulletin de la Societe de pathologie exotique (1990), , Volume: 100, Issue:1, 2007
Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate.The British journal of dermatology, , Volume: 156, Issue:2, 2007
Suspected drug-induced destructive cholangitis in a young dog.The Journal of small animal practice, , Volume: 47, Issue:6, 2006
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.International journal of antimicrobial agents, , Volume: 26, Issue:5, 2005
Impetigo-like vegetating nasal lesions caused by Klebsiella pneumoniae.The American journal of medicine, , Volume: 118, Issue:8, 2005
Primary Nocardia brasiliensis of the eyelid.American journal of ophthalmology, , Volume: 138, Issue:3, 2004
Antibiotic prophylaxis for haematogenous bacterial arthritis in patients with joint disease: a cost effectiveness analysis.Annals of the rheumatic diseases, , Volume: 60, Issue:4, 2001
Lymphocutaneous Nocardia brasiliensis infection: a pediatric case cured with amoxicilin/clavulanate.The Pediatric infectious disease journal, , Volume: 19, Issue:10, 2000
Melioidosis--an emerging disease in New Zealand?The New Zealand medical journal, , May-14, Volume: 112, Issue:1087, 1999
[Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 42, Issue:12, 1997
Comparative studies of cefprozil in the management of skin and soft-tissue infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 13, Issue:10, 1994
Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.The American journal of medicine, , Mar-22, Volume: 94, Issue:3A, 1993
Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen.Acta dermato-venereologica, , Volume: 81, Issue:4
[Pasteurella pneumotropica skin infection in a child].Presse medicale (Paris, France : 1983), , Volume: 23, Issue:26
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATInternational journal of antimicrobial agents, , Volume: 56, Issue:1, 2020
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.International journal of antimicrobial agents, , Volume: 53, Issue:6, 2019
Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.Antimicrobial agents and chemotherapy, , Volume: 63, Issue:11, 2019
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.Journal of clinical pharmacology, , Volume: 57, Issue:3, 2017
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.The Pediatric infectious disease journal, , Volume: 36, Issue:5, 2017
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbiditiesThe Journal of antimicrobial chemotherapy, , Volume: 71, Issue:12, 2016
In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012-2014.Diagnostic microbiology and infectious disease, , Volume: 86, Issue:2, 2016
A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection.The Pediatric infectious disease journal, , Volume: 35, Issue:8, 2016
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.Surgical infections, , Volume: 17, Issue:4, 2016
In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.The Journal of antimicrobial chemotherapy, , Volume: 71, Issue:1, 2016
Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP).Journal of chemotherapy (Florence, Italy), , Volume: 28, Issue:3, 2016
Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline.The Journal of antimicrobial chemotherapy, , Volume: 70, Issue:10, 2015
Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.Antimicrobial agents and chemotherapy, , Volume: 59, Issue:8, 2015
Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013.Diagnostic microbiology and infectious disease, , Volume: 82, Issue:1, 2015
Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function.International journal of antimicrobial agents, , Volume: 45, Issue:4, 2015
Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency.Expert review of clinical pharmacology, , Volume: 8, Issue:1, 2015
[Therapy of skin and soft tissue infections from surgeon's point of view].Deutsche medizinische Wochenschrift (1946), , Volume: 139 Suppl 3, 2014
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections].Deutsche medizinische Wochenschrift (1946), , Volume: 139 Suppl 3, 2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections in obese patients.Postgraduate medicine, , Volume: 126, Issue:5, 2014
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patients.Hospital practice (1995), , Volume: 42, Issue:3, 2014
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).The Pediatric infectious disease journal, , Volume: 33, Issue:8, 2014
[Role of ceftaroline in skin and soft tissue infections].Enfermedades infecciosas y microbiologia clinica, , Volume: 32 Suppl 2, 2014
Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.Antimicrobial agents and chemotherapy, , Volume: 58, Issue:5, 2014
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012).Diagnostic microbiology and infectious disease, , Volume: 78, Issue:4, 2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.Expert review of clinical pharmacology, , Volume: 7, Issue:2, 2014
Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).Diagnostic microbiology and infectious disease, , Volume: 78, Issue:4, 2014
Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.Journal of chemotherapy (Florence, Italy), , Volume: 25, Issue:6, 2013
Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia.Journal of clinical pharmacology, , Volume: 53, Issue:11, 2013
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , Jun-15, Volume: 70, Issue:12, 2013
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).Diagnostic microbiology and infectious disease, , Volume: 76, Issue:1, 2013
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).International journal of antimicrobial agents, , Volume: 41, Issue:4, 2013
In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.International journal of antimicrobial agents, , Volume: 40, Issue:3, 2012
Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Drugs, , Jul-30, Volume: 72, Issue:11, 2012
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.Expert opinion on pharmacotherapy, , Volume: 13, Issue:8, 2012
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:5, 2012
Early endpoints for acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:5, 2012
[Ceftaroline fosamil, a broad spectrum cephalosporin antibiotic for the treatment of community-acquired pneumonia and complicated skin and skin structure infections].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 56, Issue:7-8, 2011
MRSA new treatments on the horizon: current status.Injury, , Volume: 42 Suppl 5, 2011
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.The Annals of pharmacotherapy, , Volume: 45, Issue:11, 2011
Ceftaroline (Teflaro): a new cephalosporin.The Nurse practitioner, , Volume: 36, Issue:11, 2011
Ceftaroline fosamil: a new broad-spectrum cephalosporin.The Journal of antimicrobial chemotherapy, , Volume: 66 Suppl 3, 2011
Ceftaroline: a comprehensive update.International journal of antimicrobial agents, , Volume: 37, Issue:5, 2011
Ceftaroline fosamil (Teflaro) - a new IV cephalosporin.The Medical letter on drugs and therapeutics, , Jan-24, Volume: 53, Issue:1356, 2011
Ceftaroline fosamil: drug profile and clinical data.Future microbiology, , Volume: 6, Issue:1, 2011
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
The problem of complicated skin and skin structure infections: the need for new agents.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.The Journal of antimicrobial chemotherapy, , Volume: 65 Suppl 4, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-15, Volume: 51, Issue:6, 2010
Ceftaroline for complicated skin and skin-structure infections.Expert opinion on pharmacotherapy, , Volume: 11, Issue:7, 2010
Ceftaroline: a cephalosporin with expanded Gram-positive activity.Future microbiology, , Volume: 4, Issue:1, 2009
Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America - results of AWARE surveillance 2012.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 19, Issue:6
Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 17, Issue:5
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.Diagnostic microbiology and infectious disease, , Volume: 64, Issue:2, 2009
Cefditoren, a new aminothiazolyl cephalosporin.Pharmacotherapy, , Volume: 22, Issue:10, 2002
Oral prodrug enters cephalosporin market.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , Nov-01, Volume: 58, Issue:21, 2001
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing tedJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 28, Issue:9, 2022
Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.International journal of clinical pharmacology and therapeutics, , Volume: 59, Issue:9, 2021
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.The Pediatric infectious disease journal, , 03-01, Volume: 40, Issue:3, 2021
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.Antimicrobial agents and chemotherapy, , 11-17, Volume: 65, Issue:12, 2021
Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections.Expert review of clinical pharmacology, , Volume: 13, Issue:6, 2020
Safety and Tolerability of More than Six Days of Tedizolid Treatment.Antimicrobial agents and chemotherapy, , 06-23, Volume: 64, Issue:7, 2020
Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials.Diagnostic microbiology and infectious disease, , Volume: 94, Issue:3, 2019
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.Drug design, development and therapy, , Volume: 11, 2017
Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity InfectionsJournal of the American Podiatric Medical Association, , Volume: 107, Issue:4, 2017
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 59, Issue:2, 2015
What's new in the treatment of serious MRSA infection?Current opinion in infectious diseases, , Volume: 27, Issue:6, 2014
Tedizolid population pharmacokinetics, exposure response, and target attainment.Antimicrobial agents and chemotherapy, , Volume: 58, Issue:11, 2014
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-02, Volume: 73, Issue:3, 2021
Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity.AAPS PharmSciTech, , Feb-02, Volume: 22, Issue:2, 2021
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.Antimicrobial agents and chemotherapy, , Volume: 63, Issue:7, 2019
Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , Volume: 24, Issue:6, 2018
Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections.Expert opinion on drug safety, , Volume: 17, Issue:4, 2018
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.Antimicrobial agents and chemotherapy, , Volume: 61, Issue:5, 2017
Antibiotics.Nursing, , Volume: 47, Issue:3, 2017
Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.Expert opinion on drug metabolism & toxicology, , Volume: 13, Issue:3, 2017
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled Trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-15, Volume: 64, Issue:2, 2017
Outpatient treatment of acute bacterial skin and skin structure infections (ABSSSI) with tedizolid phosphate and linezolid in patients in the United States: Subgroup analysis of 2 randomized phase 3 trials.Medicine, , Volume: 96, Issue:52, 2017
In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China.Journal of medical microbiology, , Volume: 65, Issue:10, 2016
Clinician-reported lesion measurements in skin infection trials: Definitions, reliability, and association with patient-reported pain.Contemporary clinical trials, , Volume: 50, 2016
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections.Connecticut medicine, , Volume: 80, Issue:3, 2016
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 22 Suppl 2, 2016
Tedizolid for treatment of acute bacterial skin and skin structure infections.Expert review of anti-infective therapy, , Volume: 13, Issue:9, 2015
Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections.The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, , Volume: 30, Issue:7, 2015
Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Oct-15, Volume: 61, Issue:8, 2015
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.Drugs, , Volume: 75, Issue:3, 2015
Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections.Drugs of today (Barcelona, Spain : 1998), , Volume: 50, Issue:11, 2014
Tedizolid population pharmacokinetics, exposure response, and target attainment.Antimicrobial agents and chemotherapy, , Volume: 58, Issue:11, 2014
Two new drugs for skin and skin structure infections.The Medical letter on drugs and therapeutics, , Aug-18, Volume: 56, Issue:1449, 2014
New antibiotics for skin and skin-structure infections.The Lancet. Infectious diseases, , Volume: 14, Issue:8, 2014
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.The Lancet. Infectious diseases, , Volume: 14, Issue:8, 2014
Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study.Surgical infections, , Volume: 15, Issue:2, 2014
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.Drug design, development and therapy, , Volume: 7, 2013
Antibiotics for skin infections: new study design and a step toward shorter course therapy.JAMA, , Feb-13, Volume: 309, Issue:6, 2013
Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.JAMA, , Feb-13, Volume: 309, Issue:6, 2013
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:2, 2011
Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 20, Issue:2
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.Current medical research and opinion, , Volume: 22, Issue:12, 2006
Therapeutic experience with cefdinir in the treatment of uSSSIs.International journal of clinical practice, , Volume: 60, Issue:10, 2006
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?Diagnostic microbiology and infectious disease, , Volume: 55, Issue:4, 2006
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.Diagnostic microbiology and infectious disease, , Volume: 49, Issue:4, 2004
Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections.Cutis, , Volume: 73, Issue:5 Suppl, 2004
Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria.Anaerobe, , Volume: 16, Issue:4, 2010
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated fAntimicrobial agents and chemotherapy, , Volume: 42, Issue:5, 1998
Effective treatment of tinea corporis due to Trichophyton mentagrophytes with combined isoconazole nitrate and diflucortolone valerate therapy.Mycoses, , Volume: 56 Suppl 1, 2013
Inflammatory tinea pedis with bacterial superinfection effectively treated with isoconazole nitrate and diflucortolone valerate combination therapy.Mycoses, , Volume: 56 Suppl 1, 2013
Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids.Mycoses, , Volume: 56 Suppl 1, 2013
The benefits of combination therapy in dermatomycoses.Mycoses, , Volume: 56 Suppl 1, 2013
Paederus dermatitis in Sierra Leone.Dermatology online journal, , Dec-10, Volume: 12, Issue:7, 2006
A Review of Scabies: An Infestation More than Skin Deep.Dermatology (Basel, Switzerland), , Volume: 235, Issue:2, 2019
Ignoring the "Itch": The Global Health Problem of Scabies.The American journal of tropical medicine and hygiene, , Volume: 97, Issue:6, 2017
A case report of crusted scabies in an adult patient with Down syndrome.Dermatology online journal, , Aug-15, Volume: 21, Issue:8, 2015
[Cutaneous myiasis by Cochliomyia hominivorax (Coquerel) (Diptera Calliphoridae) in Hospital Universidad del Norte, Soledad, Atlántico].Biomedica : revista del Instituto Nacional de Salud, , Volume: 29, Issue:1, 2009
Generalised demodicosis in the dog: the unresponsive or recurrent case.Australian veterinary journal, , Volume: 78, Issue:4, 2000
Generalised demodicosis in dogs, clinical perspective.Australian veterinary journal, , Volume: 78, Issue:4, 2000
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Disease-a-month : DM, , Volume: 50, Issue:7, 2004
Novel antibacterial agents for skin and skin structure infections.Journal of the American Academy of Dermatology, , Volume: 50, Issue:3, 2004
Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.Journal of drugs in dermatology : JDD, , Volume: 2, Issue:4, 2003
Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid) in healthy volunteers.Journal of clinical pharmacology, , Volume: 41, Issue:4, 2001
[Superficial pyoderma requiring oral antibiotic therapy: fusidic acid versus pristinamycin]].Presse medicale (Paris, France : 1983), , Mar-03, Volume: 30, Issue:8, 2001
Quinupristin/dalfopristin: a therapeutic review.Clinical therapeutics, , Volume: 23, Issue:1, 2001
Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid) during a worldwide clinical program.Diagnostic microbiology and infectious disease, , Volume: 37, Issue:1, 2000
Optimal treatment of complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 44 Suppl A, 1999
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection GrThe Journal of antimicrobial chemotherapy, , Volume: 44, Issue:2, 1999
[Pristinamycin in the treatment of acute bacterial dermohypodermitis in adults. An open study of 42 patients].Annales de dermatologie et de venereologie, , Volume: 123, Issue:1, 1996
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract.Chemotherapy, , Volume: 51 Suppl 1, 2005
Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin.Journal of the American Academy of Dermatology, , Volume: 37, Issue:3 Pt 1, 1997
Oritavancin versus oral antibiotics for treatment of skin and skin structure infections in the emergency department.The American journal of emergency medicine, , Volume: 60, 2022
Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.PloS one, , Volume: 16, Issue:3, 2021
Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications.Current opinion in infectious diseases, , 04-01, Volume: 34, Issue:2, 2021
In brief: Oritavancin (Kimyrsa) for skin and skin structure infections.The Medical letter on drugs and therapeutics, , 08-23, Volume: 63, Issue:1631, 2021
Treatment of chronic osteomyelitis with multidose oritavancin: A case series and literature review.International journal of antimicrobial agents, , Volume: 53, Issue:4, 2019
Newest lipoglycopeptides for the management of acute bacterial skin and skin structure infections.The Nurse practitioner, , Volume: 43, Issue:10, 2018
Review of oritavancin for the treatment of acute bacterial skin and skin structure infections.Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, , 03-01, Volume: 42, Issue:2, 2018
Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies.Antimicrobial agents and chemotherapy, , Volume: 62, Issue:4, 2018
Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 24, Issue:4, 2018
Antibiotics.Nursing, , Volume: 47, Issue:3, 2017
Managing acute bacterial skin and skin structure infections: Focus on new lipoglycopeptides.The Nurse practitioner, , 05-12, Volume: 42, Issue:5, 2017
Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus.International journal of antimicrobial agents, , Volume: 48, Issue:5, 2016
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections.Connecticut medicine, , Volume: 80, Issue:3, 2016
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 22 Suppl 2, 2016
Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment.Clinical therapeutics, , Volume: 38, Issue:3, 2016
Oritavancin: A Novel Lipoglycopeptide.The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, , Volume: 31, Issue:2, 2016
Economic Impact of Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in the Emergency Department or Observation Setting: Cost Savings Associated with Avoidable Hospitalizations.Clinical therapeutics, , Jan-01, Volume: 38, Issue:1, 2016
Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis.Clinical drug investigation, , Volume: 36, Issue:2, 2016
In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.International journal of antimicrobial agents, , Volume: 46, Issue:6, 2015
Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram-Positive Infections.Pharmacotherapy, , Volume: 35, Issue:10, 2015
Oritavancin: a review in acute bacterial skin and skin structure infections.Drugs, , Volume: 75, Issue:16, 2015
Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis.Current medical research and opinion, , Volume: 31, Issue:8, 2015
Oritavancin: A Long-Half-Life Lipoglycopeptide.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Aug-15, Volume: 61, Issue:4, 2015
Oritavancin for acute bacterial skin and skin structure infections.Expert opinion on pharmacotherapy, , Volume: 16, Issue:7, 2015
Oritavancin, a single-dose, complete regimen, for the treatment of acute bacterial skin and skin structure infections.Expert review of anti-infective therapy, , Volume: 13, Issue:4, 2015
Oritavancin (Orbactiv) for skin and skin structure infections.The Medical letter on drugs and therapeutics, , Jan-05, Volume: 57, Issue:1459, 2015
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).The Journal of antimicrobial chemotherapy, , Volume: 70, Issue:2, 2015
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-15, Volume: 60, Issue:2, 2015
Oritavancin: first global approval.Drugs, , Volume: 74, Issue:15, 2014
What's new in the treatment of serious MRSA infection?Current opinion in infectious diseases, , Volume: 27, Issue:6, 2014
Pharmacology and the treatment of complicated skin and skin-structure infections.The New England journal of medicine, , Jun-05, Volume: 370, Issue:23, 2014
Single-dose oritavancin in the treatment of acute bacterial skin infections.The New England journal of medicine, , Jun-05, Volume: 370, Issue:23, 2014
MRSA new treatments on the horizon: current status.Injury, , Volume: 42 Suppl 5, 2011
Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:7, 2011
Antimicrobial development in the era of emerging resistance.Mini reviews in medicinal chemistry, , Volume: 9, Issue:8, 2009
Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:1, 2005
New antibiotics in the management of acute bacterial skin and skin structure infections.Skin therapy letter, , Volume: 20, Issue:5
A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.Clinical therapeutics, , Volume: 28, Issue:8, 2006
Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.Surgical infections, ,Fall, Volume: 6, Issue:3, 2005
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.Drugs, , Volume: 49 Suppl 2, 1995
Liposomes-in-chitosan hydrogel boosts potential of chlorhexidine in biofilm eradication in vitro.Carbohydrate polymers, , Jun-15, Volume: 262, 2021
Synthesis and Biological Evaluation of Amoxicillin Loaded Hybrid Material Composite Spheres Against Methicillin-Resistant Staphylococcus aureus.Current pharmaceutical biotechnology, , Volume: 22, Issue:5, 2021
Graphene Oxide/Copper Nanoderivatives-Modified Chitosan/Hyaluronic Acid Dressings for Facilitating Wound Healing in Infected Full-Thickness Skin Defects.International journal of nanomedicine, , Volume: 15, 2020
Silver nanoparticles in situ synthesized by polysaccharides from Sanghuangporus sanghuang and composites with chitosan to prepare scaffolds for the regeneration of infected full-thickness skin defects.International journal of biological macromolecules, , Mar-15, Volume: 125, 2019
Exploring chitosan nanoparticles as effective inhibitors of antibiotic resistant skin microorganisms - From in vitro to ex vitro testing.Carbohydrate polymers, , Dec-01, Volume: 201, 2018
pH-triggered charge-reversible of glycol chitosan conjugated carboxyl graphene for enhancing photothermal ablation of focal infection.Acta biomaterialia, , 03-15, Volume: 69, 2018
Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens.The Journal of investigative dermatology, , Volume: 133, Issue:5, 2013
Comparison of bleach, acetic acid, and other topical anti-infective treatments in pediatric atopic dermatitis: A retrospective cohort study on antibiotic exposure.Pediatric dermatology, , Volume: 36, Issue:1, 2019
Antibiotic therapy in the management of atopic dermatitis.Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, , Volume: 150, Issue:3, 2015
Modified Dakin's solution for cutaneous vibrio infections.Annals of plastic surgery, , Volume: 43, Issue:4, 1999
The use of a modified Dakin's solution (sodium hypochlorite) in the treatment of Vibrio vulnificus infection.Wilderness & environmental medicine, ,Spring, Volume: 10, Issue:1, 1999
Loofah sponges as reservoirs and vehicles in the transmission of potentially pathogenic bacterial species to human skin.Journal of clinical microbiology, , Volume: 32, Issue:2, 1994
Cutaneous abscess after Conus textile sting.Journal of travel medicine, , Volume: 18, Issue:3
Disseminated Gonococcal Infection in an Immunosuppressed Patient.The American journal of medicine, , Volume: 134, Issue:2, 2021
A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.BMC pediatrics, , 06-05, Volume: 19, Issue:1, 2019
Case Report of an Anthrax Presentation Relevant to Special Operations Medicine.Journal of special operations medicine : a peer reviewed journal for SOF medical professionals, ,summer, Volume: 16, Issue:2, 2016
Nocardiosis: a 15-year experience in a tertiary medical center in Israel.European journal of internal medicine, , Volume: 24, Issue:6, 2013
Cutaneous gonococcal abscess of the abdomen in a child.Pediatric emergency care, , Volume: 27, Issue:9, 2011
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.International journal of antimicrobial agents, , Volume: 33, Issue:2, 2009
New rash, old foe.The American journal of medicine, , Volume: 121, Issue:3, 2008
Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone.The Journal of antimicrobial chemotherapy, , Volume: 55, Issue:5, 2005
Therapy of Lyme borreliosis in children.Infection, , Volume: 24, Issue:2
Comparative efficacy of ceftriaxone in experimental infections involving Bacteroides fragilis and Escherichia coli.Chemotherapy, , Volume: 39, Issue:5
Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.Expert opinion on pharmacotherapy, , Volume: 18, Issue:10, 2017
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.Infection control and hospital epidemiology, , Volume: 36, Issue:8, 2015
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).Current medical research and opinion, , Volume: 29, Issue:7, 2013
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.The Journal of antimicrobial chemotherapy, , Volume: 66, Issue:11, 2011
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.International journal of antimicrobial agents, , Volume: 26, Issue:5, 2005
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.International journal of antimicrobial agents, , Volume: 23, Issue:3, 2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.The Journal of antimicrobial chemotherapy, , Volume: 53 Suppl 2, 2004
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.Surgical infections, ,Winter, Volume: 3, Issue:4, 2002
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Disease-a-month : DM, , Volume: 50, Issue:7, 2004
Novel antibacterial agents for skin and skin structure infections.Journal of the American Academy of Dermatology, , Volume: 50, Issue:3, 2004
Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.Journal of drugs in dermatology : JDD, , Volume: 2, Issue:4, 2003
Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid) in healthy volunteers.Journal of clinical pharmacology, , Volume: 41, Issue:4, 2001
Quinupristin/dalfopristin: a therapeutic review.Clinical therapeutics, , Volume: 23, Issue:1, 2001
Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid) during a worldwide clinical program.Diagnostic microbiology and infectious disease, , Volume: 37, Issue:1, 2000
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection GrThe Journal of antimicrobial chemotherapy, , Volume: 44, Issue:2, 1999
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Helcobacillus massiliensis gen. nov., sp. nov., a novel representative of the family Dermabacteraceae isolated from a patient with a cutaneous discharge.International journal of systematic and evolutionary microbiology, , Volume: 59, Issue:Pt 9, 2009
Population pharmacokinetic analysis of dalbavancin, a novel lipoglycopeptide.Journal of clinical pharmacology, , Volume: 45, Issue:11, 2005
Immuno-histopathology in the diagnosis of early leprosy.International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, , Volume: 68, Issue:4, 2000
Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin.The British journal of dermatology, , Volume: 171, Issue:6, 2014
Heat-killed Propionibacterium acnes is capable of inducing inflammatory responses in skin.Experimental dermatology, , Volume: 18, Issue:12, 2009
Effects of 2 different anti-tumor necrosis factor-alpha agents in a primate model of subcutaneous abscess formation.The Journal of infectious diseases, , Jan-15, Volume: 185, Issue:2, 2002
Controlled release of tetracycline hydrochloride from poly(ω-pentadecalactone-co-ε-caprolactone)/gelatin nanofibers.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, , Volume: 162, 2021
Characterization of Pathogens Isolated from Cutaneous Abscesses in Patients Evaluated by the Dermatology Service at an Emergency Department.Puerto Rico health sciences journal, , Volume: 39, Issue:3, 2020
In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 25, Issue:3, 2015
Panton-valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:4, 2011
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
Disseminated subcutaneous Mycobacterium fortuitum infection in a dog.Journal of the American Veterinary Medical Association, , Jan-01, Volume: 206, Issue:1, 1995
[Therapy of bacterial skin infections].Zeitschrift fur Haut- und Geschlechtskrankheiten, , Dec-01, Volume: 25, Issue:11, 1958
[Local antibiotic treatment of bacterial skin diseases with the broad spectrum antibiotic hostacyclin (tetracycline Hoechst)].Dermatologische Wochenschrift, , Jun-01, Volume: 135, Issue:22, 1957
[Local treatment of bacterial dermatoses with individually-dosed hostacyclin].Dermatologische Wochenschrift, , Feb-02, Volume: 135, Issue:5, 1957
An outbreak of dermatophilosis and caseous lymphadenitis mixed infection in camels (Camelus dromedaries) in Jordan.Journal of infection in developing countries, , May-31, Volume: 10, Issue:5, 2016
Three eyelid localized cutaneous anthrax cases.Cutaneous and ocular toxicology, , Volume: 33, Issue:4, 2014
Atypical dermatophilosis of sheep in Kenya.Journal of the South African Veterinary Association, , Volume: 78, Issue:3, 2007
Identification and treatment of dermatophilosis in a Cumbrian cattle herd.The Veterinary record, , May-15, Volume: 154, Issue:20, 2004
Isolation of Dermatophilus congolensis from a cat.Journal of veterinary medicine. B, Infectious diseases and veterinary public health, , Volume: 47, Issue:2, 2000
Chemotherapy of dermatophilosis--a preliminary study.Tropical animal health and production, , Volume: 28, Issue:2 Suppl, 1996
Treatment of ovine dermatophilosis with long-acting oxytetracycline or a lincomycin-spectinomycin combination.Australian veterinary journal, , Volume: 72, Issue:6, 1995
[Case of Baker-Rosenbach erysipeloid treated with terramycin].Archivio italiano di dermatologia, sifilografia, e venereologia, , Volume: 28, Issue:6, 1956
[Baker-Rosenbach's erysipeloid and antibiotics; a further case of erysipeloid cured with terramycin].Archivio italiano di dermatologia, sifilografia, e venereologia, , Volume: 26, Issue:5, 1954
[Terramycin treatment of cutaneous anthrax].Srpski arhiv za celokupno lekarstvo, , Volume: 83, Issue:5-6
[Baker-Rosenbach erysipeloid and antibiotics: a case of erysipeloid treated with terramycin].Athena; rassegna mensile di biologia, clinica e terapia, , Volume: 20, Issue:6-7
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline.Pharmacotherapy, , Volume: 41, Issue:11, 2021
Image Gallery: Fish tank granuloma on the face with sporotrichoid cervicofacial lymphadenitis and abscesses due to Mycobacterium marinum infection.The British journal of dermatology, , Volume: 180, Issue:6, 2019
[no title available]BMJ case reports, , Feb-22, Volume: 2018, 2018
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections.Journal of medical microbiology, , Volume: 67, Issue:1, 2018
Minocycline successfully treats exaggerated granulomatous hypersensitivity reaction to Mw immunotherapy.Dermatologic therapy, , Volume: 30, Issue:2, 2017
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.The Journal of antimicrobial chemotherapy, , 10-01, Volume: 72, Issue:10, 2017
Do bacteria isolated from ICU patients 'ESKAPE' antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline.Anaesthesiology intensive therapy, , Volume: 49, Issue:3, 2017
Cutaneous Mycobacterium chelonae in a 95-year-old woman.Dermatology online journal, , Feb-15, Volume: 23, Issue:2, 2017
Antimicrobial activity against a global collection of skin and skin structure pathogens: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2010-2014.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 49, 2016
Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.International journal of antimicrobial agents, , Volume: 46, Issue:3, 2015
Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.Surgical infections, , Volume: 16, Issue:5, 2015
In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007-2012.Diagnostic microbiology and infectious disease, , Volume: 79, Issue:1, 2014
[Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α].Medicina clinica, , Feb-20, Volume: 142, Issue:4, 2014
Tigecycline: an update.Diagnostic microbiology and infectious disease, , Volume: 75, Issue:4, 2013
An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a sThe Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Tigecycline: an antibiotic for the twenty-first century.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital.International journal of clinical practice, , Volume: 67, Issue:6, 2013
Is tigecycline drug of choice for cIAI and cSSTI?International journal of clinical practice, , Volume: 67, Issue:6, 2013
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.BMC infectious diseases, , Nov-12, Volume: 12, 2012
Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities.Chemotherapy, , Volume: 58, Issue:4, 2012
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 56, Issue:11, 2012
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 16, Issue:1, 2012
Maximum growth temperature test for cutaneous Mycobacterium chelonae predicts the efficacy of thermal therapy.The Journal of dermatology, , Volume: 39, Issue:2, 2012
Tigecycline penetration into skin and soft tissue.Surgical infections, , Volume: 12, Issue:6, 2011
Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents.Journal of the American Academy of Dermatology, , Volume: 65, Issue:5, 2011
Antibiotic activity of tigecycline against clinical pathogens by the micro dilution method.Anaerobe, , Volume: 17, Issue:6, 2011
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, , Volume: 44, Issue:2, 2011
Anti-anaerobic activity of serum from patients treated with tigecycline for skin/soft tissue infections.Anaerobe, , Volume: 17, Issue:4, 2011
Lymphocutaneous type of nocardiosis caused by Nocardia vinacea in a patient with polymyositis.Mycopathologia, , Volume: 172, Issue:1, 2011
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:3, 2011
Mycobacterium abscessus infection complicating a professional tattoo.The Australasian journal of dermatology, , Volume: 51, Issue:4, 2010
Cutaneous nocardiosis: report of two cases and review of the literature.International journal of dermatology, , Volume: 49, Issue:12, 2010
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Expert review of anti-infective therapy, , Volume: 8, Issue:9, 2010
[Therapy of SSTI and role of tigecycline].Le infezioni in medicina, , Volume: 17 Suppl 4, 2009
Subcutaneous nodules with sporotrichoid spread.Dermatology online journal, , May-15, Volume: 15, Issue:5, 2009
[Tigecycline: a systematic review of clinical experience during first years of prescription].Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, , Volume: 26, Issue:2, 2009
Tigecycline-induced acute pancreatitis: case report and literature review.International journal of antimicrobial agents, , Volume: 34, Issue:5, 2009
[Tigecycline: antimicrobial action, chemotherapeutic efficacy and adverse reactions].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 54, Issue:1-2, 2009
Application of patient population-derived pharmacokinetic-pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci.Diagnostic microbiology and infectious disease, , Volume: 63, Issue:2, 2009
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints.Diagnostic microbiology and infectious disease, , Volume: 63, Issue:1, 2009
Pharmacodynamic performance of tigecycline versus common intravenous antibiotics for the empiric treatment of complicated skin and skin structure infections.Surgical infections, , Volume: 9, Issue:1, 2008
Mycobacterium mucogenicum: report of a skin infection associated with etanercept.Dermatology online journal, , Jan-15, Volume: 14, Issue:1, 2008
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.Journal of chemotherapy (Florence, Italy), , Volume: 20 Suppl 1, 2008
Establishing the role of tigecycline in an era of antimicrobial resistance.Expert review of anti-infective therapy, , Volume: 6, Issue:5, 2008
Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 12, Issue:3, 2008
Tigecycline pharmacokinetic/pharmacodynamic update.The Journal of antimicrobial chemotherapy, , Volume: 62 Suppl 1, 2008
Tigecycline: a critical update.Journal of chemotherapy (Florence, Italy), , Volume: 20, Issue:4, 2008
Lymphocutaneous type of nocardiosis caused by Nocardia brasiliensis: a case report and review of primary cutaneous nocardiosis caused by N. brasiliensis reported in Japan.The Journal of dermatology, , Volume: 35, Issue:6, 2008
Tigecycline: a new antibiotic.Intensive & critical care nursing, , Volume: 24, Issue:4, 2008
Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections.International journal of antimicrobial agents, , Volume: 30, Issue:6, 2007
Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 11 Suppl 1, 2007
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections.Antimicrobial agents and chemotherapy, , Volume: 51, Issue:6, 2007
New 'superbug' drug launched in the UK.Future microbiology, , Volume: 1, Issue:2, 2006
Tigecycline: a glycylcycline antimicrobial agent.Clinical therapeutics, , Volume: 28, Issue:8, 2006
Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?The Journal of infection, , Volume: 53, Issue:5, 2006
Tigecycline: first of a new class of antimicrobial agents.Pharmacotherapy, , Volume: 26, Issue:8, 2006
An update on tetracyclines.Current opinion in investigational drugs (London, England : 2000), , Volume: 7, Issue:2, 2006
Tigecycline: a novel glycylcycline antibiotic.Expert review of anti-infective therapy, , Volume: 4, Issue:1, 2006
Efficacy of tigecycline in complicated skin and skin structure infections and complicated intra-abdominal infections.Journal of chemotherapy (Florence, Italy), , Volume: 17 Suppl 1, 2005
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:11, 2005
Tigecycline: a review of a new glycylcycline antibiotic.The Journal of dermatological treatment, , Volume: 16, Issue:4, 2005
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).Diagnostic microbiology and infectious disease, , Volume: 52, Issue:3, 2005
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 9, Issue:5, 2005
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 41 Suppl 5, 2005
In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 41 Suppl 5, 2005
Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients.Clinical therapeutics, , Volume: 26, Issue:5, 2004
Why minocycline can cause systemic lupus - a hypothesis and suggestions for therapeutic interventions based on it.Medical hypotheses, , Volume: 63, Issue:1, 2004
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:3, 2004
[Cutaneous nodules to an aquarist].La Revue de medecine interne, , Volume: 24, Issue:5, 2003
Primary cutaneous actinomycosis of the forehead.Journal of the European Academy of Dermatology and Venereology : JEADV, , Volume: 17, Issue:3, 2003
Efficacy of oral minocycline and hyperthermic treatment in a case of atypical mycobacterial skin infection by Mycobacterium marinum.The Journal of dermatology, , Volume: 29, Issue:12, 2002
Mycobacterium marinum with associated bursitis.Journal of cutaneous medicine and surgery, , Volume: 3, Issue:4, 1999
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.Journal of dermatological science, , Volume: 19, Issue:1, 1999
Superficial cutaneous abscess and multiple brain abscesses from Nocardia asteroides in an immunocompetent patient.Journal of the American Academy of Dermatology, , Volume: 39, Issue:5 Pt 1, 1998
A pediatric case of atypical Mycobacterium avium infection of the skin.The Journal of dermatology, , Volume: 25, Issue:6, 1998
Disseminated subcutaneous Nocardia farcinica abscesses in a nephrotic syndrome patient.Journal of the American Academy of Dermatology, , Volume: 38, Issue:5 Pt 2, 1998
Cutaneous disseminated actinomycosis in a patient with acute lymphocytic leukemia.The Journal of dermatology, , Volume: 25, Issue:1, 1998
Infection with methicillin-resistant Staphylococcus aureus after carbon dioxide resurfacing of the face. Successful treatment with minocycline, rifampin, and mupiricin ointment.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], , Volume: 24, Issue:2, 1998
Cutaneous and pulmonary infections caused by Mycobacterium vaccae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 23, Issue:1, 1996
Primary cutaneous nocardiosis caused by Nocardia otitidiscaviarum: two cases and a review of the literature.The Journal of tropical medicine and hygiene, , Volume: 98, Issue:6, 1995
Mycobacterium marinum skin infections. Report of 31 cases and review of the literature.Archives of internal medicine, , Jun-27, Volume: 154, Issue:12, 1994
[Mycobacterium kansasii cutaneous infection].Annales de dermatologie et de venereologie, , Volume: 120, Issue:4, 1993
Extending the phenotypic spectrum of keratitis-ichthyosis-deafness syndrome: report of a patient with GJB2 (G12R) Connexin 26 mutation and unusual clinical findings.Pediatric dermatology, , Volume: 29, Issue:3
Aquarium-borne Mycobacterium marinum skin infection. Report of 15 cases and review of the literature.European journal of dermatology : EJD, , Volume: 23, Issue:4
Influence of age on the clinical efficacy of tigecycline in severely ill patients.Journal of global antimicrobial resistance, , Volume: 18, 2019
[no title available]BMJ case reports, , Feb-22, Volume: 2018, 2018
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections.Journal of medical microbiology, , Volume: 67, Issue:1, 2018
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.The Journal of antimicrobial chemotherapy, , 10-01, Volume: 72, Issue:10, 2017
Do bacteria isolated from ICU patients 'ESKAPE' antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline.Anaesthesiology intensive therapy, , Volume: 49, Issue:3, 2017
Antimicrobial activity against a global collection of skin and skin structure pathogens: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2010-2014.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 49, 2016
Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.International journal of antimicrobial agents, , Volume: 46, Issue:3, 2015
Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.Surgical infections, , Volume: 16, Issue:5, 2015
In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007-2012.Diagnostic microbiology and infectious disease, , Volume: 79, Issue:1, 2014
[Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α].Medicina clinica, , Feb-20, Volume: 142, Issue:4, 2014
Tigecycline: an update.Diagnostic microbiology and infectious disease, , Volume: 75, Issue:4, 2013
An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a sThe Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Tigecycline: an antibiotic for the twenty-first century.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.The Journal of antimicrobial chemotherapy, , Volume: 68 Suppl 2, 2013
Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital.International journal of clinical practice, , Volume: 67, Issue:6, 2013
Is tigecycline drug of choice for cIAI and cSSTI?International journal of clinical practice, , Volume: 67, Issue:6, 2013
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.BMC infectious diseases, , Nov-12, Volume: 12, 2012
Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities.Chemotherapy, , Volume: 58, Issue:4, 2012
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 16, Issue:1, 2012
Tigecycline penetration into skin and soft tissue.Surgical infections, , Volume: 12, Issue:6, 2011
Antibiotic activity of tigecycline against clinical pathogens by the micro dilution method.Anaerobe, , Volume: 17, Issue:6, 2011
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, , Volume: 44, Issue:2, 2011
Anti-anaerobic activity of serum from patients treated with tigecycline for skin/soft tissue infections.Anaerobe, , Volume: 17, Issue:4, 2011
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.Antimicrobial agents and chemotherapy, , Volume: 55, Issue:3, 2011
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Expert review of anti-infective therapy, , Volume: 8, Issue:9, 2010
[Therapy of SSTI and role of tigecycline].Le infezioni in medicina, , Volume: 17 Suppl 4, 2009
[Tigecycline: a systematic review of clinical experience during first years of prescription].Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, , Volume: 26, Issue:2, 2009
Tigecycline-induced acute pancreatitis: case report and literature review.International journal of antimicrobial agents, , Volume: 34, Issue:5, 2009
[Tigecycline: antimicrobial action, chemotherapeutic efficacy and adverse reactions].Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], , Volume: 54, Issue:1-2, 2009
Application of patient population-derived pharmacokinetic-pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci.Diagnostic microbiology and infectious disease, , Volume: 63, Issue:2, 2009
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints.Diagnostic microbiology and infectious disease, , Volume: 63, Issue:1, 2009
Pharmacodynamic performance of tigecycline versus common intravenous antibiotics for the empiric treatment of complicated skin and skin structure infections.Surgical infections, , Volume: 9, Issue:1, 2008
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.Journal of chemotherapy (Florence, Italy), , Volume: 20 Suppl 1, 2008
Establishing the role of tigecycline in an era of antimicrobial resistance.Expert review of anti-infective therapy, , Volume: 6, Issue:5, 2008
Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, , Volume: 12, Issue:3, 2008
Tigecycline pharmacokinetic/pharmacodynamic update.The Journal of antimicrobial chemotherapy, , Volume: 62 Suppl 1, 2008
Tigecycline: a critical update.Journal of chemotherapy (Florence, Italy), , Volume: 20, Issue:4, 2008
Tigecycline: a new antibiotic.Intensive & critical care nursing, , Volume: 24, Issue:4, 2008
Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections.International journal of antimicrobial agents, , Volume: 30, Issue:6, 2007
Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 11 Suppl 1, 2007
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections.Antimicrobial agents and chemotherapy, , Volume: 51, Issue:6, 2007
New 'superbug' drug launched in the UK.Future microbiology, , Volume: 1, Issue:2, 2006
Tigecycline: a glycylcycline antimicrobial agent.Clinical therapeutics, , Volume: 28, Issue:8, 2006
Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?The Journal of infection, , Volume: 53, Issue:5, 2006
Tigecycline: first of a new class of antimicrobial agents.Pharmacotherapy, , Volume: 26, Issue:8, 2006
An update on tetracyclines.Current opinion in investigational drugs (London, England : 2000), , Volume: 7, Issue:2, 2006
Tigecycline: a novel glycylcycline antibiotic.Expert review of anti-infective therapy, , Volume: 4, Issue:1, 2006
Efficacy of tigecycline in complicated skin and skin structure infections and complicated intra-abdominal infections.Journal of chemotherapy (Florence, Italy), , Volume: 17 Suppl 1, 2005
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:11, 2005
Tigecycline: a review of a new glycylcycline antibiotic.The Journal of dermatological treatment, , Volume: 16, Issue:4, 2005
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).Diagnostic microbiology and infectious disease, , Volume: 52, Issue:3, 2005
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 9, Issue:5, 2005
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 41 Suppl 5, 2005
In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-01, Volume: 41 Suppl 5, 2005
Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients.Clinical therapeutics, , Volume: 26, Issue:5, 2004
Lymphocutaneous nocardiosis in a kidney transplant patient successfully treated with tigecycline.Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, , Volume: 29, Issue:5
Tigecycline-Associated Acute Pancreatitis.American journal of therapeutics, , Volume: 25, Issue:6
Omadacycline in treating community-based infections: a review and expert perspective.Expert review of anti-infective therapy, , Volume: 21, Issue:3, 2023
Omadacycline in Skin Infections and Pneumonia: A Review of the Evidence.The Journal of family practice, , Volume: 71, Issue:5 Suppl, 2022
Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection.Clinical drug investigation, , Volume: 42, Issue:3, 2022
Linezolid versus omadacycline in diabetic soft tissue infections: a signal of different adjunctive immunological properties?The Journal of antimicrobial chemotherapy, , 05-29, Volume: 77, Issue:6, 2022
Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections.The Journal of antimicrobial chemotherapy, , 04-13, Volume: 76, Issue:5, 2021
Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment.International journal of antimicrobial agents, , Volume: 57, Issue:2, 2021
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline.Pharmacotherapy, , Volume: 41, Issue:11, 2021
Omadacycline: a therapeutic review of use in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Future microbiology, , Volume: 15, 2020
Omadacycline for Acute Bacterial Skin and Skin Structure Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-01, Volume: 69, Issue:Suppl 1, 2019
An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 08-01, Volume: 69, Issue:Suppl 1, 2019
Omadacycline (Nuzyra)--a new tetracycline antibiotic.The Medical letter on drugs and therapeutics, , May-20, Volume: 61, Issue:1572, 2019
Omadacycline: A New Tetracycline Antibiotic.The Annals of pharmacotherapy, , Volume: 53, Issue:5, 2019
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections.The New England journal of medicine, , 02-07, Volume: 380, Issue:6, 2019
Enriching the antibiotic armamentarium for acute bacterial skin and skin structure infections.The Lancet. Infectious diseases, , Volume: 19, Issue:10, 2019
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.The Lancet. Infectious diseases, , Volume: 19, Issue:10, 2019
Omadacycline: First Global Approval.Drugs, , Volume: 78, Issue:18, 2018
Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.Future microbiology, , Volume: 11, 2016
The value of procalcitonin measurement in localized skin and skin structure infection, diabetic foot infections, septic arthritis and osteomyelitis.Expert review of molecular diagnostics, , Volume: 14, Issue:1, 2014
Correlation of serum procalcitonin with the severity of skin and skin structure infections - a pilot study.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, , Volume: 10, Issue:8, 2012
Incorporation of a Theranostic "Two-Tone" Luminescent Silver Complex into Biocompatible Agar Hydrogel Composite for the Eradication of ESKAPE Pathogens in a Skin and Soft Tissue Infection Model.Inorganic chemistry, , Jun-04, Volume: 57, Issue:11, 2018
New insights on the antibacterial efficacy of miconazole in vitro.Mycoses, , Volume: 60, Issue:8, 2017
An in vitro model for studying the effect of the subcutaneous tunnel and the skin exit site on the accuracy of central venous catheter tip cultures.The Journal of burn care & rehabilitation, , Volume: 13, Issue:6
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI.International journal of antimicrobial agents, , Volume: 61, Issue:4, 2023
The Efficacy and Safety of High-dose Daptomycin in the Treatment of Complicated Skin and Soft Tissue Infections in Asians.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 95, 2020
Determination of daptomycin in human plasma and breast milk by UPLC/MS-MS.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, , May-15, Volume: 1116, 2019
Daptomycin for Complicated Skin Infections: A Randomized Trial.Pediatrics, , Volume: 139, Issue:3, 2017
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.BMC infectious diseases, , 01-07, Volume: 17, Issue:1, 2017
Towards a definition of daptomycin optimal dose: Lessons learned from experimental and clinical data.International journal of antimicrobial agents, , Volume: 47, Issue:1, 2016
Use of Daptomycin in Critically Ill Children With Bloodstream Infections and Complicated Skin and Soft-tissue Infections.The Pediatric infectious disease journal, , Volume: 35, Issue:2, 2016
In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.International journal of antimicrobial agents, , Volume: 46, Issue:6, 2015
Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Sep-15, Volume: 61 Suppl 2, 2015
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.Advances in therapy, , Volume: 32, Issue:6, 2015
Daptomycin-induced hyperkalemia in a patient with normal renal function.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , Dec-15, Volume: 71, Issue:24, 2014
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.Journal of medical economics, , Volume: 17, Issue:10, 2014
The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials.BMJ open, , Jun-24, Volume: 4, Issue:6, 2014
Acute focal bacterial nephritis due to methicillin-resistant Staphylococcus aureus in an immunocompetent adult.Infection, , Volume: 42, Issue:2, 2014
Daptomycin: the role of high-dose and combination therapy for Gram-positive infections.International journal of antimicrobial agents, , Volume: 42, Issue:3, 2013
Effectiveness and safety of daptomycin in complicated skin and soft-tissue infections and bacteraemia in clinical practice: results of a large non-interventional study.International journal of antimicrobial agents, , Volume: 41, Issue:4, 2013
[Daptomycin in complicated skin and soft tissue infections].Enfermedades infecciosas y microbiologia clinica, , Volume: 30 Suppl 1, 2012
Daptomycin: evaluation of a high-dose treatment strategy.International journal of antimicrobial agents, , Volume: 38, Issue:3, 2011
Prospective, non-comparative study of daptomycin for the treatment of superficial and deep incisional surgical site infections.Surgical infections, , Volume: 12, Issue:2, 2011
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Expert review of anti-infective therapy, , Volume: 8, Issue:9, 2010
Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Jan-01, Volume: 50 Suppl 1, 2010
Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis.The Annals of pharmacotherapy, , Volume: 44, Issue:1, 2010
[Therapy of SSTI and role of tigecycline].Le infezioni in medicina, , Volume: 17 Suppl 4, 2009
In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.Diagnostic microbiology and infectious disease, , Volume: 65, Issue:2, 2009
Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.The Annals of pharmacotherapy, , Volume: 43, Issue:7, 2009
Future directions with daptomycin.The Journal of antimicrobial chemotherapy, , Volume: 62 Suppl 3, 2008
When less is more: high-dose, short duration regimens and antibiotic resistance.International journal of clinical practice, , Volume: 62, Issue:9, 2008
A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.International journal of clinical practice, , Volume: 62, Issue:9, 2008
Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin.The American journal of medicine, , Volume: 120, Issue:10 Suppl 1, 2007
Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.Drugs, , Volume: 67, Issue:10, 2007
Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria.Future microbiology, , Volume: 1, Issue:3, 2006
Management of cSSTIs: the role of daptomycin.Current medical research and opinion, , Volume: 22, Issue:11, 2006
[Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections].Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, , Sep-21, Volume: 126, Issue:18, 2006
Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.International journal of clinical practice, , Volume: 60, Issue:3, 2006
Antimicrobial update: Daptomycin.The Pediatric infectious disease journal, , Volume: 24, Issue:10, 2005
Daptomycin: a cyclic lipopeptide antimicrobial agent.Clinical therapeutics, , Volume: 26, Issue:11, 2004
Daptomycin: overview of an innovative antibiotic.South Dakota journal of medicine, , Volume: 57, Issue:10, 2004
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Disease-a-month : DM, , Volume: 50, Issue:7, 2004
Novel antibacterial agents for skin and skin structure infections.Journal of the American Academy of Dermatology, , Volume: 50, Issue:3, 2004
Daptomycin.Drugs, , Volume: 64, Issue:4, 2004
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Clinicopathological and radiographic features in 40 cats diagnosed with pulmonary and cutaneous Journal of feline medicine and surgery, , Volume: 22, Issue:8, 2020
Travel-related Streptococcal toxic shock syndrome caused by emm type 78 Streptococcus pyogenes.Journal of clinical microbiology, , Volume: 49, Issue:8, 2011
Focal non-typhoidal Salmonella infections from a single center in Malaysia.The Southeast Asian journal of tropical medicine and public health, , Volume: 36, Issue:3, 2005
Identification of Neisseria gonorrhoeae as the causative agent in a case of culture-negative dermatitis-arthritis syndrome using real-time PCR.Journal of travel medicine, , Volume: 15, Issue:5
Inactivation of cyclic Di-GMP binding protein TDE0214 affects the motility, biofilm formation, and virulence of Treponema denticola.Journal of bacteriology, , Volume: 195, Issue:17, 2013
Effect of exogenous nitric oxide on murine immune response induced by Aggregatibacter actinomycetemcomitans lipopolysaccharide.Journal of periodontal research, , Volume: 44, Issue:4, 2009
Mycobacterium marinum: A brief update for clinical purposes.European journal of internal medicine, , Volume: 105, 2022
Image Gallery: Fish tank granuloma on the face with sporotrichoid cervicofacial lymphadenitis and abscesses due to Mycobacterium marinum infection.The British journal of dermatology, , Volume: 180, Issue:6, 2019
A case of cutaneous nodules in a sporotrichoid pattern.Dermatology online journal, , Mar-15, Volume: 25, Issue:3, 2019
Mycobacterium marinum infections in Denmark from 2004 to 2017: A retrospective study of incidence, patient characteristics, treatment regimens and outcome.Scientific reports, , 04-30, Volume: 8, Issue:1, 2018
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.Journal of clinical microbiology, , Volume: 56, Issue:4, 2018
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections.Journal of medical microbiology, , Volume: 67, Issue:1, 2018
Image Gallery: Cutaneous botryomycosis at an unusual site in an immunocompetent patient.The British journal of dermatology, , Volume: 176, Issue:1, 2017
Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 62, 2017
Cutaneous Mycobacterium intracellulare infection in an immuno-competent person.Acta dermato-venereologica, , Volume: 93, Issue:6, 2013
Anaplastic large cell lymphoma and lepromatous leprosy: a rare coexistence.Leprosy review, , Volume: 83, Issue:1, 2012
A case of leprosy mistaken for cutaneous sarcoidosis.Acta dermato-venereologica, , Volume: 92, Issue:2, 2012
Buruli ulcer in an 18-day-old baby.Tropical doctor, , Volume: 42, Issue:1, 2012
An unusual presentation of primary cutaneous nocardiosis at a rare site: succesful treatment with a modified Welsh regimen.Dermatology online journal, , Dec-15, Volume: 17, Issue:12, 2011
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.Emerging infectious diseases, , Volume: 17, Issue:9, 2011
Granulomatous lesion on the face successfully treated with antitubercular therapy.Dermatology online journal, , Sep-15, Volume: 16, Issue:9, 2010
Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.Journal of Korean medical science, , Volume: 25, Issue:2, 2010
"MAC" attack.The American journal of medicine, , Volume: 122, Issue:12, 2009
Question: Can you identify this condition? Tuberculoid leprosy.Canadian family physician Medecin de famille canadien, , Volume: 55, Issue:1, 2009
International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.Tropical medicine & international health : TM & IH, , Volume: 13, Issue:5, 2008
Central nervous system infection and cutaneous lymphadenitis due to Mycobacterium kansasii in an immunocompetent patient.Infection, , Volume: 35, Issue:4, 2007
Mycobacterium marinum infection: a case report and review of the literature.Cutis, , Volume: 79, Issue:1, 2007
A cutaneous cyst caused by brucellosis with a negative serological test.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, , Volume: 11, Issue:1, 2007
Case report of non-healing wounds presenting to a DGH, South East London.Emergency medicine journal : EMJ, , Volume: 23, Issue:8, 2006
Mycobacterium avium infection involving skin and soft tissue of the hand treated by radical debridement and reconstruction in addition to multidrug chemotherapy.Journal of hand surgery (Edinburgh, Scotland), , Volume: 31, Issue:6, 2006
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.Antimicrobial agents and chemotherapy, , Volume: 49, Issue:8, 2005
Buruli ulcer recurrence, Benin.Emerging infectious diseases, , Volume: 11, Issue:4, 2005
[Cutaneous infection with Mycobacterium marinum. successful therapy with rifampicin and clarithromycin].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, , Volume: 55, Issue:1, 2004
[Cutaneous nodules to an aquarist].La Revue de medecine interne, , Volume: 24, Issue:5, 2003
Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene.International journal of dermatology, , Volume: 40, Issue:8, 2001
Skin disease and nontuberculous atypical mycobacteria.International journal of dermatology, , Volume: 39, Issue:9, 2000
[Cutaneous nodular infection with hemopathy].Annales de pathologie, , Volume: 20, Issue:4, 2000
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.The American journal of tropical medicine and hygiene, , Volume: 61, Issue:5, 1999
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum].Deutsche medizinische Wochenschrift (1946), , Oct-15, Volume: 124, Issue:41, 1999
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.Transplant international : official journal of the European Society for Organ Transplantation, , Volume: 12, Issue:1, 1999
Infection with methicillin-resistant Staphylococcus aureus after carbon dioxide resurfacing of the face. Successful treatment with minocycline, rifampin, and mupiricin ointment.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], , Volume: 24, Issue:2, 1998
Emergence of leprosy in a patient with mycosis fungoides.Journal of the American Academy of Dermatology, , Volume: 30, Issue:2 Pt 2, 1994
Mycobacterium marinum skin infections. Report of 31 cases and review of the literature.Archives of internal medicine, , Jun-27, Volume: 154, Issue:12, 1994
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Volume: 16, Issue:4, 1993
A case of disseminated Mycobacterium marinum infection in an immunocompetent patient.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 11, Issue:10, 1992
Rifampin in dermatology.Clinics in dermatology, , Volume: 21, Issue:1
Aquarium-borne Mycobacterium marinum skin infection. Report of 15 cases and review of the literature.European journal of dermatology : EJD, , Volume: 23, Issue:4
[Tuberculosis of the breast].Biomedica : revista del Instituto Nacional de Salud, , Volume: 33, Issue:1
Efficacy and safety of ceftobiprole in patients aged 65 years or older: a Future microbiology, , Volume: 16, 2021
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 10-05, Volume: 73, Issue:7, 2021
Possible clinical indications of ceftobiprole.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, , Volume: 32 Suppl 3, 2019
What's new in the treatment of serious MRSA infection?Current opinion in infectious diseases, , Volume: 27, Issue:6, 2014
Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.Expert review of anti-infective therapy, , Volume: 7, Issue:7, 2009
Antimicrobial development in the era of emerging resistance.Mini reviews in medicinal chemistry, , Volume: 9, Issue:8, 2009
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.Diagnostic microbiology and infectious disease, , Volume: 61, Issue:1, 2008
Pharmacokinetic and pharmacodynamic profile of ceftobiprole.Diagnostic microbiology and infectious disease, , Volume: 61, Issue:1, 2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:9, 2008
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:1, 2008
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , Volume: 13 Suppl 2, 2007
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , Mar-01, Volume: 46, Issue:5, 2008
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.Antimicrobial agents and chemotherapy, , Volume: 52, Issue:1, 2008
Case Report of an Anthrax Presentation Relevant to Special Operations Medicine.Journal of special operations medicine : a peer reviewed journal for SOF medical professionals, ,summer, Volume: 16, Issue:2, 2016
Periocular cutaneous anthrax in Jimma Zone, Southwest Ethiopia: a case series.BMC research notes, , Aug-07, Volume: 6, 2013
Evaluation of cutaneous palpebral anthrax.Cutaneous and ocular toxicology, , Volume: 32, Issue:4, 2013
Infections and some other conditions affecting the skin and subcutis of the naso-ocular region of cats--clinical experience 1987-2003.Journal of feline medicine and surgery, , Volume: 6, Issue:6, 2004
Protein Targets (0)